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ABSTRACT 
 
Plant secretory peroxidases are important commercial enzymes and play a central role in 
plant stress responses. The focus of this work is a unique peroxidase from the leaves of a cold 
tolerant palm, Trachycarpus fortunei, (i.e., windmill palm tree). Like other palm tree 
peroxidases, windmill palm tree peroxidase is stable at high temperatures and in the presence of 
denaturants. It is distinct from other palm tree peroxidases in its substrate specificity. The amino 
acid sequence and glycosylation had not been determined. Because glycosylation is known to 
play a critical role in plant peroxidase stability and activity, this knowledge is essential for 
structure activity studies, selection of an expression system for enzyme production, and 
engineering the enzyme. Glycosylation is a complex modification that is difficult to study; 
furthermore, there is a lack of analytical tools for characterizing plant glycoproteins. The 
complete amino acid sequence was determined using cDNA sequencing and biological mass 
spectrometry. The mature amino acid sequence is 306 residues in length. The presence of a C-
terminal signal peptide predicts vacuolar targeting of the enzyme. Native windmill palm tree 
peroxidase was analyzed at the glycopeptide level to give a qualitative and quantitative 
assessment of glycosylation at each site. Windmill palm tree peroxidase has 13 sites for N-linked 
glycosylation, 2 of which are unique. Each site is at least partially occupied by a glycan. Major 
glycans are paucimannosidic, which supports the assignment of windmill palm tree peroxidase as 
a vacuolar peroxidase. To carry-out this work, a workflow for analyzing the glycopeptide mass 
spectrometry data was developed. Included in the workflow are novel tools for glycan database 
construction, pGlycoFilter, and validation of glycopeptide assignment, gPSMvalidator. New 
analytical methods are needed for the emerging field of plant glycoproteomics. The novel 
 vi 
 
methods developed in this dissertation will be useful for the study of other important plant 
glycoproteins. This knowledge can be used to study the roles of glycosylation in this 
exceptionally stable and unique palm peroxidase. 
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CHAPTER 1. INTRODUCTION 
 
BACKGROUND 
Peroxidases are important enzymes. Plant secretory peroxidases are stress responsive 
enzymes and are central to a plant’s ability to adapt and survive (Zipor and Oren-Shamir 2013). 
There can be as many as 70 different isoforms of peroxidases in a single plant species (Welinder 
et al., 2002). Peroxidases are involved in myriad processes including cell wall synthesis and 
responses to abiotic and biotic stresses, such as synthesis and degradation of UV absorbing 
compounds and synthesis of anti-microbial compounds (Takahama 2004; Zipor and Oren-Shamir 
2013). The precise in vivo mechanism of the different peroxidase isoforms is unclear for the most 
part. A recent study identified a single vacuolar peroxidase involved in pigment metabolism 
(Zipor et al., 2015). An additional level of complexity stems from the fact that they are 
glycoproteins. Glycoproteins generally exist as a population of glycosylation variants (i.e., 
glycoforms), and this is true for plant secretory peroxidases (Yang et al., 1996; Zhang et al., 
2004; Gray and Montgomery 2006). The role of plant peroxidase glycoforms remains obscure. 
There are many biotechnological uses for plant peroxidases making them highly valued 
commercial enzymes (Regaldo et al., 2004). The major use is in biosensors. A biosensor is a 
generic term for an analytical device that uses a biological component, such as an enzyme, to 
‘sense’ or detect a target substance. Sensitive and quantitative detection of a broad range of 
organic molecules have made peroxidase-based biosensors useful in agricultural, biomedical, and 
environmental diagnostics (Farré et al., 2007). Peroxidases can be used for ‘green’ 
environmentally safe synthesis of useful polymers and nano-materials (Sakharov et al., 2003). 
They can also be used for bioremediation of industrial wastewater containing toxic pollutants 
such as phenols and cresols (Klibanov et al., 1983). Commercially available peroxidase is mostly 
limited to horseradish peroxidase (HRP), which is isolated and purified from the roots of the 
horse-radish plant Armoracia rusticana. Peroxidases expressed in alternative expression systems 
such as the yeast Pichia pastoris have instability problems associated with non-native 
glycosylation (Capone et al., 2014; Krainer et al., 2014). 
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Palm tree peroxidases are an alternative to HRP. Anionic peroxidases purified 
from palm tree leaves possess high stability and have excellent catalytic properties (Sakharov 
2004). Palm peroxidase-based biosensors were more stable and could tolerate higher 
concentrations of H2O2 (Alpeeva et al., 2005). The exceptional stability of palm peroxidases at 
acidic pH met the requirement for synthesis of conductive and chiral polymers under mild 
conditions (Sakharov et al., 2003; Caramyshev et al., 2007). 
Windmill palm tree peroxidase. The windmill palm tree Trachycarpus fortunei is 
the source of windmill palm tree peroxidase (WPTP) (Caramyshev et al., 2006). Like other palm 
peroxidases, WPTP is unusually stable and has uncommon substrate specificity, making it 
attractive for industrial applications. WPTP retained catalytic activity after incubation for 1 hour 
at up to 80 °C, pH 7.5, but under acidic conditions had lower stability. In high concentrations of 
the denaturant guanidine (up to 4 M), WPTP maintained 100% activity toward o-dianisidine. 
Interestingly, in just 1 M guanidine, there was 70% inactivation when 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS) was the substrate. 
WPTP had a heme group like other peroxidases, and it uniquely contained 6.5 Ca
2+
 ions 
per protein, whereas most plant peroxidases, including HRP, contain only 2 Ca
2+
 (Gajhede et al., 
1997). WPTP is an anionic peroxidase with a pI of 3.5. Its molecular weight, as measured by 
SDS-PAGE was 50 kDa. Class III peroxidases are typically 300 amino acids in length with an 
estimated polypeptide molecular weight (MW) of 32 kDa (Veitch 2004); therefore, WPTP is 
probably highly glycosylated. 
 
PURPOSE 
The purpose of this study is to characterize the structure of WPTP, including the amino acid 
sequence and glycosylation. The methods developed herein will allow for structure 
determination of WPTP and will contribute methodologies needed for study of other plant 
glycoproteins. 
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OBJECTIVES 
1. Determine the amino acid sequence of windmill palm tree peroxidase 
2. Develop tools and a workflow for analysis of windmill palm tree peroxidase glycopeptide 
mass spectrometry data 
3. Determine the site-specific glycosylation and microheterogeneity of windmill palm tree 
peroxidase 
 
RATIONALE 
Objective 1. The amino acid sequence of a protein gives the primary information about 
the protein and is requisite to studying the structure further. The first 20 amino acids were 
determined by Caramyshev et al. (2006) using Edman Degradation. The sequence was 
determined to be DLQIGFYXQSXPSAESLVXQ; where each letter corresponds to an amino 
acid residue and X corresponds to an indeterminable residue. This reveals the main limitation of 
this method- amino acid residues containing modifications, including post-translational 
modifications, cannot be determined. We decided to take an approach that combined gene 
cloning and mass spectrometry. These two methods provide complementary information as well 
as confirmation of the results. These data would give the necessary information for gene 
expression and would also enable selection of a model protein with which WPTP could be 
compared. Objective 1 is discussed in Chapter 2. 
Objective 2. Mass spectrometry was selected as the main analytical tool for determining 
the glycosylation of WPTP. Characterization of glycosylation involves identifying the glycans 
attached to each N-glycosylation site and their relative abundance. A glycan is defined as a 
compound containing monosaccharides joined by glycosidic bonds. Analysis of the mass 
spectrometry data was the biggest hurdle encountered in the course of this dissertation. Most of 
the published studies did not give a detailed description of how the data in the study were 
analyzed; a problem noted in a recent review (Desaire 2013). Another notable challenge was that 
most of the available software were designed for analysis of mammalian protein glycosylation. 
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Software were often linked to mammalian glycan databases. Mammalian glycans have 
significantly different structures from plant glycans. 
The analytical challenges associated with studying glycoproteins result from the fact that 
the peptide is attached a branched polymer, the structure of which is assembled in a non-template 
driven process. The process depends on several factors including protein-protein interactions 
between the target and glycosylation enzymes, availability of the sugar nucleotide building 
blocks, number and distribution of the glycosylation enzymes, and protein residence time in the 
Golgi apparatus and its final destination (i.e., the apoplast or vacuole for plant glycoproteins). 
The interplay of these various factors ultimately leads to a heterogeneous population of glycans 
attached to each glycosylation site. 
The process of N-glycosylation begins with the targeting of proteins containing an N-
terminal signal peptide to the secretory pathway (Stanley et al., 2009). This signals the nascent 
polypeptide to be introduced into the lumen of the endoplasmic reticulum (ER). If the sequence 
Asn-Xxx-Ser/Thr, where Xxx is not Pro, is encountered, it may be recognized by the 
oligosaccharyltransferase (OST) complex and have a bulky glycan attached. Local amino acid 
sequence will affect the efficiency of glycosylation at that site (Petrescu et al., 2004). Subsequent 
secretion to the Golgi puts the glycoprotein in contact with glycosidases and glycosyltransferases 
which participate in a process called ‘maturation.’ Maturation enzymes are also not 100% 
efficient. Glycans are then trimmed after being exported to the extracellular matrix or the 
vacuole (Rayon et al., 1998). Therefore, a single glycoprotein exists as a population of different 
‘glycoforms’, i.e., the same polypeptide with different glycosylation. The presence of different 
glycans at one site is termed microheterogeneity. This can be a mechanism that evolved to add a 
level of fine-tuning that can be used to the advantage of the organism. A detailed description of 
the plant N-glycan biosynthesis pathway is presented in Appendix D. 
The ER portion of the N-glycan biosynthesis pathway is conserved among plants and 
animals, but significantly differs in the subsequent maturation steps carried out in the Golgi and 
post-Golgi (Stanley et al., 2009; Gomord et al., 2010). Plant glycoprotein N-linked glycans have 
several distinct characteristics: 1) fewer branches, 2) absence of sialylation, and 3) presence of 
 5 
 
xylosylation and α(13)-fucosylation as opposed to α(16)-fucosylation (Johnson and 
Chrispeels, 1987; Tezuka et al., 1992). 
Plant glycoproteomics is a growing field and there is a demand for analytical methods 
(Strasser 2014). Some workflows/reviews have been published (Song et al., 2011; Zhang et al., 
2011). One of the main problems with software for glycopeptide mass spectrometry data 
interpretation is the fact that most were developed with mammalian glycans in mind. Scoring in 
some cases depends on mammalian glycan-specific fragmentation. Importantly, glycan databases 
and prediction algorithms did not contain plant glycan-specific features. The tools and workflow 
developed for analysis of WPTP glycosylation data are presented in Chapter 3. 
Objective 3. Glycosylation may play an important role in WPTP. Partial 
deglycosylation of peroxidases results in decreased stability (Tams and Welinder, 1998; Lige et 
al., 2001) and lower rates of catalysis (Lige et al., 2001; Nielsen et al., 2001). A decrease in 
specific activity of a peroxidase from avocado was correlated with the loss of ability to chelate 
calcium ions (Sánchez-Romero et al., 1994). Considering that WPTP contains 6.5 Ca
2+
 per 
peroxidase molecule, this may be of considerable importance. Further investigations into the 
molecular basis of glycan contribution are needed. 
A major motivation of this dissertation is that palm peroxidases would be good models 
for studying roles of glycosylation. The X-ray crystal structure of native, highly glycosylated 
royal palm tree peroxidase (RPTP) was recently solved (Watanabe et al., 2010). At the time of 
proof-reading this dissertation, the X-ray crystal structure of native Chamerops excelsa 
peroxidase (CEP) was reported (Bernardes et al., 2015). Probing the differences between WPTP, 
CEP, and RPTP will give insights into specific stabilizing roles of glycosylation. The 
microheterogeneity and site-specific glycosylation of WPTP are presented in Chapter 3. 
Appendices. The workflow developed for objective 2 is described in detail in 
Appendix A. The configurations for proteomics software are in Appendix B. A thorough review 
of the known plant glycan biosynthesis pathway is presented in Appendix C. It was necessary for 
development of a novel plant glycan database generation tool, pGlycoFilter. A description of all 
of the supplementary data is given in Appendix D. 
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Additionally, I developed a method called ‘freebase guanidination.’ It was originally 
intended to be used in structure characterization of WPTP, but in the end was not used. 
Accordingly, the reprint of this publication is attached in Appendix E. During the course of 
learning mass spectrometry, I collaborated with another laboratory and studied cone snail 
peptides. The reprints of these publications are in Appendices F-I. 
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CHAPTER 2. AMINO ACID SEQUENCE OF ANIONIC PEROXIDASE 
FROM THE WINDMILL PALM TREE TRACHYCARPUS FORTUNEI1 
 
INTRODUCTION 
Plant secretory peroxidases (class III peroxidases; EC 1.11.1.7) are ubiquitous in nature. 
They are extracellular or vacuolar glycoproteins and catalyze redox reactions that facilitate a 
myriad of biological processes including cell wall synthesis and response to abiotic and biotic 
stresses (Zipor and Oren-Shamir 2013). The peroxidase-catalyzed reaction occurs in 3 steps 
according to the “ping-pong” mechanism. First, the resting state peroxidase (E) is oxidized by 
hydrogen peroxide (H2O2). Next, two back-to-back single electron transfers to an aromatic 
reducing substrate (AH2) proceed. The reaction ends with the return of peroxidase to the resting 
state and generation of water and radical products (AH
•
) (Veitch 2004). The reaction can be 
summarized as H2O2 + 2 AH2  
𝐸
→  2 H2O + 2 AH
•
. 
Peroxidases are an important component of biosensors and immunochemical kits due to 
their sensitive and quantitative detection of H2O2 (Gaspar et al., 2000; Chen et al., 2013) and 
persistent organic compounds such as pesticides (Farré et al., 2007). Detection of polyphenols 
and flavonoids in fruits and vegetables is used to assess the nutritive quality of foodstuffs 
(Litescu et al., 2010). Some enzyme immunoassays have been developed using horseradish 
peroxidase (HRP) to detect food allergens (Zhang et al., 2014) and metal ions that may 
contaminate food and agricultural soil (Zhao et al., 2011). 
Anionic peroxidases purified from palm tree leaves possess extremely high stability 
(Sakharov 2004). Moreover, these enzymes showed distinct substrate specificity compared with 
other plant peroxidases. Their unique properties have allowed for development of novel and 
improved applications. Palm peroxidase-based biosensors were more stable and could tolerate 
higher concentrations of H2O2 (Alpeeva et al., 2005). The exceptional stability of palm 
peroxidases at acidic pH met the requirement for synthesis of conductive and chiral polymers 
                                                 
1
 Reproduced in part with permission from Baker, M. R.; Zhao, H.; Sakharov, I. Y.; Li, Q. X. Amino Acid Sequence 
of Anionic Peroxidase from the Windmill Palm Tree Trachycarpus fortunei. Journal of Agricultural and Food 
Chemistry 2014, 62, 11941–11948. Copyright © 2014, rights managed by the American Chemical Society. 
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under environmentally safe conditions (Sakharov et al., 2003; Caramyshev et al., 2005; 
Caramyshev et al, 2007). 
Some plant peroxidases, particularly HRP are well studied, however, relatively little is 
known about the structure of palm peroxidases. The X-ray crystal structure of native, highly 
glycosylated royal palm tree peroxidase (RPTP) was recently solved (Watanabe et al., 2010). 
However, it is a unique work and structural data for other palm tree peroxidases were practically 
absent in the literature, except the sequence of 20 amino acids of the N-terminus of windmill 
palm tree peroxidase (WPTP, Trachycarpus fortunei) (Caramyshev et al., 2006). Also, it is 
known that WPTP uniquely contains 6.5 calcium cations per molecule, whereas most plant 
peroxidases, including HRP and RPTP, contain only 2 Ca
2+
 (Watanabe et al., 2010; Gajhede et 
al., 1997). 
To fill in the knowledge gap about the structures of palm peroxidases, herein we describe 
the complete amino acid sequence of WPTP and provide evidence of its modification with N-
linked glycans. The complete amino acid sequence and glycosylation were determined by 
MALDI-top-down sequencing of native WPTP, MALDI-TOF/TOF MS/MS of WPTP tryptic 
peptides, and cDNA sequencing. The propeptide of WPTP contained N- and C-terminal signal 
sequences. Mature WPTP was 306 amino acids in length and its carbohydrate content was in the 
range of 21 to 29%. The results can be used to guide engineering of WPTP and its novel 
applications. 
 
MATERIALS AND METHODS 
Materials. WPTP was isolated and purified from T. fortunei leaves as previously 
described (Caramyshev et al., 2006). Trypsin (MS grade) was purchased from Promega 
(Madison, WI). Bovine serum albumin (BSA; 98% purity), used as a protein standard, was from 
Sigma (St. Louis, MO). The MALDI matrix 2,5-dihydroxybenzoic acid (DHB), peptide 
calibration standard II, and protein calibration standard II were from Bruker (Billerica, MA). C4 
ziptips were from EMD Millipore (Darmstadt, Germany). Other reagents, including HPLC grade 
acetonitrile (ACN), trifluoroacetic acid (TFA), and ammonium bicarbonate (AMBIC) were from 
Fisher Scientific (Waltham, MA). Water was purified on a Milli-Q Advantage A10 system 
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(EMD Millipore). Dithiothreitol was from Acros Organics (New Jersey, USA) and 
iodoacetamide was from BioRad (Hercules, CA). For gene cloning, an RNeasy Plant Mini Kit 
(Qiagen, Venlo, Limburg), a SMARTer RACE cDNA Amplification kit and an Advantage 2 
PCR kit from Clontech (Mountain View, CA), a pGEM-T vector (Promega), and Escherichia 
coli strain JM109 were used. 
Molecular mass measurement. Purified WPTP was dissolved in 0.1% TFA (v/v), 
mixed 1:1 with a MALDI matrix solution (20 g/L DHB in 50% ACN (v/v) in 0.1% TFA (v/v)), 
spotted onto a polished steel target plate (Bruker), and allowed to air dry. 
The molecular mass was measured with an Ultraflex III MALDI-TOF/TOF mass 
spectrometer (Bruker) in linear positive mode. In 200 shot increments, 1,500 laser shots were 
accumulated. The matrix suppression cut-off, using gating, was at 9,500 m/z. Pulsed ion 
extraction (PIE) delay was set to 150 ns. Instrument voltages were at 25 kV (ion source 1 [IS1]), 
23.1 kV (IS2), and 6.5 kV (lens). The WPTP molecular mass value was calibrated using the 
protein mix II calibration standard (Bruker). Spectrum processing, consisting of peak detection 
(centroid algorithm, peak width 1000 m/z) and smoothing (Savitzky-Golay algorithm, 1 cycle at 
20 m/z), was done in Flex Analysis 3.4 (Bruker). 
Top down sequencing. Top-down sequencing (TDS) of native WPTP was performed 
after solid-phase reduction of its disulfide bonds, for which the late Mr. Sam Fu graciously 
provided consultation. BSA was used as the control and the molecular mass calibrator. For solid-
phase disulfide bond reduction, a C4 ziptip was wetted with 50% ACN (v/v) in 250 mM AMBIC 
solution several times. The protein sample (25 pmol in 15 μL of 100 mM AMBIC) was loaded 
on the tip equilibrated with 100 mM AMBIC by slowly repipetting at least 10 times. Then, 50 
mM dithiothreitol (200 μL) was introduced to the tip by aspirating and dispensing the solution 
for 2 min at 60 °C. The ziptip was then incubated in that solution for 30 min at 60 °C. The tip 
was washed 3 times with 0.1% TFA (v/v). The protein was eluted with 5 μL of a MALDI matrix 
solution (40 g/L DHB in 70% ACN (v/v) in 0.1% TFA (v/v)) and 0.25 μL were spotted directly 
on the target plate and allowed to air dry. 
TDS spectra were acquired with an Ultraflex III MALDI-TOF/TOF mass spectrometer in 
reflector positive mode. In 200 shot increments, 19,000 laser shots were accumulated. The 
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matrix suppression cut-off, using deflection, was at 900 m/z. PIE delay was set to 40 ns. 
Instrument voltages were at 25 kV (IS1), 21.4 kV (IS2), 9.7 kV (lens), 26.3 kV (reflector 1), and 
13.8 kV (reflector 2). Spectrum processing, consisting of peak detection (SNAP algorithm, peak 
width 0.75 m/z), baseline subtraction (TopHat algorithm), and smoothing (Savitzky-Golay 
algorithm, 5 cycles at 1.5 m/z), as well as peak annotation was carried out in Flex Analysis 3.4. 
Peaks were assigned with a mass tolerance of 300 ppm. Interpretation of the ions comprising the 
near C-terminus was aided by the characteristic m/z difference of 15 (Δ m/z) between y- and 
z+2-ion series. Additional annotation was done with BioTools (Bruker) and Sequence Editor 
(Bruker). 
Bottom-up sequencing. WPTP (10 µg, 1 µg/μL in 25 mM AMBIC) was reduced 
with 50 mM dithiothreitol (20 μL) for 30 min at 60 °C, alkylated with 100 mM iodoacetamide 
(25 μL) for 45 min at room temperature in the dark. The alkylation reaction was quenched by 
addition of 1 µL of 143 mM dithiothreitol. Reduced and alkylated WPTP was diluted with water, 
and then digested in solution with 0.5 µg of trypsin (50 μL) at 37 °C for 12 h. Peptides were 
dried via SpeedVac and resuspended in 5% ACN (v/v) in 0.1% TFA (v/v). The peptide solution 
was mixed 1:1 with a MALDI matrix solution (20 g/L DHB in 50% ACN (v/v) in 0.1% TFA 
(v/v)) and then spotted on a target plate. 
Mass spectra of the peptides were acquired with an Ultraflex III MALDI-TOF/TOF mass 
spectrometer in reflector positive mode. In 200 shot increments, 600 shots were accumulated. 
The matrix suppression cut-off, using deflection, was at 850 m/z. PIE delay was set to 0 ns. 
Instrument voltages were at 25 kV (IS1), 21.45 kV (IS2), 9.5 kV (lens), 26.3 kV (reflector 1), 
and 13.8 kV (reflector 2). External calibration was performed using peptide mix II calibration 
standard (Bruker). Spectrum processing, consisting of peak detection (SNAP algorithm, peak 
width 0.75 m/z) and smoothing (Savitzky-Golay algorithm, 1 cycle at 0.2 m/z), was done in Flex 
Analysis 3.4. 
Several peaks in the mass spectrum were selected for fragmentation in LIFT mode 
(Suckau et al., 2003). Several thousand laser shots were accumulated in 200 shot increments. PIE 
delay was set to 0 ns. Instrument voltages were at 8 kV (IS1), 7.2 kV (IS2), 3.6 kV (lens), 29.5 
kV (reflector 1), and 13.85 kV (reflector 2). Spectrum processing, consisting of peak detection 
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(SNAP algorithm, peak width 0.75 m/z) and smoothing (Savitzky-Golay algorithm, 4 cycles at 
0.15 m/z) as well as peak annotation, was carried out in Flex Analysis 3.4. Additional annotation 
was done with BioTools and Sequence Editor with a mass tolerance of 0.3 m/z for peptides and 1 
m/z for glycopeptides. Fragmentation spectra were interpreted and used for primer design in the 
gene cloning experiment. 
Cloning and sequencing of the cDNA. Total RNA was isolated from 0.1 g of T. 
fortunei leaves using an RNeasy Plant Mini Kit (Qiagen). The first-strand cDNA was 
synthesized from the isolated RNA using a SMARTer RACE cDNA Amplification kit 
(Clontech). The WPTP gene was cloned in 2 steps. In the first step, the forward degenerate 
primers (5ʹ-GAYCTNCARATHGGNTT-3ʹ and 5ʹ-GAYTTRCARATHGGNTT-3ʹ) targeted the 
previously determined amino acid sequence of the N-terminus of WPTP (DLQGIFY) 
(Caramyshev et al., 2006). The reverse primer, UPM, was provided with the same kit. PCR 
amplification was performed using an Advantage 2 PCR kit (Clontech). The PCR protocol 
consisted of an initial denaturation step at 94 
o
C (2 min); which was followed by 5 cycles of 
denaturation at 94 
o
C (30 s), annealing at 60 
o
C (30 s), and extension at 68 
o
C (1 min); then 5 
cycles of denaturation at 94 
o
C (30 s), annealing at 55 
o
C (30 s), and extension at 68 
o
C (1 min); 
then followed by 25 cycles of denaturation at 94 
o
C (30 s), annealing at 50 
o
C (30 s), and 
extension at 68 
o
C (1 min); and then a final extension for 3 min at 68 
o
C. The resulting 1,200 bp 
product was used as a template in the second step. The forward primer (5ʹ-
ATGCAYTTYCAYGAYTGYTT-3ʹ) was designed from the amino acid sequence MHFHDCF, 
obtained by tandem mass spectrometry analysis of WPTP tryptic peptides in this study. The PCR 
protocol was the same as above except that the annealing temperatures were 65 
o
C, 62 
o
C, and 60 
o
C, respectively. The PCR product was cloned into a pGEM-T vector and transformed into E. 
coli strain JM109. Positive transformants were screened by PCR. Plasmids were extracted from 
positive clones and confirmed by sequencing. For 5ʹ-RACE, the reverse primer, 5ʹ-
GGACCTGGTAGGTGATGTTGCCG-3ʹ, was designed from the DNA sequence obtained in the 
previous step. The forward primer, UPM, was from the same kit. The PCR protocol was the 
same as above except that the annealing temperatures were 65 
o
C, 62 
o
C, and 58 
o
C, respectively. 
The PCR product was cloned, transformed, screened, and sequenced as before. The complete 
cDNA sequence of WPTP was obtained by combining the 5ʹ- and 3ʹ-cDNA sequences which 
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were overlapping with each other. Analysis of the data was conducted with the software Mega5 
(Tamura et al., 2011). These data can be accessed at NCBI accession: KM504969.  
 
RESULTS AND DISCUSSION 
Determination of the molecular mass of WPTP. The MALDI-TOF mass spectrum 
of WPTP indicated the presence of a single glycoprotein with considerable heterogeneity (Fig. 
2.1A). An expanded view of the +2 charged peak revealed that it was composed of many 
partially resolved peaks, probably corresponding to WPTP glycoforms, i.e., differentially 
glycosylated WPTP (Fig. 2.1B). A similar view of the +1 charged peak also showed multiple, 
partially resolved peaks. 
The obtained data allowed for calculation of the MW of WPTP which ranged from 41 to 
45 kDa (Fig. 2.1C). These values are a little lower than the value previously reported for WPTP 
(50 kDa), which was measured using SDS-PAGE (Caramyshev et al., 2006). Due to decreased 
binding of SDS to glycans relative to the polypeptide backbone, the migration of a glycoprotein 
during SDS-PAGE is altered relative to what is expected for a similarly sized non-glycosylated 
protein (Segrest et al., 1971). Therefore, the previous measurement was likely an over-
estimation. Similarly, the first report of RPTP’s MW, as measured by SDS-PAGE, was 51 kDa 
(Sakharov et al., 2001) and the MW as measured by mass spectrometry was 44,596 Da 
(Watanabe et al., 2010). 
Top-down sequencing. It is well known that drawbacks of MALDI-TDS are the 
requirement of a high purity of analyte, low sensitivity, and lack of fragmentation in the presence 
of disulfide bonds (Resemann et al., 2010). The isolated WPTP used in this study was high 
purity. To overcome the other problems, we reduced WPTP’s disulfide bonds while it was 
immobilized onto a C4 ziptip by hydrophobic interactions. This provided a quick and effective 
way to reduce WPTP’s disulfide bonds, remove contaminating salts, and concentrate the reduced 
protein in one simple step. 
MALDI-TDS results in ladder fragmentation of the intact protein leaving glycans 
attached to the modified Asn residues (Hanisch 2011). Partial amino acid sequence near the N-
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terminus of WPTP was gained through interpretation of the c-ion series in the MALDI-TDS 
spectrum (Fig. 2.2A). The y- and z+2-ions were interpreted as a continuous 30-amino acid 
residue sequence (Fig. 2.2A). A protein BLAST search of the NCBInr database 
(blast.ncbi.nlm.nih.gov) predicted that this sequence originated from a protein in the peroxidase 
super family. The top hit was RPTP (PDB: 3HDL; E value: 6e
-16
). The y ions at m/z 5290.1 and 
6575.7 (N*) (and the corresponding z+2-ions) had a mass difference corresponding to a 
glycosylated Asn, Asn-GlcNAc2Man3FucXyl (exact Δ m/z 1284.5 and accurate Δ m/z 1285.6). 
This glycan is the predominant glycan found on HRP (Yang et al., 1996), soybean peroxidase 
(SBP) (Gray and Montgomery 2006), RPTP (Watanabe et al., 2010), and other plant peroxidases. 
A scheme of the glycan is depicted in Fig. 2.2B according to the conventions of the Consortium 
for Functional Glycomics. All assigned peaks had a mass error within 200 ppm and the root 
mean square error (RMSError) was 65.32 ppm (Fig. 2.2C). 
Bottom-up sequencing. Additional amino acid sequence information was gained 
through a more traditional “bottom-up” approach. For this, WPTP was digested with trypsin and 
the resulting tryptic peptides were subjected to MALDI-TOF MS (Fig. 2.3A). Tandem mass 
spectrometry was performed to obtain the amino acid sequence of the tryptic peptides of WPTP 
(Figs. 2.3B-F). Among these, fragments of the parent ion at m/z 1264.6 could be unambiguously 
interpreted as M
[ox]
HFHDCFVR (Fig. 2.3D). Furthermore, this sequence overlapped with an 
amino acid sequence ladder from the MALDI-TDS experiment. Thus, this amino acid sequence 
was used for primer design for cDNA cloning and sequencing of WPTP. 
Fragments of the parent ion at m/z 2890.3 displayed a characteristic spectrum of a 
glycopeptide (Fig. 2.4F). Man and GlcNAc oxonium ions were observed at m/z 163 and 204, 
respectively. We also observed cross-ring fragmentation of the innermost GlcNAc (
0,2
X). 
Additionally, the glycan moiety fragmented into a series of Y-ions corresponding to mass shifts 
indicative of the glycan GlcNAc2Man3XylFuc (Fig. 2.2C). 
cDNA sequencing. The gene for WPTP was cloned and sequenced from mRNA 
isolated from the leaves of T. fortunei. The gene consisted of 5ʹ- and 3ʹ- untranslated regions, 
which included a poly-A tail, and 1,032 bp encoding a polypeptide of 344 amino acids (Fig. 2.4). 
There was an N-terminal signal peptide upstream of the previously sequenced N-terminus of 
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mature WPTP, which targets class III peroxidases to the secretory pathway (Welinder et al., 
2002). Some peroxidases additionally bear a C-terminal signal peptide for vacuolar targeting 
(Welinder et al., 2002). Insights into in vivo processing of the C-terminus of WPTP were 
obtained by combining information from the MALDI-TDS spectrum of intact WPTP and its 
cDNA sequence. In a MALDI-TDS spectrum, the ion with the lowest m/z value in each ion 
series corresponds to the mass of the N-terminus (for c-ions) or the C-terminus (for y- and z-type 
ions). Therefore, the y 11-ion (Fig. 2.2) corresponded to the mass of RTN*CSVVNSAS (exact 
m/z 2307.9 and accurate m/z 2307.8), where the mass shift for Asn
298
 (N*) in the WPTP 
sequence corresponded to GlcNAc2Man3FucXyl. Thus, the vacuolar targeting signal for WPTP 
was LGDIVMASGHLTEVATS (Fig. 2.4). 
Using the same logic for the N-terminus, the c 17-ion at m/z 2878.1 (Fig. 2.2) 
corresponded to the sequence DLQIGFYN
#
QSCPSAESLVQQAVAAAFAN*NSGIAPGLIR 
(exact m/z 3920.0 and accurate m/z 6098.4) (Fig. 2.4), where the mass difference of 2178.4 could 
be accounted for by adding a glycan to Asn
8
 (N#) and one to Asn
28
 with the potential sequences 
GlcNAc2Man2FucXyl (Δ m/z 1008.4) and GlcNAc2Man3FucXyl (Δ m/z 1170.4), giving an 
overall mass error of 65.6 ppm. 
Structure overview. Mature WPTP was composed of a single polypeptide, 306 amino 
acid residues in length, with an average mass of 32,172 Da. The cDNA sequence showed that 
there were 13 potential glycosylation sites, identified by the sequence Asn-Xxx-Ser/Thr, where 
Xxx is any amino acid except Pro. When the mass as measured by MALDI-TOF MS is 
considered, WPTP has 21 - 29% glycans (Fig. 2.1). This level of complexity made it difficult to 
assign a specific glycoform structure to each peak in that spectrum. Positions 8, 28, 114, 267, 
and 298 were glycosylated. A more detailed study of WPTP’s glycosylation profile is underway. 
Class III peroxidases share a common 3D structure despite a low sequence identity 
(Veitch 2004; Gajhede et al., 1997; Schuller et al, 1996). For example, RPTP and HRP were only 
36% identical, but their Cα backbone structures were closely related, having an overall root 
mean squared deviation of 1.07 Å (Watanabe et al., 2010). A structurally guided alignment 
revealed that WPTP and RPTP were 88% identical in primary structure and likely were very 
similar in secondary and tertiary structures (Fig. 2.5). 
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Structural integrity of plant peroxidases is maintained largely by an extensive hydrogen 
bonding network that extends above and below the heme-containing active site to distal and 
proximal Ca
2+
 (Smulevich et al., 2005). Additionally, 4 invariant disulfide bridges tie the protein 
together. These 8 cysteine residues were present in WPTP (Fig. 2.5). Importantly, the disulfide 
bridge between Cys
44
 and Cys
49
 stabilizes the BC loop, which comprises majority of the distal 
Ca
2+
 binding residues (Fig. 2.5). Distal Ca
2+
 was critical for maintaining the proper tertiary 
structure of the active site (Szigeti et al, 2008). The disulfide bridge between Cys
176
 and Cys
208
 
stabilizes the region between helices F and H, which is important for substrate binding and 
contains residues necessary for binding proximal Ca
2+
. The additional 4.5 Ca
2+
 found in the 
WPTP structure were difficult to account for since only one other peroxidase, anionic peanut 
peroxidase (Hu et al., 1997), had elevated Ca
2+
 content and its 3D structure was still not 
available. 
Features of potential importance to substrate specificity. The new WPTP 
structure information presented in this study allowed for exploration of features of potential 
importance in palm tree peroxidases. One striking functional difference is substrate reactivity 
differences between WPTP, RPTP, and HRP (Table 2.1). Ferulic acid was the better substrate for 
RPTP and HRP (Sakharov et al., 2001). Moreover, the difference in reactivity between ferulic 
acid and ABTS was not too different for those 2 peroxidases, i.e., there was a 1.26 fold 
difference for RPTP and 3.25-fold difference for HRP (Sakharov et al., 2001). The better 
substrate for WPTP was ABTS and ferulic acid had 20-fold lower reactivity (Caramyshev et al., 
2006). Investigation of the 3D structure of RPTP, using Swiss-PdbViewer 4.1.0 (Arnold et al., 
2006), revealed amino acid residues and features of known and putative importance to substrate 
binding (Table 2.2). 
Amino acids involved in substrate binding should be within 12 Å of the heme iron, as 
indicated by NMR studies of HRP-substrate complexes (Veitch 1995). There were 64 residues 
within this distance in RPTP (Fig. 2.5) and 5 of those differed between WPTP and RPTP. Of 
those 5, the lowest conservation was at position 142. Interactions between residue 142 and 
conserved Phe
143
 resulted in topological features thought to affect interactions with substrates 
(Veitch 2004; Henriksen et al., 2001). Residue 142 was hydrophobic in HRP, RPTP, and WPTP, 
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except that it was large in HRP (Phe) and RPTP (Ile) but small in WPTP (Thr). This difference 
could be a major factor causing the large deficit in WPTP’s reactivity toward ferulic acid. The 
absence of a 3D structure complex between peroxidase and ABTS prevented speculation about 
features responsible WPTP’s superior catalysis of that large substrate. 
The RPTP crystal structure contained a potential inhibitor; an MES molecule (Watanabe 
et al., 2010). Residues within van der Waals radius (4.6 Å) of MES may affect substrate 
reactivity. Nine residues (Ile
68
, Ser
140
, Pro
141
, Leu
142
, Ser
177
, Ser
178
, Ser
212
, Thr
213
, and Arg
214
) 
were within that region. Five of the 9 residues did not overlap with the residues that were 12 Å 
from the heme iron (Fig. 2.5). The position with the lowest conservation between RPTP and 
WPTP was at position 177. In WPTP, it was large, hydrophobic, and aromatic Phe, whereas in 
RPTP, it was small and polar Ser. Moreover, this MES binding site was in the most structurally 
divergent region between HRP and RPTP (Fig. 2.5). In HRP, this loop region was pointing away 
from the active site, whereas in RPTP, it was pointing toward it. This difference in topology 
brought Arg
214
 into hydrogen bonding distance with MES (Watanabe et al., 2010). Further 
investigation into this distinct region is warranted. 
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Table 2.1. Substrate reactivity as measured by kapp (M
-1
s
-1
). 
 WPTP
a
 RPTP
b
 HRP
b
 
ferulic acid 3.0 x 10
6
 6.3 x 10
7
 1.3 x 10
7
 
ABTS
c
 6.0 x 10
7
 5.0 x 10
7
 4.0 x 10
6
 
a
The data for WPTP are from (Caramyshev et al., 2006) 
b
The data for RPTP and HRP are from (Sakharov et al., 2001) 
c
2,2′-Azinobis(3-ethylbenzothiazoline-6-sulfonic acid) 
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Table 2.2 Residues of known and potential importance for protein-substrate interactions 
residue
a
 WPTP RPTP 
predicted 
effect evidence 
Distance within 12 Å of heme iron 
38 R R critical 
two H-bonds to ferulic acid (FA) (HRP);
b
 Arg
38
 to 
Leu 10 - 100x slower substrate oxidation (HRP)
c
 
69 P P minor 
putative hydrophobic interaction between FA and 
anionic A. thaliana peroxidase (ATP A2)
 d
 
138 I I minor putative hydrophobic bond to FA (ATP A2)
d
 
139 P P major 
H-bond to active site H2O which is H-bonded to 
FA (HRP)
b
 
140 A S minor 
Ala: tiny
e
 and hydrophobic vs. Ser: small
f
 and 
polar; hydrophobic interaction with FA (HRP: 
Ala
140
);
b
 H-bond to MES
g
 (RPTP)
h 
 
142 T L major 
Thr: small
c
 and hydrophobic vs. Leu: large, 
hydrophobic, and aliphatic; hydrophobic 
interaction with FA (HRP)
b
 
Distance within 4.6 Å of MES
d
 
68 A I minor 
Ile: large, hydrophobic, and aliphatic vs. Ala: tiny
b
 
and hydrophobic; hydrophobic interaction with FA 
(HRP: Gly
68
)
b
 
177 F S major 
Phe: large, hydrophobic, and aromatic vs. Ser: 
small
c
 and polar 
212 - 
214 
STR STR major 
structurally distinct region (HRP vs. RPTP); H-
bond with MES
d
 (RPTP: Arg
214
)
h
 
a
position in the amino acid sequence (Fig. 2.5); 
b
Henriksen et al., 1999; 
c
Rodriguez-Lopez et al., 
1996; 
d
Nielsen et al., 2001; 
e
less than 35 Å
3
;
 f
less than 60 Å
3
; 
g
2-(N-morpholino)ethanesulfonic 
acid; 
h
Watanabe et al., 2010.  
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Figure 2.1. MALDI-TOF MS of WPTP. (A) +1, +2, and +3 charged peaks and an expanded view 
of the (B) +2 charged and (C) +1 charged peak. 
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Figure 2.2. MALDI-top-down sequencing of WPTP. The amino acid sequence was interpreted 
from c-, y- and z+2-ion series. (A) Δ m/z between y 39 at m/z 5290.1 and y 40 at 6575.7 
corresponded to Asn modified with the glycan GlcNAc2Man3XylFuc (N*); (B) a cartoon 
structure of the glycan GlcNAc2Man3XylFuc; and (C) a plot showing the mass error (ppm) for 
each matched ion. ( ) N-acetylglucosamine (GlcNAc); ( ) mannose (Man); ( ) fucose (Fuc);     
( ) xylose (Xyl). 
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Figure 2.3. MALDI-TOF/TOF MS/MS of WPTP tryptic peptides. (A) mass spectrum WPTP 
tryptic peptides and fragmentation spectra of the parent ion at m/z (B) 905.6; (C) 1054.6; (D) 
1264.6; (E) 1646.9; and (F) 2980.3. (M
[ox]
) sulfoxide methionine; ( ) N-acetylglucosamine 
(GlcNAc); ( ) mannose (Man); ( ) fucose (Fuc); ( ) xylose (Xyl). 
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Figure 2.4. cDNA sequencing of WPTP. Nucleotide and amino acid residue numbers are on the 
right. (gray italicized) N- and C-terminal signal peptides; amino acid sequence ( ) used for 
primer design, ( ) covered by MALDI-TDS, and ( ) determined by MALDI-TOF/TOF 
MS/MS; (N) potential glycosylation site; (#) GlcNAc2Man2FucXyl; and (*) 
GlcNAc2Man3FucXyl. 
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Figure 2.5. Alignment of WPTP and RPTP. The alignment was done to determine features 
related to substrate specificity, according to Armougom et al. (2006). Determination of 
(highlighted in gray) residues less than 12 Å from heme iron and (highlighted in black) less than 
4.6 Å from MES with Swiss-PdbViewer 4.1.0
 
(Arnold et al., 2006) and (box) residues with 
significant structural deviation between RPTP (PDB: 3HDL) and HRP (PDB: 1ATJ) with a 
protein structure alignment tool (Shindyalov et al., 1998). (&) occupied glycosylation site 
(Watanabe et al., 2010); (c) cysteine; (+) Ca
2+
 binding; ( ) helices; and ( ) sheets. Helices 
labeled according to Watanabe et al.
 
(2010) and conservation according to Livingston and Barton 
(1993). The figure was drawn in JalView (Waterhouse et al., 2009). 
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CHAPTER 3. SITE-SPECIFIC N-GLYCOSYLATION AND 
MICROHETEROGENEITY OF A PEROXIDASE FROM THE WINDMILL 
PALM TREE TRACHYCARPUS FORTUNEI 
 
INTRODUCTION 
Windmill palm tree peroxidase is the main anionic vacuolar peroxidase present in the 
leaves of the windmill palm tree Trachycarpus fortunei during the winter (Caramyshev et al., 
2006; Baker et al., 2014). Vacuolar peroxidases are stress responsive enzymes (Zipor and Oren-
Shamir, 2013). In the presence of hydrogen peroxide, vacuolar peroxidases catalyze oxidative 
polymerization of aromatic reducing substrates present in the plant vacuole, which includes a 
diverse array of secondary metabolites. The physiological roles of vacuolar peroxidases include 
hydrogen peroxide scavenging, synthesis of anti-microbial compounds, and degradation of 
pigment molecules, an adaptation to low light conditions. 
A characteristic feature of secretory proteins, including vacuolar peroxidases, is N-linked 
glycosylation (Ruiz-May et al., 2012). Vacuolar peroxidases are decorated on their loop regions 
with paucimannose-type sugars (Yang et al., 1996; Gray and Montgomery 2006). Partial 
deglycosylation of peroxidases results in decreased stability (Tams and Welinder, 1998; Lige et 
al., 2001) and lower rates of catalysis (Lige et al., 2001; Nielsen et al., 2001). A decrease in 
specific activity of a peroxidase from avocado was correlated with the loss of ability to chelate 
calcium ions (Sánchez-Romero et al., 1994). Typically, peroxidases contain 2 Ca
2+
 per 
peroxidase molecule (Veitch 2004). Considering that WPTP contains 6.5 Ca
2+
 (Caramyshev et 
al., 2006), this may be of considerable importance. 
The complete amino acid sequence and partial glycosylation of WPTP were recently 
determined (Baker et al., 2014). Herein, detailed N-glycosylation mapping of WPTP is 
described. Analysis at the glycopeptide level allowed for detailed investigation of the 
glycosylation profile at each of the 13 sites of N-glycosylation. The work was conducted with 
novel approaches to N-glycan database construction and validation of glycopeptide assignment 
using pGlycoFilter and gPSMvalidator, respectively. A detailed description of palm peroxidase 
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glycosylation is important for future studies on the structure-activity relationships in N-
glycosylation variants of WPTP. 
MATERIALS AND METHODS 
Materials. Green palm tree leaves were harvested from the territory of the Nikita 
Botanic Garden (Crimea, Ukraine). Reagents for sample preparation, including acetonitrile 
(HPLC grade), ammonium bicarbonate, and 1,4-dithiothreitol (DTT) (No-Weigh DTT) were 
purchased from Fisher Scientific (Waltham, MA). Trypsin (Trypsin Gold, Mass Spectrometry 
Grade) and chymotrypsin (Sequencing Grade) were purchased from Promega (Madison, WI). 
Water (HPLC Grade, JT Baker) was purchased from VWR (Randor, PA). Other reagents used 
for sample preparation included iodoacetamide (98%, Sigma Aldrich, St. Louis, MO) formic acid 
(Suprapur, 98%; EMD Chemicals), and 2,2,2-trifluoroethanol (TFE) (99.8% pure, Acros). For 
desalting and enrichment, C18 ZipTips (Milipore) and polyhydroxylethyl resin, 200 Å (PolyLC, 
Inc.) were used. 
WPTP isolation and purification. WPTP was isolated from the leaves of 
Trachycarpus fortunei in the winter. Isolation and purification were carried out by Dr. Sakharov 
at Lomonosov University in Moscow, Russia. Full details of the procedure are described by 
Caramyshev et al., (2006). Briefly, soluble proteins were extracted from milled windmill palm 
leaves (5 kg) in water with periodic agitation for a total of 30 h at ambient temperature. The 
debris was removed by filtration and centrifugation. Next, phenolic compounds were separated 
from the extract by adding solid polyethylene glycol. Addition of ammonium sulfate allowed for 
protein precipitation. The resulting protein containing aqueous fraction was subjected to a series 
of preparative chromatography columns, including separation based on hydrophobicity, size-
exclusion, and weak anion-exchange. For each chromatography step, the fraction containing 
peroxidase activity was collected. Peroxidase was purified to homogeneity, which was assessed 
by SDS-PAGE and isoelectric focusing. 
Sample preparation. Duplicate samples were prepared for site-specific glycosylation 
analysis. Dry WPTP was resuspended in 50% 2,2,2-trifluoroethanol (TFE)/50% 100 mM 
ammonium bicarbonate. Disulfide bonds were reduced with 50 mM 1,4-dithiothreitol (60 °C, 15 
min) and then alkylated with 100 mM iodoacetamide (RT, 15 min, dark). After dilution to 10% 
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TFE, trypsin or chymotrypsin was added in a 1:50 ratio of trypsin or chymotrypsin to sample 
(w/w). Proteolytic digests were carried out overnight at 37 °C and were terminated by addition of 
1 µL of formic acid. 
Digested samples were either desalted with C18 ZipTips (Milipore) according to the 
manufacturer’s instructions, or enriched for glycopeptides using a method adapted from 
(Kolarich et al., 2012). For enrichment of glycopeptides, a hydrophilic interaction liquid 
chromatography (HILIC) microcolumn was made with the following procedure: About 9 µL of a 
slurry of polyhydroxylethyl resin, 200 Å (PolyLC, Inc.) mixed with acetonitrile was added to the 
top of a 10 µL C18 ZipTip. The height of the polyhydroxylethyl resin layer was about 5 mm. The 
microcolumn was centrifuged for 1 min at 5,000 rpm in a benchtop microcentrifuge (Eppendorf 
5417R) and then was washed with 20 µL of 0.1% formic acid (v/v) by centrifuging for 1 min at 
1,000 rpm and equilibrated with 20 µL of 5% formic acid (v/v), 80% acetonitrile (v/v). The 
sample, WPTP chymotryptic peptides (4 µg) in 20 µL of 5% formic acid (v/v), 80% acetonitrile 
(v/v), was loaded and centrifuged for 1 min at 400 rpm. Next, the microcolumn was washed 
twice with 20 µL of 5% formic acid (v/v), 80% acetonitrile (v/v) by centrifuging for 1 min at 
2,000 rpm. A ‘fast-spin’ for 2 s removed all excess liquid from the microcolumn, at which time 
the material turned from translucent to white. The first elution was with 20 µL of 0.1% formic 
acid (v/v), and subsequently with 10 µL of 5% formic acid (v/v), 80% acetonitrile (v/v). Each 
time, centrifugation was performed for 1 min at 2,000 rpm, followed by a 2 s fast-spin. The 
eluents were collected and combined. Next, the eluents were evaporated on a SpeedVac. The 
enriched glycopeptides were reconstituted in 50 µL of 0.1% formic acid (v/v), 5% acetonitrile 
(v/v) by bath sonication for 10 min. After spinning down the sample for 3 min at a high speed, 
40 µL of the solution was added to an HPLC vial for LC-MS analysis. 
Liquid chromatography-mass spectrometry. All chromatographic separations 
were performed using an Easy nLC-1000 pump and autosampler system (Thermo Fisher 
Scientific). For each analysis, 2 µL of each sample (equivalent to 0.6 µg) was injected and 
loaded onto an in-line solid-phase extraction column (100 µm x 6 cm) packed in-house with 
ReproSil-Pur C18 AQ 3 µm resin (Dr. Maisch GmbH) using a frit generated with liquid silicate 
Kasil 1 at a flow rate of 2 mL/min with 100% Solvent A (0.1 % formic acid (v/v)). After the 
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washing period of a total volume of 7 mL, the pre-column was placed in-line with a PicoFrit 
capillary column (New Objective, 11 cm x 75 µm) packed in-house with the same resin. The 
peptides were separated using a linear gradient of 2% - 35% Solvent B (0.1% formic acid (v/v) in 
acetonitrile) at a flow rate of 300 nL/min over 40 min followed by an increase to 90% B over 4 
min and held at 90% B for 6 min before returning to initial conditions of 2% B. The samples 
were analyzed on a Q Exactive Orbitrap (Thermo Scientific). The normalized collision energy 
was set to 28% for HCD fragmentation. The top 12 ions were fragmented in HCD mode with an 
isolation window of 2.5 m/z and dynamic exclusion period of 20 s.  
Bioinformatics. The detailed workflow for analysis of the glycopeptide mass 
spectrometry data can be found in Appendix A. Configurations for the different proteomic 
searches can be found in Appendix B. The workflow contains 5 general steps (Fig. 3.1). Mass 
spectrometry data were converted to mzML format using msconvert (ProteoWizard v.3.0.5006). 
Proteins were identified with a MyriMatch (v. 2.1.138; Tabb et al., 2007) search using a protein 
database containing the target protein sequence, potential protein contaminants and an entire 
organism’s proteome for a total of 25,930 protein sequences. Preliminary identifications were 
assessed with IDPicker 3.0 (v. 3.0.537 64-bit) with a q-value of 2%. A subset protein database 
was constructed from the results and used in subsequent glycopeptide identifications using the 
proteomics software. 
All possible glycan compositions were predicted using GlycoMod (Cooper et al., 2001; 
web.expasy.org/glycomod). The list of glycans was evaluated using pGlycoFilter, an in-house 
tool written in Excel macros (Supplementary Data) that tests the predicted glycan compositions 
against the known N-glycan biosynthesis pathway in plants (Appendix C).  
Glycopeptides were identified using several proteomics search engines and the subset 
database produced in step 1. The proteomics search engines included MyriMatch (v. 2.1.138; 
Tabb et al., 2007), a database search engine, DirecTag-TagRecon (v. 1.4.71; Dasari et al., 2010), 
a tag-based search engine, and MassRecon (v. 1.4.71; Dasari et al., 2010), a mass-based search 
engine. Alternatively, glycopeptides were identified using a modified GlycoMod search. 
Preliminary identifications from the proteomics searches were assessed with IDPicker 3.0 (v. 
3.0.537 64-bit) with a q-value of 2%. Additional glycopeptide identifications were obtained 
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using GlycoMod. All glycopeptide spectrum matches (gPSMs) were validated using 
gPSMvalidator, an in-house built tool modified from PTM_MarkerFinder (Nanni et al., 2013) 
written in R. Each gPSM within 15 ppm of the exact mass was considered valid if 2 or more 
HexNAc
+
 oxonium ions and one or more Y1 (peptide + GlcNAc) or Y0 (peptide) ion were 
detected within an error of 5 ppm or 50 ppm, respectively. All gPSMs were manually validated. 
Relative quantitation was done by comparing the summed intensity of selected ion 
chromatograms (SIC) of glycopeptide precursor ions. 
 
SUPPLEMENTARY DATA 
A description of the supplementary data is in Appendix D. The raw mass spectrometry 
files have been uploaded to the ProteoSAFe webserver (massive.ucsd.edu) under MassIVE ID: 
MSV000079086. 
 
RESULTS 
Sample preparation. WPTP, an anionic glycoprotein, pI 3.5 (Caramyshev et al., 2006) 
was isolated from the leaves of Trachycarpus fortunei in the winter. The enzyme was purified to 
homogeneity and migrated as a single band at approximately 50 kDa on SDS-PAGE (data not 
shown). It is expected that the N-linked glycans of WPTP were not altered by the isolation and 
purification procedure. The possibility of glycan modification during the extraction step was low 
because the concentration of the peroxidase and glycosidases remained low. Moreover, the 
homogenate contained very high concentrations of polysaccharides, which have higher affinity to 
glycosidases than glycosylated proteins. At all other steps of purification the enzyme 
concentration was low and the experimental conditions were not favorable for glycosidases; e.g., 
a buffer containing 1.7 M ammonium sulfate was used for hydrophobic chromatography. 
The preferred peptide backbone length for site-specific glycosylation analysis is 8 - 25 
amino acids (Kolarich et al., 2012). This was achieved using chymotrypsin, which cleaves after 
large, hydrophobic amino acids such as Phe, Tyr, Trp, and Leu. WPTP was alternatively digested 
with trypsin to give complementary information. A portion of the chymotrypsin digested sample 
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was enriched for glycopeptides using hydrophilic interaction liquid chromatography (HILIC). 
Enriched glycopeptides were used to provide a more comprehensive profile of glycosylation at 
each site; however, such treatment is biased against peptides meaning that information on 
unoccupied glycosylation sites is lost (Kolarich et al., 2012). Therefore, the unenriched 
chymotrypsin sample was used to assess the relative abundance of glycoforms at each 
glycosylation site. 
The total ion chromatogram (TIC) shows the summed intensity of each detected 
compound and its elution time (Fig. 3.2A-C). The majority of compounds were eluted between 
25 and 60 min. As evident from the TICs of each sample, trypsin digestion resulted in fewer 
cleavage products (Fig. 3.2A) than chymotrypsin digestion (Fig. 3.2B). Also, enrichment of the 
chymotrypsin sample resulted in detection of a much more heterogeneous sample (Fig. 3.2C). 
Data analysis workflow. Data analysis was performed in 5 general steps (Fig. 3.1). At 
each step, the results were assessed against specific criteria, as described in each section below. 
Glycopeptide structures reported in this study include the peptide backbone sequence and the 
glycan composition. Glycan attachment sites were inferred based on the presence of the 
consensus sequence for N-linked glycosylation, Asn-Xxx-Ser/Thr, where Xxx ≠ Pro. Glycan 
structures were predicted from the glycan composition and the known glycan biosynthesis 
pathway in plants (Appendix C). 
Step 1: Protein identification. In step 1, results were assessed based on the detection 
of WPTP as the main protein component as well as detection of known contaminants including 
proteases (chymotrypsin or trypsin) and keratins. The primary component was WPTP (1382 
filtered spectra), followed by keratins (20 filtered spectra), and the proteases chymotrypsin (11 
filtered spectra) or trypsin (6 filtered spectra). The complete list of peptide spectrum matches 
(PSMs) and annotated fragmentation spectra are available in the Supplementary Data. 
Step 2: Glycan identification. Glycan compositions were predicted from precursor 
masses and WPTP peptide masses using GlycoMod (Cooper et al., 2001). There were 280 
predicted glycan compositions. At the time of this publication, there were no comprehensive 
plant glycan databases available to confirm the glycan compositions. This prompted the need for 
a tool that could omit biologically impossible glycan compositions. A tool, called pGlycoFilter, 
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was written in Excel macros (Supplementary Data). The predicted glycan compositions were 
checked against the known plant N-glycosylation pathway (Appendix C). A set of N-glycans, 
determined experimentally from plants (Wilson et al., 2001), was tested against pGlycoFilter and 
all 30 glycans passed. Of the 280 glycan compositions predicted by GlycoMod, 80 of them 
passed pGlycoFilter. Following validation of the glycopeptide spectrum matches (gPSMs) 
(described below), 45 different glycans were confirmed to be present on WPTP. The gPSMs that 
were not confirmed were matched based on the parent ion mass, but not fragment ion masses. 
Table 3.1 lists the glycan composition, the change in mass observed, and a symbol designator. 
Glycopeptide fragmentation. Fragmentation spectra were used to determine the 
glycopeptide structures. The fragmentation mode used in this study was Higher-energy C-trap 
Dissociation (HCD) (Olsen et al., 2006). The nomenclature used to describe glycopeptide and 
peptide fragmentation is from Domon and Costello (1988) and Roepstorff and Fohlmann (1984), 
respectively. 
A major benefit of HCD glycopeptide fragmentation is the reliable formation of the Y1 
ion, which is the peptide-GlcNAc ion (Segu and Mechref 2010; Hart-Smith and Rafferty 2012). 
The Y1 and peptide (Y0) ions were detected as a prominent doublet of peaks in the high m/z 
region and often appeared in multiple charge states (e.g., +1, +2, and/or +3). A representative 
glycopeptide spectrum is shown in Fig. 3.3. The most prominent features are carbohydrate 
oxonium ions in the low mass region and the Y0 and Y1 ions in the high mass region. Oxonium 
ions have long been used as markers for glycopeptides in a mixture (Huddleston et al., 1993). 
Commonly observed oxonium ions include Hex
+
 (m/z 163.06), GlcNAc
+
 (m/z 204.09), and Hex-
GlcNAc
+
 (m/z 366.14). HCD fragmentation causes GlcNAc
+
 and Hex
+
 to further decompose to 
form highly abundant internal fragment ions
 
(Zhao et al., 2011) as illustrated in Fig. 3.4, which is 
a zoomed in view of the spectrum presented in Fig. 3.3. 
The only major deviation from the characteristic detection of the Y0/Y1 pair is a 
(proposed) cross-ring fragmentation observed prominently for glycopeptides bearing glycan 
GlcNAcMan2XylGlcNAc2 (glycan o; Δ mass 1065.386) or GlcNAcMan3XylGlcNAc2 (glycan t; 
Δ mass 1227.439) (Fig. 3.5). It is proposed to be 2,5X cross-ring cleavage, with additional loss of 
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(-COCH3) from the N-acetyl group, of the innermost GlcNAc (m/z Y0 + 57.02) or the second 
GlcNAc (m/z Y1 + 57.02). 
The presence of peptide backbone fragmentation ions (b,y) and glycan-peptide 
fragmentation ions (Y), unlike the relatively constant Y1, Y0, and oxonium ions, appeared to be 
strongly dictated by the characteristics of the peptide backbone (Table 3.2). These results were in 
accordance with the mobile proton model of peptide fragmentation as reviewed by Paisz and 
Suhai (2005). For example, the features of peptide 3, LDSTANNTAEKDAAPNNPSLRGF, with 
pI 4.6, made it particularly amenable to y-ion formation (Fig. 3.6). C-Terminal to the 
glycosylation site are 17 amino acids which include both acidic (Glu, Asp) and basic amino acids 
(Lys, Arg). Acidic amino acids promote fragmentation, whereas basic amino acids tend to inhibit 
fragmentation via proton sequestration. In stark contrast, peptide 10: RTKCPSNSTRF, showed 
abundant glycan + peptide fragmentation in the form of Y-ions and very little peptide backbone 
fragmentation (Fig. 3.7). This basic peptide, pI 10.86, had short stretches of amino acids flanking 
the glycosylation site which contained proton sequestering basic residue(s) (Lys, Arg) and no 
intervening acidic residues. 
Steps 3 and 4: Glycopeptide identification and validation. Glycopeptides were 
identified using proteomics or glycoproteomics software. The proteomics software included 
MyriMatch (Tabb et al., 2007), a database search engine, DirecTag-TagRecon (Dasari et al., 
2010), a tag-based search engine, and MassRecon (Dasari et al., 2010), a mass-based search 
engine. The online tool GlycoMod (Cooper et al., 2001) identified glycopeptides by their 
accurate precursor mass.  
Because glycopeptide-specific fragment ions are not detected by those software, 
additional steps were required to validate the glycopeptide spectrum matches (gPSMs). To serve 
this purpose, a tool called gPSMvalidator was developed. Instructions for the use of 
gPSMvalidator are in Appendix A. The R scripts for gPSMvalidator are provided in 
Supplementary Data. The exceptional mass accuracy and the reliable formation of the Y1 
fragment ion were the basis for unambiguous glycopeptide validation using gPSMvalidator. It 
was modified from an existing tool in the R package ProtViz called PTM_MarkerFinder (Nanni 
et al., 2013). PTM_MarkerFinder was, in part, designed to search through HCD data for spectra 
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that contained the characteristic HexNAc
+
 oxonim ion and its internal fragments. The modified 
tool, gPSMvalidator, additionally looks for the Y1 and Y0 ions. Due to the high mass accuracy 
achieved with an orbitrap mass analyzer, the observed mass, Y1 and Y0 ions were sufficient for 
validation of glycopeptides from a single glycoprotein in this study. A list of all identified 
glycopeptides can be found in the Supplementary Data. Table 3.3 summarizes the glycopeptide 
identification results according to glycosylation site. 
Step 5: Relative quantitation of glycoforms observed at each site. The 
relative abundance of glycoforms was determined for each of the 13 glycosylation sites of WPTP 
using the relative intensity of confidently identified glycopeptides. For each glycosylation site, a 
representative peptide backbone was selected using data collected for the unenriched 
chymotrypsin digested sample. In a multi-institutional study, it was found that relative 
quantitation results for glycopeptides were most comparable between different laboratories if a 
single peptide backbone was used (Leymarie et al., 2013). Each glycoform series was observed 
in multiple charge states. The most abundant charge state for each glycoform series was used for 
relative quantitation analysis (Ozohanics et al., 2012). The selected ion chromatogram (SIC) for 
the monoisotopic peak of each compound was extracted from the total ion chromatogram. 
Alternatively, more peaks in the isotope cluster could be used; however, this approach presents 
problems in the case of overlapping isotope clusters (Ozohanics et al., 2012). To calculate the 
relative abundance, the summed intensity of each SIC was divided by the summed intensity for 
the entire glycoform series.  
The complete list of glycoforms of each glycosylation site and their relative abundance is 
presented in the Supplementary Data. Also included in this analysis was a comparison between 
the duplicate unenriched chymotrypsin samples, which were in excellent agreement. 
More than 90% of the population of each glycosylation site could be described by 3 or 
fewer glycoforms made up of only 5 of the observed glycans (Fig. 3.8). Table 3.4 shows the 
relative abundance of the major glycoforms of WPTP. Chromatographic separation of 
glycopeptides is primarily dictated by the hydrophobicity of the peptide backbone. As a result, 
each glycoform in a particular glycoform series was eluted within a specific time period. Those 
with larger, more hydrophilic glycans attached were eluted earlier (data not shown). 
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DISCUSSION 
Site occupancy. Glycoproteins may have evolved to maximize the desired interactions 
with the oligosaccharyltransferase (OST) complex in order to ensure that certain sites are always 
occupied; whereas partial occupation in the other sites may allow for fine-tuning of the 
glycoprotein function (Petrescu et al., 2004). Sites 11 and 12 were glycosylated only half of the 
time (Table 3.4). This is potentially regulated by the presence of an acidic residue just upstream 
of each of the two glycosylation sites, as seemed to be the case in other glycoproteins (Petrescu 
et al., 2004). 
Surprisingly, the proximity of sites 8 and 9 does not cause steric hindrance during the 
OST complex reaction (Table 3.4). These 2 sites were both glycosylated more than 90% of the 
time. Horseradish peroxidase (HRP) (Yang et al., 1996) and soybean peroxidase (SBP) (Gray 
and Montgomery 2006) are also diglycosylated most of the time in this region, although the sites 
are further apart. Royal palm tree peroxidase (Watanabe et al., 2010) and peanut peroxidase 
(PNP) (Zhang et al., 2004) maintain constant glycosylation in this region, using only one site. 
Site-directed removal of this glycosylation site in PNP showed that glycosylation in this region 
plays an important role in thermostability of the enzyme (Lige et al., 2001). 
Heterogeneity. An exceptional degree of heterogeneity was observed (Table 3.3); 
however, more than 90% of each glycosylation site can be described by 3 or fewer glycoforms 
(Table 3.4). Plant peroxidases are known to be heterogeneous glycoproteins; however, the 
presence of up to 30 different glycans at one site is unprecedented for plant peroxidases. The 
most heterogeneous site in HRP had 11 glycans (Yang et al., 1996), and the most in one site of 
PNP was 8 glycans (Zhang et al., 2004). Detection of so many more of the very minor complex 
components compared to existing studies is probably reflective of the huge advancements made 
in analytical mass spectrometry in the recent years. The relatively low amount of heterogeneity 
observed in PNP may stem from the fact that this is not a vacuolar peroxidase, or possibly 
because it was produced in cell culture (Zhang et al., 2004). 
The major glycans of WPTP. The paucimannosidic nature of the major glycoforms 
reiterates that WPTP is a vacuolar peroxidase. Secretion to the vacuole puts N-glycoproteins in 
contact with glycosidases (reviewed by Leonard et al., 2009) which trim the N-linked glycans to 
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reveal the major glycans observed in WPTP (Fig. 3.8). The broad-spectrum N-hexosaminidase 
HEXO1 is responsible for, Man3XylFucGlcNAc2 (glycan p; Δ mass 1170.417), the predominant 
glycan on WPTP and other vacuolar peroxidases including HRP (Yang et al., 1996), SBP (Gray 
and Montgomery 2006), and barley grain peroxidase (Henriksen et al., 1998). Endo-β-
mannosidase catalyzes production of GlcNAc2, necessary for HEXO1 to generate the other 
major glycan GlcNAc (glycan b; Δ mass 203.079) (Strasser et al., 2007), found to be prominent 
at site 3. 
Site 3. Site 3, represented by Asn 60 in WPTP is occupied by a single GlcNAc (glycan 
b; Δ mass 203.079) residue 70% of the time and by Man2XylFucGlcNAc2 (glycan k; Δ mass 
1008.365) 25% of the time. At the analogous site in HRP and SBP, Man3XylFucGlcNAc2 
(glycan p; Δ mass 1170.417) and high mannose-type glycans are found, respectively. This 
glycosylation site is in the vicinity of the distal calcium binding region. The distal calcium is 
important for maintaining the tertiary structure of the active site (Szigeti et al., 2008). Deletion of 
this site in PNP caused a 40% decrease in enzyme activity (Lige et al., 2001). The role of 
glycosylation at site 3 may be to prevent proton exchange with the solvent, maintaining the 
hydrogen bonding network between the heme active site and the distal and proximal calcium 
ions. 
The stabilizing effects of N-linked glycans appear to result from hydrophobic/hydrophilic 
interactions between the first few residues of the glycan and the side chains of neighboring 
amino acids (Wormald et al. 2002). Endo-H is an endoglycosidase that cleaves N-linked glycans 
to leave a single GlcNAc attached. After digestion of the human complement protein, CD2 with 
Endo-H, it was observed that this single carbohydrate attachment was sufficient to stabilize the 
protein (Wyss et al., 1997). Thus, the specific glycan itself may not matter as much as its 
presence. 
Workflow and tools for analysis of plant glycopeptide mass spectrometry 
data. Automated analysis of glycoproteomics data lags far behind proteomics (Desaire 2013; Li 
et al., 2013). There is a growing need for analytical tools for the analysis of plant glycoproteins 
(Strasser 2014). For plant glycoproteomics, only a few analytical workflows have been reported, 
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and none include a strategy for automated data analysis (Song et al., 2011; Ruiz-May et al., 
2012; Ruiz-May et al., 2014). 
Herein we describe a workflow and tools for analysis of plant glycopeptide mass 
spectrometry data. The workflow relied on free software. The glycan database generation tool, 
pGlycoFilter relied on GlycoMod and Excel macros. Additionally, gPSMvalidator was written in 
R. Both of these can be readily modified to suit the needs of the user. The workflow was geared 
toward HCD fragmentation data, which was a limitation. This may be the subject of future work- 
to make it compatible with other fragmentation types. 
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Table 3.1. Glycans observed on WPTP 
symbol 
glycan Δ 
mass glycan composition 
a 0 unoccupied 
b 203.079 GlcNAc(1) 
c 406.159 GlcNAc(2) 
d 552.217 GlcNAc(2)Fuc(1) 
e 714.27 GlcNAc(2)Hex(1)Fuc(1) 
f 730.264 GlcNAc(2)Hex(2) 
g 846.312 GlcNAc(2)Hex(1)Fuc(1)Xyl(1) 
h 862.307 GlcNAc(2)Hex(2)Xyl(1) 
i 876.322 GlcNAc(2)Hex(2)Fuc(1) 
j 892.317 GlcNAc(2)Hex(3) 
k 1008.365 GlcNAc(2)Hex(2)Fuc(1)Xyl(1) 
l 1024.36 GlcNAc(2)Hex(3)Xyl(1) 
m 1038.375 GlcNAc(2)Hex(3)Fuc(1) 
n 1054.37 GlcNAc(2)Hex(4) 
o 1065.386 GlcNAc(3)Hex(2)Xyl(1) 
p 1170.417 GlcNAc(2)Hex(3)Fuc(1)Xyl(1) 
q 1186.412 GlcNAc(2)Hex(4)Xyl(1) 
r 1200.428 GlcNAc(2)Hex(4)Fuc(1) 
s 1211.444 GlcNAc(3)Hex(2)Fuc(1)Xyl(1) 
t 1227.439 GlcNAc(3)Hex(3)Xyl(1) 
u 1241.455 GlcNAc(3)Hex(3)Fuc(1) 
v 1257.449 GlcNAc(3)Hex(4) 
w 1332.47 GlcNAc(2)Hex(4)Fuc(1)Xyl(1) 
x 1348.465 GlcNAc(2)Hex(5)Xyl(1) 
y 1357.502 GlcNAc(3)Hex(2)Fuc(2)Xyl(1) 
z 1362.481 GlcNAc(2)Hex(5)Fuc(1) 
aa 1373.497 GlcNAc(3)Hex(3)Fuc(1)Xyl(1) 
bb 1378.476 GlcNAc(2)Hex(6) 
cc 1389.492 GlcNAc(3)Hex(4)Xyl(1) 
dd 1403.507 GlcNAc(3)Hex(4)Fuc(1) 
ee 1430.518 GlcNAc(4)Hex(3)Xyl(1) 
ff 1494.523 GlcNAc(2)Hex(5)Fuc(1)Xyl(1) 
gg 1519.555 GlcNAc(3)Hex(3)Fuc(2)Xyl(1) 
hh 1535.55 GlcNAc(3)Hex(4)Fuc(1)Xyl(1) 
ii 1540.528 GlcNAc(2)Hex(7) 
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Table 3.1 (Continued) Glycans observed on WPTP 
symbol 
glycan Δ 
mass glycan composition 
jj 1551.545 GlcNAc(3)Hex(5)Xyl(1) 
kk 1576.576 GlcNAc(4)Hex(3)Fuc(1)Xyl(1) 
ll 1681.608 GlcNAc(3)Hex(4)Fuc(2)Xyl(1) 
mm 1697.602 GlcNAc(3)Hex(5)Fuc(1)Xyl(1) 
nn 1738.629 GlcNAc(4)Hex(4)Fuc(1)Xyl(1) 
oo 1859.655 GlcNAc(3)Hex(6)Fuc(1)Xyl(1) 
pp 1884.687 GlcNAc(4)Hex(4)Fuc(2)Xyl(1) 
qq 1900.682 GlcNAc(4)Hex(5)Fuc(1)Xyl(1) 
rr 2046.74 GlcNAc(4)Hex(5)Fuc(2)Xyl(1) 
ss 2192.798 GlcNAc(4)Hex(5)Fuc(3)Xyl(1) 
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Table 3.2. Peptide backbone features and observed fragment ion types 
peptide peptide sequence
a
 pI
b
 observed fragment ion types
c
 
1 NQSCPSAESL 4 y-ions 
2 ANNSGIAPGLIRMHF 9.8 y-ions 
3 LDSTANNTAEKDAAPNNPSLRGF 4.6 y-ions 
4 AARDSAALAGNITY 5.9 b-ions 
5 QVPSGRRDGNVSLASEAL 6 Y-ions  
6 NATQLINSF 5.5 y-ions; b-ions with loss of glycan 
7 AGKNLTADEMVTL 4.4 y-ions; b-ions with loss of glycan 
8, 9 NFSNTSQVDPTLSSSY 3.8 y-ions 
10 RTKCPSNSTRF 10.9 Y-ions 
11 TSDQALVTEANL 3.7 b-ions 
12 SAAVKNNADNLTAW 5.5 b,y-ions 
13 TGTQGEIRTNCSVVNSAS 5.7 y-ions; b-ions with loss of glycan 
a
N-Glycosylation sites underlined; all cysteines carbamidomethylated; 
b
Calculated with the 
ProtParam online tool (Gasteiger et al., 2005; web.expasy.org/protparam); 
c
Peptide ions referred 
to as b-, y-ions; glycan (with peptide attached) ions referred to as Y-ions
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Table 3.3. Microheterogeneity of glycosylation of WPTP 
site 
number of 
glycoforms observed glycans
a
 
1 3 k, m, p 
2 8 l, m, p, q, s, t, v, w 
3 12 a, b, c, d, h, i, k, o, p, t, w, aa 
4 22 d, f, g, i, j, k, l, m, p, q, r, t, v, w, aa, cc, ff, hh, kk, nn, rr, ss 
5 15 b, d, g, h, k, m, o, p, q, t, aa, hh, nn, rr, ss 
6 12 a, j, k, l, m, p, q, t, w, aa, cc, hh 
7 5 k, l, m, p, t 
8, 9 19 b, k, p, q, aa, cc, gg, hh, ii, i+p, k+n, k+p, k+q, e+ff, p+p, p+q, k+y, k+ff, p+ff 
10 33 a, b, c, e, f, g, h, i, j, k, l, m, o, p, q, t, u, w, x, z, aa, cc, ee, ff, hh, jj, ll, mm, nn, oo, pp, qq, rr 
11 2 a, p 
12 14 a, b, c, d, k, l, m, p, q, t, w, aa, ff, hh 
13 20 a, d, j, k, l, m, p, q, r, t, w, x, z, aa, bb, cc, dd, ff, hh, jj 
a
Designated by symbol defined in Table 3.1 
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Table 3.4. Relative abundance of major glycoforms of WPTP 
site peptide sequence charge 
retention 
time (min) 
glycan 
Δm 
glycan 
symbol 
expected 
m/z
a
 
relative 
ratio 
1 NQSCPSAESL 3 36 - 38 
1008.365 k 700.947 0.25 
1170.417 p 754.965 0.71 
2 ANNSGIAPGLIRM
ox
HF 3 45 - 46.2 
1170.417 p 928.751 0.89 
1227.439  947.758 0.11 
3 LDSTANNTAEKDAAPNNPSLRGF 3 42.1 - 43.8 
203.079 b 869.416 0.70 
1008.365 k 1137.844 0.25 
4 AARDSAALAGNITY 3 41 - 44 
1170.417 p 855.380 0.51 
1227.439  874.387 0.43 
5 QVPSGRRDGNVSLASEAL 3 39 - 43 
1008.365 k 955.447 0.20 
1170.417 p 1009.465 0.75 
6 NATQLINSF 2 50.2 - 50.8 1170.417 p 1089.470 0.97 
7 AGKNLTADEMVTL 2 46 - 47 1170.417 p 1267.059 0.93 
8, 9 NFSNTSQVDPTLSSSY 3 44.3 - 45 
2178.782 k + p 1309.193 0.07 
2340.834 p + p 1363.210 0.83 
10 RTKCPSNSTRF 4 27.5 - 30 
1170.417 p 631.777 0.78 
1227.439 t 646.033 0.08 
1332.47 w 672.290 0.04 
11 TSDQALVTEANL 2 46.4 - 48.9 
0 a 631.317 0.51 
1170.417 p 1216.526 0.49 
12 SAAVKNNADNLTAW 2 43.8 - 46.5 
0 a 737.868 0.65 
1170.417 p 1323.077 0.35 
13 TGTQGEIRTNCSVVNSAS 3 35.5 - 36.5 
1170.417 p 1017.770 0.80 
1332.47 w 1071.787 0.11 
a
Standard deviation of observed m/z less than 5 ppm 
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Figure 3.1. Steps of the data analysis workflow 
Step 1:  
Protein 
identification 
Step 2:  
Glycan 
identification 
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Glycopeptide 
identification 
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Relative 
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glycosylation 
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Glycopeptide 
spectrum match 
validation 
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Figure 3.2. Total ion chromatograms of digested WPTP samples. WPTP was digested with (A) 
trypsin, (B) chymotrypsin, or (C) chymotrypsin and enriched for glycopeptides. 
  
A 
B 
C 
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Figure 3.3. HCD fragmentation spectrum of a WPTP glycopeptide. The Y1 and Y0 ions are 
prominent features of the high m/z region, whereas, oxonium ions (diamonds) dominate the low 
m/z region. The assigned glycopeptide, with peptide sequence TKCPSNSTR and N-linked 
glycan, Man3XylFucGlcNAc2, glycan p (Table 3.1), is shown with reference to the cleavage sites 
for the Y1 and Y0 ions. The glycan structure was drawn with GlycanBuilder (Damerell et al., 
2012). 
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Figure 3.4. Oxonium ions in a WPTP glycopeptide HCD fragmentation spectrum. The oxonium 
ions include HexNAc
+
 (m/z 204.09) and its internal fragments (m/z 186.08, 168.07, 138.06, and 
126.06), and Hex
+
 (m/z 163.05) and its internal fragments (m/z 145.05, 127.04, and 115.04). 
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Figure 3.5. Cross-ring fragmentation of a WPTP glycopeptide. HCD fragmentation spectrum of 
this WPTP glycopeptide exhibited prominent cross-ring fragmentation. The 
2,5
X1 and 
2,5
X0, as 
opposed to the Y1 and Y0, ions were prominent features of the high m/z region. Oxonium ions 
(diamonds) dominated the low m/z region. The assigned glycopeptide, with peptide sequence 
AARDSAALAGNITY and N-linked glycan, GlcNAcMan3XylGlcNAc2, glycan t (Table 3.1), is 
shown with reference to the cleavage sites for the b- and y-peptide fragment ions as well as the 
Y1 and Y0 ions. The glycan structure was drawn with GlycanBuilder (Damerell et al., 2012). The 
chemical structure of the first 3 residues of the N-linked glycan is shown with proposed cross-
ring fragments. 
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Figure 3.6. Extensive peptide backbone fragmentation of a WPTP glycopeptide. This is an HCD 
fragmentation spectrum of a WPTP glycopeptide that exhibited extensive peptide backbone 
fragmentation. In addition to the Y1, Y0 ions, and oxonium ions (diamonds), several peptide 
backbone y-ions were detected. The assigned glycopeptide, with peptide sequence 
LDSTANNTAEKDAAPNNPSLRGF and N-linked glycan, GlcNAcMan3XylFucGlcNAc2, 
glycan aa (Table 3.1), is shown with reference to the cleavage sites for the b- and y-peptide 
fragment ions as well as the Y1 and Y0 ions. The glycan structure was drawn with GlycanBuilder 
(Damerell et al., 2012). 
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Figure 3.7. Extensive glycan fragmentation of a WPTP glycopeptide. This is an HCD 
fragmentation spectrum of a WPTP glycopeptide that exhibited extensive glycan fragmentation 
with the peptide still attached. In addition to the Y1, Y0 ions, and oxonium ions (diamonds), a 
number of glycan fragments, with peptide attached, were detected in the high m/z region, each of 
which is labeled with the glycan fragment that was attached to the peptide backbone. The 
assigned glycopeptide, with peptide sequence RTKCPSNSTRF and N-linked glycan, 
GlcNAcMan3XylGlcNAc2, glycan t (Table 3.1), is shown with reference to the cleavage sites for 
the Y1 and Y0 ions. The glycan structure was drawn with GlycanBuilder (Damerell et al., 2012). 
The chemical structure of the first 3 residues of the N-linked glycan is shown with proposed 
cross-ring fragments. 
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Figure 3.8. Proposed structures for the 5 major glycans observed on WPTP. The symbol 
designator refers to Table 3.1. The glycan structure was drawn with GlycanBuilder (Damerell et 
al., 2012). 
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CHAPTER 4. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
PURPOSE 
Windmill palm tree peroxidase has exceptional stability and unique substrate specificity; 
however, there was a knowledge gap concerning its structure. The purpose of this study was to 
fill in the gaps by determining the amino acid sequence and N-glycosylation. In the process, tools 
and a workflow for analysis of glycopeptide mass spectrometry data were developed. 
 
OBJECTIVES 
1. Determine the amino acid sequence of windmill palm tree peroxidase 
2. Develop tools and a workflow for analysis of windmill palm tree peroxidase glycopeptide 
mass spectrometry data 
3. Determine the site-specific glycosylation and microheterogeneity of windmill palm tree 
peroxidase 
 
Objective 1. The first essential knowledge gap to address was the amino acid sequence. 
As described in Chapter 2, the complete amino acid sequence and partial glycosylation were 
determined by MALDI-top-down sequencing of native WPTP, MALDI-TOF/TOF MS/MS of 
WPTP tryptic peptides, and cDNA sequencing. The propeptide of WPTP contained N- and C-
terminal signal sequences which contained 21 and 17 amino acid residues, respectively. Mature 
WPTP was 306 amino acids in length and its carbohydrate content ranged from 21 - 29%. 
An important question to answer with this study was if the royal palm tree peroxidase 
(RPTP) X-ray crystal structure could be used as a model for WPTP. Both are anionic vacuolar 
peroxidases; based on the pI and a C-terminal signal peptide for secretion to the vacuole. WPTP 
and RPTP are 88% identical suggesting that it would be a good model for WPTP. The most 
important measure of quality for a homology model is sequence identity to the template (Bordoli 
et al., 2008). At the time of proof-reading, the X-ray crystal structure of Chamaerops excelsa 
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peroxidase was reported (Bernardes et al., 2015). WPTP and CEP are 98% identical, which 
means that the X-ray crystal structure of CEP should be another good model for WPTP. 
Another important finding of the study presented in Chapter 2 was the identification of 
two amino acid residues that may explain the differences in substrate specificity of WPTP and 
RPTP (Table 2.1). Data mining of the RPTP 3D structure revealed 69 residues of potential 
importance for substrate interaction. Of these, only seven were not identical. Of the seven, only 
two had significantly different properties. Residue 142 was hydrophobic in HRP, RPTP, and 
WPTP, except that it was large in HRP (Phe) and RPTP (Ile) but small in WPTP (Thr). This 
difference could be a major factor causing the large deficit in WPTP’s reactivity toward ferulic 
acid. Residue 177 in WPTP was large, hydrophobic, and aromatic Phe, whereas it was small and 
polar Ser in RPTP. These mutations could be used to assess the validity of a 3D computational 
model of WPTP. 
Aside from the new knowledge of WPTP, the workflow used in this section is an 
accessible approach for determining the amino acid sequence of proteins. The mRNA sequence 
gives the gene sequence, but could also include the sequences of signal peptides. Edman 
degradation can give the sequence of the true N-terminus, but not that for the C-terminus. This 
issue is addressed with MALDI-top down sequencing. The simple solid-phase disulfide bond 
reduction method presented in Chapter 2 had not been reported elsewhere and it is a good 
method for dealing with top-down sequencing of proteins containing disulfide bonds. 
Objective 2. Mass spectrometry was the main analytical tool for elucidating the 
glycosylation of WPTP. The most difficult hurdle encountered during my dissertation work was 
in figuring out how to analyze the glycopeptide mass spectrometry data. The available software 
for such analyses were designed for analysis of mammalian glycosylation. Additionally, most of 
the published studies did not give a detailed description of how the data in the study were 
analyzed; a problem noted in a recent review (Desaire 2013). I had initially intended to conduct a 
structure-activity study using a mutant of WPTP; however, upon encountering this major hurdle, 
it was clear to me that I had to reevaluate my plan and design a workflow and tools tailored to 
studying the glycosylation observed on WPTP. 
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To address this need, I developed a detailed workflow for analysis of plant glycopeptide 
mass spectrometry data (Appendix A). Included in the workflow are novel tools for glycan 
database construction, pGlycoFilter, and validation of glycopeptide assignment, gPSMvalidator. 
This issue was addressed in Chapter 3. 
During the course of this work, several papers came out demonstrating the need for 
understanding the function of complex glycosylation in plants (Zhang et al., 2009; Fanata et al., 
2013; Barba-Espin et al., 2014; Strasser 2014; Sultana et al., 2015). It was previously thought 
that complex glycosylation did not play a major role in plants; as evidenced by the lack of 
phenotype associated with knock-out of complex glycosylation in Arabidopsis thaliana (von 
Schaewen et al., 1993). The only major phenotype occurred under salt stress (Kang et al., 2008). 
A recent study of the effect in rice, showed a completely different story. The mutation taking 
away the ability to form complex N-glycans was lethal (Fanata et al., 2013). As suggested by a 
recent review (Strasser 2014), new analytical platforms for studying plant glycoproteins, such as 
that developed for this study, are needed in the field of plant biology. 
The benefits of the automated workflow go far beyond saving time. An automated 
workflow takes the analysis out of the hands of the expert and makes it accessible to non-experts. 
Automated analysis reduces error and results in comparability between laboratories (Deutsch et 
al., 2008). Manual interpretation should never be completely discarded. It should always be used 
as a confirmation of the assignments. 
Objective 3. Mass spectrometry analysis of WPTP at the glycopeptide level allowed for 
detailed investigation of the glycosylation profile at each of the 13 sites of N-linked 
glycosylation. The microheterogeneity of glycosylation shows the different glycans observed at 
each site. At the most heterogeneous site, 30 different glycans were observed. Relative 
quantitation of the different glycans at each site revealed that 90% of each glycosylation site was 
occupied by 3 or fewer different glycans and that two of the sites are not occupied by a glycan 
about half of the time. Complex, hybrid, and high mannose-type sugars were observed; however, 
the major glycans were paucimannosidic which is characteristic of plant vacuolar glycoproteins 
(Yang et al., 1996; Gray and Montgomery 2006). 
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The major glycoforms identified in this objective could be modeled onto a 3D 
computational model of WPTP. A 3D structure of WPTP could reveal protein-glycan 
interactions such as hydrogen bonding. The validity of the model could be assessed by 
comparisons with the RPTP X-ray crystal structure, and another plant peroxidase crystal 
structure that was recently solved with well resolved glycans (Palm et al., 2014). 
 
FUTURE WORK 
The next step would be to make use of the structure data and test a hypothesis. In my 
opinion, the most exciting hypothesis to test would be that WPTP’s exceptional stability and 
catalysis are directly related to glycosylation and quaternary structure. The most important 
consideration for this step as far as experimental design is concerned is the selection of an 
expression system. 
A lot of evidence points to WPTP having a quaternary structure, the most important 
being the 6.5 Ca
2+
 ions. The presence of a metal cation is common at protein-protein interfaces 
(Song et al., 2014). Interestingly, palm peroxidases appear to operate as homodimers under 
normal conditions, a feature that may account for the exceptional stability and fast catalysis 
(Zamorano et al., 2008; Zamorano et al., 2009). Also, disruption of hydrogen bonding and 
hydrophobic interactions affects WPTP interactions with substrate in interesting and unsuspected 
ways (Caramyshev et al., 2006). Hydrogen bonds and salt bridges are common interactions that 
stabilize protein-protein interactions. 
In depth understanding of the roles of glycosylation and quaternary structure in WPTP 
and other peroxidases requires departure from standard expression systems such as Escherichia 
coli which fail to produce native structures. Typically, plant peroxidase structure function 
research is conducted on the recombinant enzyme produced in bacteria or yeast which affords 
high expression, ease of purification, and the ability to produce mutant forms of the enzyme. 
Such non-native enzymes are not suitable for study of glycosylation and quaternary structures. 
Thirty one HRP structures deposited in the protein data bank (PDB) were all expressed in 
E. coli. Nine class III peroxidases from other plants were also in the PDB. Of those nine, five 
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were produced in E. coli and four were from the native source. Of the 36 E. coli derived plant 
peroxidase structures, all were monomers. Two of the four native derived peroxidases were 
dimers. This provides evidence of the importance of studying the native glycosylated enzyme. 
The obvious choice is to use a plant expression system; however, expression in typical 
plant systems would be tedious and practically infeasible for studies involving mutagenesis of 
WPTP which contains 13 N-glycosylation sites, where stable transformation requires from 
several months to a year. Transient expression in tobacco would be a viable alternative 
(Leuzinger et al., 2013). In transient expression, the gene of interest is introduced to the 
developed plant system and instead of integrating into the genome; the gene of interest is directly 
manufactured in the developed plant tissue. Overall, a protein can be harvested and purified in 
less than 2 months. Such a short turnaround would allow for mutagenesis experiments as well. 
Expression yields in a 10 mg/kg range would be ample for biochemical and structural studies. 
Peroxidases from phylogenetically divergent plants tend to have similar glycosylation profiles. 
The dominant glycan in soybean peroxidase (Gray and Montgomery 2006), HRP (Yang et al., 
1996), peanut peroxidase (Zhang et al., 2004), and barley peroxidase (Henricksen et al., 1998) is 
GlcNAc2Man3FucXyl and other glycans are paucimannosidic in general. Therefore, I 
hypothesize that recombinant WPTP transiently expressed in tobacco leaves would be highly 
native-like. 
 
FUTURE PERSPECTIVES 
New analytical methods are needed for the emerging field of plant glycoproteomics 
(Ruiz-May et al., 2012; Strasser 2014). The novel methods developed in this dissertation will be 
useful for the study of other important plant glycoproteins. The tools and workflow for analysis 
of plant glycoprotein mass spectrometry data are accessible to plant biologists. The novel use of 
transient expression to produce materials to study the structure-activity relationships in plant 
glycoproteins would enable in depth study of important glycoproteins identified in plant 
glycoproteomics studies. The new knowledge of WPTP’s structure will enable in depth analysis 
of the roles of glycosylation in this unique enzyme.  
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APPENDIX A: WORKFLOW FOR ANALYSIS OF PLANT 
GLYCOPEPTIDE MASS SPECTROMETRY DATA 
 
Step 1: Protein identification 
The raw mass spectrometry files were converted to mzML format using the ‘msconvert’ 
tool in ProteoWizard (v.3.0.5006; Chambers et al., 2013; proteowizard.sourceforge.net). The 
data were filtered to only include MS level 2 and the ‘precursorRefine’ filter was applied. This 
was executed with the command: [msconvert.exe *.RAW --filter precursorRefine --filter 
“msLevel 2-”]. 
The proteins were identified with MyriMatch (v. 2.1.138; Tabb et al., 2007; 
fenchurch.mc.vanderbilt.edu), a database search engine for proteomics. The configuration for 
this and other proteomics searches is in Appendix B. The goals of the protein database were to 1) 
contain the target protein sequence, 2) contain a set of potential protein contaminants, and 3) to 
be of sufficient size for proper calculation of the false discovery rate [i.e., to be of a sufficient 
size so that the reverse sequence can be detected for false discovery rate estimation (Elias and 
Gygi, 2010)]. The protein database was constructed on November 11, 2013. It contained the 
target protein sequence obtained from mRNA sequencing (WPP_mature), a compilation of 248 
proteins that are potential contaminants in proteomics samples made available from the Max 
Planck Institute of Biochemistry (http://maxquant.org/contaminants.zip), and sequences from 
UniProt.org including all known proteins from Trachycarpus fortunei and Armoracia rusticana 
and the proteome of Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (Rice 
blast fungus) (Pyricularia oryzae). The database had a total of 25,930 proteins.  
The raw identifications for each sample type, i.e., unenriched chymotrypsin digested 
WPTP, unenriched trypsin digested WPTP, and enriched chymotrypsin digested WPTP, were 
assembled in IDPicker 3.0 (v. 3.0.545 64-bit; Zhang et al., 2008; fenchurch.mc.vanderbilt.edu) 
with default settings. A subset database was exported with decoy sequences. This subset dataset 
was used for all subsequent glycopeptide identification searches. 
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Step 2: Glycan identification 
Glycan identification involved making a list of precursor masses, making a list of exact 
peptide masses from WPTP, using GlycoMod (Cooper et al., 2001; web.expasy.org/glycomod) 
to identify the potential glycans present, and applying pGlycoFilter to test the biological 
feasibility of the predicted glycan compositions.  
First, the ‘msaccess’ tool (ProteoWizard) was used to write a table containing 
information about the precursor m/z values from the mass spectrometry data. This was executed 
using the command: [msaccess.exe *.mzML -x “spectrum_table delimiter=comma”]. GlycoMod 
requires that the observed precursor mass or singly charged mass be used. This was calculated in 
R, using the function SpectrumTable (gPSMvalidator_functions.R). The output of this function is 
a text file containing the observed precursor masses each on a separate line. 
Next, the list of peptide masses was obtained first by in silico digest of the target protein, 
WPTP, with the ‘chainsaw’ tool (ProteoWizard). This was executed using the command: 
[chainsaw.exe wpp_mature.fasta --cleavageAgentName Chymotrypsin --numMissedCleavages 2 
--specificity fully]. The fasta file contained only the WPTP protein sequence. The R function 
ChainSaw (gPSMvalidator_functions.R) was used to filter for peptides that contain Asn and to 
add the mass of chemical modifications such as that for carbamidomethylation. The output of 
this function is a text file containing the exact peptide masses each on a separate line. 
Next, all possible glycan compositions were identified using the online tool GlycoMod 
(web.expasy.org/glycomod) in the Mozilla Firefox web browser. For the ‘experimental masses,’ 
the file generated with the SpectrumTable function was uploaded. For the ‘set of unmodified 
peptide masses,’ the peptide masses generated with the ChainSaw function were used. All mass 
values were monoisotopic, with a mass tolerance of 10 ppm. The ion mode was neutral. The 
monosaccharide residues were underivatized with the following allowed compositions: Hexose 
0-9, HexNAc 1-4, Deoxyhexose 0-3, and Pentose 0-1. The compositions reported in UniCarbKB 
were listed separately. 
In order to accomplish the last step, the GlycoMod results were copied and pasted into an 
Excel spreadsheet. The contents of the top row of the spreadsheet were: glycoform mass, Δ mass 
(ppm), structure, type, peptide mass [M], peptide sequence, theoretical glycopeptide mass, mod., 
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and Links. Lastly, pGlycoFilter, written in Excel macros (pGlycoFilter macros), was run to test 
the biological feasibility of the predicted glycan compositions. The results from the unenriched 
chymotrypsin and trypsin digest and the enriched chymotrypsin digest were combined into a 
single list. The duplicates were removed and the non-redundant list of glycan masses was used as 
‘preferred delta masses’ in the MyriMatch, TagRecon, and MassRecon configuration files. 
Step 3: Glycopeptide identification 
Glycopeptides were identified using several proteomics search engines and the subset 
database produced in step 1. The proteomics software included MyriMatch (v. 2.1.138; Tabb et 
al., 2007, a database search engine, DirecTag-TagRecon (v. 1.4.71; Dasari et al., 2010), a tag-
based search engine, and MassRecon (v. 1.4.71; Dasari et al., 2010), a mass-based search engine. 
Alternatively, glycopeptides were identified using a modified GlycoMod search.  
For the DirecTag-TagRecon search, DirecTag was used to generate a ‘tags’ file for each 
of the mass spectrometry data files. Next, the tags were used in a TagRecon search. MyriMatch 
and MassRecon searches were also conducted. The configuration files for each of these searches 
is in Appendix B. 
For each sample type (e.g., unenriched chymotrypsin, enriched chymotrypsin, or 
unenriched trypsin digested), the raw identifications generated from each of the proteomics 
searches were assembled in IDPicker 3.0 using the default import settings. For the WPTP 
identifications, the peptide spectrum matches (PSMs) were exported as a .tsv file. For the 
modifications, results with a minimum of 1 were rounded to 0.001 Da and exported as a .tsv file. 
For glycopeptide identification using GlycoMod, the same conditions used in ‘Step 2: 
Glycan identification’ were used except that the mass tolerance was 15 ppm and one peptide 
mass was searched at a time. 
Step 4: Validation of glycopeptide spectrum matches (gPSMs) using 
gPSMvalidator 
In order to perform the validation step, a file for each tandem mass spectrum had to be 
written. This was accomplished with the ‘msaccess’ tool (ProteoWizard), using a command such 
as: [msaccess.exe *.mzML -x “binary sn=1783,19887” -o MS2Data_Chym1_ELUTE]. 
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Next, gPSMvalidator, written in R, was used to validate the gPSMs. One script was 
written to accept the results of the proteomics-based glycopeptide searches 
(gPSMvalidator_proteomics.R) and another was written to accept the results of the 
glycoproteomics-based search (gPSMvalidator_glycoproteomics.R). Both functions accept 
gPSMs that are within a 15 ppm mass tolerance, and contain at least 2 oxonium marker ions, and 
one Y1 or Y0 ion. The output of gPSMvalidator is a .pdf file of annotated spectra and a table of 
all validated gPSMs. These annotated spectra are provided as supplementary data 
(Annotated_gPSMs). 
These results were further confirmed by manual validation. The isotope cluster of the Y1 
and or Y0 ion(s) were checked for each gPSM using the spectrum viewer in IDPicker 3.0 or the 
‘seeMS’ tool (ProteoWizard). The isotope clusters were evaluated based on whether the picked 
peak was in the correct charge state and whether the monoisotopic peak was chosen. After 
manual validation, it was clear that some gPSMs could be reliably accepted without manual 
inspection. Annotated gPSMs that clearly showed the Y1 and Y0 ions as the two most prominent 
peaks in the high m/z region were accepted automatically. For low intensity spectra, if the Y1/Y0 
pair was observed in more than one charge state, the gPSM was automatically accepted. 
Step 5A: Compilation of validated gPSMs 
The gPSMvalidator tool excludes all spectrum matches to peptides that do not bear a 
glycan. An R script was written and used in order to include peptides with unoccupied 
glycosylation sites (findUnoccupied.R). The spectrum matches of peptides with unoccupied 
glycosylation sites were manually verified. 
All of the gPSMs were compiled into one .csv file. These included the results from the 
proteomics searches, the glycoproteomics searches, and the list of unoccupied peptides. Next, a 
script written in R was used to compile a list sortable by glycosylation site, to count the number 
of spectra identified for each peptide backbone, as well as the number of glycoforms at each 
glycosylation site (glycosylationProfileTables.R). 
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Step 5B: Relative abundance of glycoforms at each glycosylation site 
The RAW files were converted to mzML format using the ‘msconvert’ tool 
(ProteoWizard). The data were filtered to only include MS level 1 using the command: 
[msconvert.exe *.RAW --filter “msLevel 1-”]. 
The selected ion chromatograms (SICs) for the precursor m/z of each identified 
glycopeptide used for quantitation was obtained with the ‘msaccess’ tool (ProteoWizard). The 
monoisotopic peak was selected with a radius of 5 ppm. This was carried out with the following 
command: [msaccess.exe *.mzML -c quantConfig.txt, where the quantConfig.txt file contained 
the following command for each precursor m/z on a separate line: “sic mzCenter=<mz> radius=5 
radiusUnits=ppm delimiter=comma]. 
The relative abundance of each glycan at each glycosylation site was calculated from the 
SICs using a script written in R (quantitationGlycoforms.R). The results were the summed 
intensity of the SIC for each precursor m/z during the period of time that it eluted. There was not 
100% specificity, since any peak within 5 ppm was detected. For the most part, for each 
glycoform, there was a major spike in the intensity over a short period time, typically 0.5 
minutes. For some glycoforms, there was one major peak in that specific time period and some 
noise peaks during other time periods. For other glycoforms, the results were more ambiguous. 
Noise was determined by examining the MS1 spectra. Actual signal was defined as the intensity 
being due to the monoisotopic peak of the precursor m/z. The charge state of the isotope pattern 
was additional evidence that the signal was due to the glycoform precursor m/z. Signal was only 
considered valid if more than one peak in the isotope cluster could be detected. Another level of 
validation was the MS2 fragmentation spectrum being acquired during that time period. 
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APPENDIX B: CONFIGURATION FILES FOR PROTEOMICS-BASED 
PROTEIN AND GLYCOPEPTIDE IDENTIFICATION 
 
Step 1: Protein identification with MyriMatch 
StaticMods = "C 57.021" 
DynamicMods = "M ^ 15.9949 (Q * -17.026 N!{P}[ST] * 203.079 N!{P}[ST] * 1008.365 
N!{P}[ST] * 1170.417"  
MinTerminiCleavages = 1 
CleavageRules = "Chymotrypsin" or “Trypsin/P” 
MaxMissedCleavages = 2 
MaxDynamicMods = 2 
ProteinDatabase = MediumDatabase.fasta 
 
DecoyPrefix = "rev_" 
NumChargeStates = 4 
OutputFormat= "pepXML" 
OutputSuffix = "_MM-proteinID_Medium" 
TicCutoffPercentage = 0.98 
MaxPeakCount = 150 
MaxResultRank = 2 
MinPeptideMass = 0 Da 
MaxPeptideMass = 10000 Da 
MinPeptideLength = 2 
MaxPeptideLength = 75 
UseSmartPlusThreeModel = false 
ComputeXCorr = true 
UseMultipleProcessors = true 
 
FragmentationAutoRule = true 
PrecursorMzToleranceRule = "mono" 
MonoPrecursorMzTolerance = 10 ppm 
MonoisotopeAdjustmentSet = [-1,1] 
FragmentMzTolerance = 0.02 m/z 
 
Step 2: Glycopeptide identification: DirectTag 
PrecursorMzTolerance= 0.015 m/z 
FragmentMzTolerance = 0.02 m/z  
ComplementMzTolerance = 0.02 m/z 
IsotopeMzTolerance = 0.01 m/z 
DuplicateSpectra = true  
UseChargeStateFromMS = true  
NumChargeStates = 4 
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TicCutoffPercentage = 0.98  
MaxPeakCount = 100  
TagLength = 3  
MaxTagCount =  50  
StaticMods = "C 57.021" 
 
Step 2: Glycopeptide identification: TagRecon 
ProteinDatabase = rep1_subset.fasta or rep2_subset.fasta 
StaticMods = "C 57.021" 
DynamicMods = "M ^ 15.9949 (Q * -17.026 N!{P}[ST] * 203.079 N!{P}[ST] * 406.159 
N!{P}[ST] * 552.217 N!{P}[ST] * 568.212 N!{P}[ST] * 700.254 N!{P}[ST] * 714.27 
N!{P}[ST] * 730.264 N!{P}[ST] * 846.312 N!{P}[ST] * 862.307 N!{P}[ST] * 876.322 
N!{P}[ST] * 892.317 N!{P}[ST] * 933.344 N!{P}[ST] * 1008.365 N!{P}[ST] * 1024.36 
N!{P}[ST] * 1038.375 N!{P}[ST] * 1054.37 N!{P}[ST] * 1065.386 N!{P}[ST] * 1079.402 
N!{P}[ST] * 1095.397 N!{P}[ST] * 1170.417 N!{P}[ST] * 1186.412 N!{P}[ST] * 1200.428 
N!{P}[ST] * 1211.444 N!{P}[ST] * 1216.423 N!{P}[ST] * 1225.46 N!{P}[ST] * 1227.439 
N!{P}[ST] * 1241.455 N!{P}[ST] * 1257.449 N!{P}[ST] * 1298.476 N!{P}[ST] * 1332.47 
N!{P}[ST] * 1348.465 N!{P}[ST] * 1357.502 N!{P}[ST] * 1362.481 N!{P}[ST] * 1373.497 
N!{P}[ST] * 1378.476 N!{P}[ST] * 1387.512 N!{P}[ST] * 1389.492 N!{P}[ST] * 1403.507 
N!{P}[ST] * 1419.502 N!{P}[ST] * 1430.518 N!{P}[ST] * 1444.534 N!{P}[ST] * 1460.529 
N!{P}[ST] * 1494.523 N!{P}[ST] * 1510.518 N!{P}[ST] * 1519.555 N!{P}[ST] * 1535.55 
N!{P}[ST] * 1540.528 N!{P}[ST] * 1549.565 N!{P}[ST] * 1551.545 N!{P}[ST] * 1565.56 
N!{P}[ST] * 1576.576 N!{P}[ST] * 1581.555 N!{P}[ST] * 1590.592 N!{P}[ST] * 1592.571 
N!{P}[ST] * 1606.587 N!{P}[ST] * 1622.582 N!{P}[ST] * 1681.608 N!{P}[ST] * 1697.602 
N!{P}[ST] * 1702.581 N!{P}[ST] * 1711.618 N!{P}[ST] * 1713.597 N!{P}[ST] * 1722.634 
N!{P}[ST] * 1727.613 N!{P}[ST] * 1736.65 N!{P}[ST] * 1738.629 N!{P}[ST] * 1752.645 
N!{P}[ST] * 1754.624 N!{P}[ST] * 1768.64 N!{P}[ST] * 1843.66 N!{P}[ST] * 1859.655 
N!{P}[ST] * 1864.634 N!{P}[ST] * 1868.692 N!{P}[ST] * 1873.671 N!{P}[ST] * 1884.687 
N!{P}[ST] * 1898.703 N!{P}[ST] * 1900.682 N!{P}[ST] * 1914.697 N!{P}[ST] * 2005.713 
N!{P}[ST] * 2030.745 N!{P}[ST] * 2046.74 N!{P}[ST] * 2060.755 N!{P}[ST] * 2192.798" 
MinTerminiCleavages =  2  
CleavageRules = "Chymotrypsin" or “Trypsin/P” 
MaxMissedCleavages = 2 
MaxDynamicMods = 2 
MassReconMode = false 
 
UnimodXML = "C:\Program Files (x86)\BumberShoot\bumberdash-bin-windows-x86-vc100-
release-1_4_115\lib\Bumbershoot\TagRecon\unimod.xml" 
Blosum = "C:\Program Files (x86)\BumberShoot\bumberdash-bin-windows-x86-vc100-release-
1_4_115\lib\Bumbershoot\TagRecon\blosum62.fas" 
 
DecoyPrefix = "rev_" 
UseChargeStateFromMS = true  
NumChargeStates = 4  
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OutputFormat= "pepXML" 
OutputSuffix = "_specific_TagRecon_allGlycans" 
TicCutoffPercentage = 0.98  
MaxPeakCount = 200 
MaxResultRank = 2 
MinPeptideMass = 0 Da 
MaxPeptideMass = 10000 Da 
MinPeptideLength = 5 
MaxPeptideLength = 75 
UseSmartPlusThreeModel = false  
ComputeXCorr = true  
UseMultipleProcessors = true 
 
FragmentationAutoRule = true 
PrecursorMzTolerance =  0.015 m/z 
FragmentMzTolerance = 0.02 m/z 
NTerminusMzTolerance =  0.02 m/z 
CTerminusMzTolerance =  0.02 m/z 
UseAvgMassOfSequences = false  
DuplicateSpectra = true 
UseNETAdjustment = false 
 
Step 2: Glycopeptide identification: MyriMatch 
StaticMods = "C 57.021" 
DynamicMods = "M ^ 15.9949 (Q * -17.026 N!{P}[ST] * 203.079 N!{P}[ST] * 406.159 
N!{P}[ST] * 552.217 N!{P}[ST] * 568.212 N!{P}[ST] * 700.254 N!{P}[ST] * 714.27 
N!{P}[ST] * 730.264 N!{P}[ST] * 846.312 N!{P}[ST] * 862.307 N!{P}[ST] * 876.322 
N!{P}[ST] * 892.317 N!{P}[ST] * 933.344 N!{P}[ST] * 1008.365 N!{P}[ST] * 1024.36 
N!{P}[ST] * 1038.375 N!{P}[ST] * 1054.37 N!{P}[ST] * 1065.386 N!{P}[ST] * 1079.402 
N!{P}[ST] * 1095.397 N!{P}[ST] * 1170.417 N!{P}[ST] * 1186.412 N!{P}[ST] * 1200.428 
N!{P}[ST] * 1211.444 N!{P}[ST] * 1216.423 N!{P}[ST] * 1225.46 N!{P}[ST] * 1227.439 
N!{P}[ST] * 1241.455 N!{P}[ST] * 1257.449 N!{P}[ST] * 1298.476 N!{P}[ST] * 1332.47 
N!{P}[ST] * 1348.465 N!{P}[ST] * 1357.502 N!{P}[ST] * 1362.481 N!{P}[ST] * 1373.497 
N!{P}[ST] * 1378.476 N!{P}[ST] * 1387.512 N!{P}[ST] * 1389.492 N!{P}[ST] * 1403.507 
N!{P}[ST] * 1419.502 N!{P}[ST] * 1430.518 N!{P}[ST] * 1444.534 N!{P}[ST] * 1460.529 
N!{P}[ST] * 1494.523 N!{P}[ST] * 1510.518 N!{P}[ST] * 1519.555 N!{P}[ST] * 1535.55 
N!{P}[ST] * 1540.528 N!{P}[ST] * 1549.565 N!{P}[ST] * 1551.545 N!{P}[ST] * 1565.56 
N!{P}[ST] * 1576.576 N!{P}[ST] * 1581.555 N!{P}[ST] * 1590.592 N!{P}[ST] * 1592.571 
N!{P}[ST] * 1606.587 N!{P}[ST] * 1622.582 N!{P}[ST] * 1681.608 N!{P}[ST] * 1697.602 
N!{P}[ST] * 1702.581 N!{P}[ST] * 1711.618 N!{P}[ST] * 1713.597 N!{P}[ST] * 1722.634 
N!{P}[ST] * 1727.613 N!{P}[ST] * 1736.65 N!{P}[ST] * 1738.629 N!{P}[ST] * 1752.645 
N!{P}[ST] * 1754.624 N!{P}[ST] * 1768.64 N!{P}[ST] * 1843.66 N!{P}[ST] * 1859.655 
N!{P}[ST] * 1864.634 N!{P}[ST] * 1868.692 N!{P}[ST] * 1873.671 N!{P}[ST] * 1884.687 
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N!{P}[ST] * 1898.703 N!{P}[ST] * 1900.682 N!{P}[ST] * 1914.697 N!{P}[ST] * 2005.713 
N!{P}[ST] * 2030.745 N!{P}[ST] * 2046.74 N!{P}[ST] * 2060.755 N!{P}[ST] * 2192.798" 
MinTerminiCleavages = 2 
CleavageRules = "Chymotrypsin" or “Trypsin/P” 
MaxMissedCleavages = 2 
MaxDynamicMods = 2 
ProteinDatabase = rep1_subset.fasta or rep2_subset.fasta 
 
DecoyPrefix = "rev_" 
NumChargeStates = 4 
OutputFormat= "pepXML" 
OutputSuffix = "_specific_MM-glycopeptideID" 
TicCutoffPercentage = 0.98 
MaxPeakCount = 150 
MaxResultRank = 2 
MinPeptideMass = 0 Da 
MaxPeptideMass = 10000 Da 
MinPeptideLength = 2 
MaxPeptideLength = 75 
UseSmartPlusThreeModel = false 
ComputeXCorr = true 
UseMultipleProcessors = true 
 
FragmentationAutoRule = true 
PrecursorMzToleranceRule = "mono" 
MonoPrecursorMzTolerance = 10 ppm 
MonoisotopeAdjustmentSet = [-1,1] 
FragmentMzTolerance = 0.02 m/z 
 
Step 2: Glycopeptide identification: MassRecon 
ProteinDatabase = rep1_subset.fasta or rep2_subset.fasta 
StaticMods = "C 57.021" 
DynamicMods = "M ^ 15.9949 (Q * -17.026 N!{P}[ST] * 203.079 N!{P}[ST] * 406.159 
N!{P}[ST] * 552.217 N!{P}[ST] * 568.212 N!{P}[ST] * 700.254 N!{P}[ST] * 714.27 
N!{P}[ST] * 730.264 N!{P}[ST] * 846.312 N!{P}[ST] * 862.307 N!{P}[ST] * 876.322 
N!{P}[ST] * 892.317 N!{P}[ST] * 933.344 N!{P}[ST] * 1008.365 N!{P}[ST] * 1024.36 
N!{P}[ST] * 1038.375 N!{P}[ST] * 1054.37 N!{P}[ST] * 1065.386 N!{P}[ST] * 1079.402 
N!{P}[ST] * 1095.397 N!{P}[ST] * 1170.417 N!{P}[ST] * 1186.412 N!{P}[ST] * 1200.428 
N!{P}[ST] * 1211.444 N!{P}[ST] * 1216.423 N!{P}[ST] * 1225.46 N!{P}[ST] * 1227.439 
N!{P}[ST] * 1241.455 N!{P}[ST] * 1257.449 N!{P}[ST] * 1298.476 N!{P}[ST] * 1332.47 
N!{P}[ST] * 1348.465 N!{P}[ST] * 1357.502 N!{P}[ST] * 1362.481 N!{P}[ST] * 1373.497 
N!{P}[ST] * 1378.476 N!{P}[ST] * 1387.512 N!{P}[ST] * 1389.492 N!{P}[ST] * 1403.507 
N!{P}[ST] * 1419.502 N!{P}[ST] * 1430.518 N!{P}[ST] * 1444.534 N!{P}[ST] * 1460.529 
N!{P}[ST] * 1494.523 N!{P}[ST] * 1510.518 N!{P}[ST] * 1519.555 N!{P}[ST] * 1535.55 
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N!{P}[ST] * 1540.528 N!{P}[ST] * 1549.565 N!{P}[ST] * 1551.545 N!{P}[ST] * 1565.56 
N!{P}[ST] * 1576.576 N!{P}[ST] * 1581.555 N!{P}[ST] * 1590.592 N!{P}[ST] * 1592.571 
N!{P}[ST] * 1606.587 N!{P}[ST] * 1622.582 N!{P}[ST] * 1681.608 N!{P}[ST] * 1697.602 
N!{P}[ST] * 1702.581 N!{P}[ST] * 1711.618 N!{P}[ST] * 1713.597 N!{P}[ST] * 1722.634 
N!{P}[ST] * 1727.613 N!{P}[ST] * 1736.65 N!{P}[ST] * 1738.629 N!{P}[ST] * 1752.645 
N!{P}[ST] * 1754.624 N!{P}[ST] * 1768.64 N!{P}[ST] * 1843.66 N!{P}[ST] * 1859.655 
N!{P}[ST] * 1864.634 N!{P}[ST] * 1868.692 N!{P}[ST] * 1873.671 N!{P}[ST] * 1884.687 
N!{P}[ST] * 1898.703 N!{P}[ST] * 1900.682 N!{P}[ST] * 1914.697 N!{P}[ST] * 2005.713 
N!{P}[ST] * 2030.745 N!{P}[ST] * 2046.74 N!{P}[ST] * 2060.755 N!{P}[ST] * 2192.798" 
MinTerminiCleavages =  2  
CleavageRules = "Chymotrypsin" or “Trypsin/P” 
MaxMissedCleavages = 2 
MaxDynamicMods = 2 
MassReconMode = true 
 
UnimodXML = "C:\Program Files (x86)\BumberShoot\bumberdash-bin-windows-x86-vc100-
release-1_4_115\lib\Bumbershoot\TagRecon\unimod.xml" 
Blosum = "C:\Program Files (x86)\BumberShoot\bumberdash-bin-windows-x86-vc100-release-
1_4_115\lib\Bumbershoot\TagRecon\blosum62.fas" 
 
DecoyPrefix = "rev_" 
UseChargeStateFromMS = true  
NumChargeStates = 4  
OutputFormat= "pepXML" 
OutputSuffix = "_specific_MassRecon_allGlycans" 
TicCutoffPercentage = 0.98  
MaxPeakCount = 200 
MaxResultRank = 2 
MinPeptideMass = 0 Da 
MaxPeptideMass = 10000 Da 
MinPeptideLength = 5 
MaxPeptideLength = 75 
UseSmartPlusThreeModel = false  
ComputeXCorr = true  
UseMultipleProcessors = true 
 
FragmentationAutoRule = true 
PrecursorMzTolerance =  0.015 m/z 
FragmentMzTolerance = 0.02 m/z 
NTerminusMzTolerance =  0.02 m/z 
CTerminusMzTolerance =  0.02 m/z 
UseAvgMassOfSequences = false  
DuplicateSpectra = true 
UseNETAdjustment = false 
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APPENDIX C: PLANT N-GLYCAN BIOSYNTHESIS PATHWAY 
 
The tool ‘pGlycFilter’ can be used to assess the biological feasibility of plant glycan 
compositions predicted by GlycoMod (Cooper et al., 2001; web.expasy.org/glycomod). It is 
based on the N-glycan biosynthesis pathway in plants. The tool pGlycoFilter is available as 
supplementary data (pGlycoFilter macros). 
Some proteins contain an N-terminal signal peptide that targets them to the secretory 
pathway (Stanley et al., 2009). This signals the nascent polypeptide to be introduced into the 
lumen of the endoplasmic reticulum (ER). If the sequence Asn-Xxx-Ser/Thr, where Xxx is not 
Pro, is encountered, it may be recognized by the oligosaccharyltransferase (OST) complex and 
have a bulky glycan attached (Glc3Man9GlcNAc2). The glycan is trimmed by α-glucosidases and 
α-mannosidases to yield an oligomannose-type glycan (Man9GlcNAc2). Glycoproteins bearing 
these oligomannose-type glycans are then secreted to the Golgi where the process of 
‘maturation’ takes place. The spatial location of the following processes was reviewed by Ruiz-
May et al. (2012). 
During residence in the Cis-Golgi α-mannosidase I (GMI) removes 1 – 4 α(1,2)-mannose 
(Man) residue(s) (Szmilo et al., 1986). Next, N-acetylglucosaminyltransferase I (GNTI) adds an 
N-acetylglucosamine (GlcNAc) residue to the α(1,3)-mannose branch. The major substrate for 
GNTI is Man5GlcNAc2. Other substrates Man6GlcNAc2, Man7GlcNAc2, and Man9GlcNAc2 
exhibited no activity (Johnson and Chrispeels, 1987; Tezuka et al., 1992).  
Upon secretion to the Medial-Golgi, Golgi α-mannosidase II (GMII) sequentially 
removes the α(1,6)-linked and α(1,3)-linked mannose residues from the α(1,6)-mannose branch 
(Strasser et al., 2006). GMII had no activity toward Man5GlcNAc2 and GlcNAc on the α(1,3)-
branch was required for activity. Next, GNTII adds a GlcNAc residue to the α(1,6)-mannose 
branch (Johnson and Chrispeels, 1987; Tezuka et al., 1992; Strasser et al., 1999). GNTII adds 
GlcNAc only after the activity of GMII. GlcNAc1Man3GlcNAc2 is the major substrate of GNTII 
and no transfer of GlcNAc to Man5GlcNAc2 and Man3GlcNAc2 was observed. Following the 
activity of GNTI or GNTII, core fucosylation and xylosylation by α(1,3)-fucosyltransferase 
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(α(1,3)-FucT) and β(1,2)-xylosyltransferase (XylT) could occur (Johnson and Chrispeels 1987; 
Tezuka et al., 1992). The major requirement of these enzymes is the presence of at least one 
terminal GlcNAc. 
The optional elaboration of Lewis A structures occurs upon secretion to the Trans-Golgi. 
The first step in this process is the addition of galactose to one or two of the terminal GlcNAc(s) 
by β(1,3)-galactosyltransferase (GalT) (Strasser et al., 2007). Only after terminal galactosylation 
can addition of terminal fucose to the terminal GlcNAc(s) occur through the action of α(1,4)-
fucosyltransferase (α(1,4)-FucT) (Leonard et al., 2002).  
Further trimming by glycosidases occurs for N-glycoproteins secreted to the vacuole 
(Leonard et al., 2009). In particular, the vacuolar β-N-acetylglucosaminidase, HEXO1 is the 
main enzyme responsible for the paucimannose glycan structures that are prevalent in vacuolar 
N-glycoproteins (Strasser et al., 2007). HEXO1 is a broad-spectrum β-N-acetylglucosaminidase 
that does not appear to have a preference for either terminal GlcNAc residue. Endo-β-
mannosidase would act on the core β-linked mannose residue whereas a vacuolar α-mannosidase 
would be responsible for removal of all other mannose residues which are α-linked. The N-
glycosylation biosynthetic pathway dictated by the action of these enzymes was the basis for 
pGlycoFilter (pGlycoFilter macros). 
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APPENDIX D. DESCRIPTION OF SUPPLEMENTARY DATA 
 
Proteomics software 
This folder contains the proteomics software used in Chapter 3. ProteoWizard contains 
many tools including a spectrum viewer, ‘seeMS,’ and all of the tools needed for processing of 
the mass spectrometry data. IDPicker 3.0 is needed for viewing the IDPicker databases which 
contain the protein identification results. BumberShoot contains all of the proteomics search 
tools including MyriMatch. Each of these software is individually under an Apache License, 
Version 2.0. 
Mass spectrometry raw data 
This folder contains the raw mass spectrometry files described in Chapter 3. The raw 
mass spectrometry files have been uploaded to the ProteoSAFe webserver (massive.ucsd.edu) 
under MassIVE ID: MSV000079086. These data can be viewed using the ‘seeMS’ tool 
(ProteoWizard). 
Protein databases 
This folder contains the protein databases used for the proteomics searches in Chapter 3. 
They are described in more detail in Appendix A. 
Identification results 
This folder contains all of the protein and glycopeptide identification results presented in 
Chapter 3. IDPicker databases are a convenient way to archive proteomics data which is 
accepted by proteomics journals such as Molecular & Cellular Proteomics. The files can be 
viewed with the IDPicker 3.0 software. The Excel spreadsheet (Supplementary_Tables.xlsx) 
contains the list of all validated glycopeptide spectrum matches (S. Table 1) as well as the 
relative quantitation table showing all glycoforms (S. Table 2). The annotated glycopeptide 
spectrum matches are in a pdf file (Annotated_gPSMs.pdf). 
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pGlycoFilter macros 
This text file contains the macros, written for use in Microsoft Excel, for pGlycoFilter. 
This tool for glycan database generation is based on the plant N-glycan biosynthesis pathway, 
described in Appendix C and Chapter 3. Instructions for its use are in Appendix A. 
R scripts 
This folder contains all R scripts used to analyze data in Chapter 3. The specific use of 
each one is described in Appendix A. The script, ‘gPSMvalidator_functions.R,’ contains all of 
the functions needed to run gPSMvalidator and to complete other tasks such as making a 
spectrum table and calculating peptide masses. One script was written to accept the results of the 
proteomics-based glycopeptide searches (gPSMvalidator_proteomics.R) and another was written 
to accept the results of the glycoproteomics-based search (gPSMvalidator_glycoproteomics.R). 
The script, ‘findUnoccupied.R,’ was written to find peptide spectrum matches for unoccupied 
glycosylation sites. Another script was written to compile a list sortable by glycosylation site, to 
count the number of spectra identified for each peptide backbone, as well as the number of 
glycoforms at each glycosylation site (glycosylationProfileTables.R). The script, 
‘quantitationGlycoforms.R ,’ was written to calculate the relative abundance of each glycan at 
each glycosylation site from the selected ion chromatograms. 
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APPENDIX E. GUANIDINATION OF TRYPTIC PEPTIDES WITHOUT 
DESALTING FOR MATRIX-ASSISTED LASER 
DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY 
ANALYSIS2 
 
 
  
                                                 
2
 Reproduced in part with permission from Baker, M. R. and Li, Q. X. Guanidination of Tryptic Peptides without 
Desalting for Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry Analysis. Analytical 
Chemistry 2013, 85, 8873–8880. Copyright  © 2013, rights managed by the American Chemical Society. 
Guanidination of Tryptic Peptides without Desalting for Matrix-
Assisted Laser Desorption/Ionization-Time-of-Flight Mass
Spectrometry Analysis
Margaret R. Baker and Qing X. Li*
Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, 1955 East-West Road, Honolulu, Hawaii
96822, United States
ABSTRACT: Derivatizations that enhance mass spectral quality
often require desalting, which presents as a bottleneck in matrix-
assisted laser desorption/ionization-time-of-ﬂight mass spec-
trometry (MALDI-TOF MS)-proteomics. Guanidination, which
converts lysine to homoarginine, an arginine analogue, can
increase detection of those peptides 5−15-fold. Our aim was to
improve guanidination by using a novel reagent, O-methylisour-
ea-freebase. In a simple reaction, interfering salts were removed
prior to guanidination. Freebase preparation took about 30 min
and could be applied to samples all at once as opposed to
desalting samples one-by-one for 5 min each. For freebase
guanidinated BSA tryptic peptides, more than 6-times the
peptides were observed relative to tryptic peptides or those
guanidinated with the conventional reagent, O-methylisourea hemisulfate. Peptide signals increased more than 10-fold relative to
those from guanidination with the conventional reagent and were equivalent to those from conventional guanidination with
desalting. In addition, freebase guanidination allowed for a lower limit of detection when combined with another derivatization,
N-terminal sulfonation, as evidenced by tandem mass spectrometry (MS/MS) fragmentation analysis of in-gel digests of
cytochrome c. Freebase guanidination of rat lung proteins after 2-D gel electrophoresis allowed for identiﬁcation of all tested
protein spots regardless of protein characteristics (MW or pI) or abundance. Co-derivatization with N-terminal sulfonation
conﬁrmed the identity of low-abundance proteins in 2-D gel spots that contained more than one protein. The freebase
guanidination reagent is simple to prepare and to implement. Desalting is not needed prior to MALDI-TOF MS. Freebase
guanidination eﬀectively increases the dynamic range of detection of lysine-containing peptides while decreasing the work needed
for sample preparation.
Matrix-assisted laser desorption/ionization-time-of-ﬂightmass spectrometry (MALDI-TOF MS) is an important
analytical tool for proteomics due to its high throughput
capability and robustness. It is the method of choice for
identifying proteins separated by 2-D gel electrophoresis (2-
DGE), which in combination with MALDI-TOF MS is valuable
for examining roles of proteins involved in biological
processes1−3 and for discovery of biomarkers.4−6
2-DGE separates proteins into single protein spots that can
be excised from the gel and digested with a protease, typically
trypsin. Trypsin cleaves proteins at the C-terminus of arginine
or lysine into peptides suitably sized for MS analysis (i.e., 700−
4000 Da). The basic functionality of the C-terminus of tryptic
peptides stabilizes the positive charge necessary for MS.
In MALDI-TOF MS, a distinct bias is observed toward
arginine-terminated peptides on the order of 5−15-fold
intensity when compared to their lysine-terminated counter-
parts.7 The guanidine side group of arginine (pKa 12.5) has a
more favorable acid−base reaction with the matrix and ionizes
more readily in the MALDI process than the amine side group
of lysine (pKa 10.5).
7,8 This so-called “arginine eﬀect” is also
observed during time-of-ﬂight (i.e., mass analysis), where
peptides terminating in arginine are less prone to metastable
fragmentation.9
Chemical derivatization is commonly employed to improve
the quality of MALDI-TOF spectra.10 Guanidination is a
derivatization that fully takes advantage of the “arginine eﬀect”
to increase the dynamic range of detection by converting lysine
to homoarginine, an arginine analogue. At an alkaline pH (pH
> 10.5), O-methylisourea reacts with the ε-amino group of
lysine to form homoarginine in a selective manner.11−13
Shifting the functionality of lysine to mirror that of arginine
is beneﬁcial for a number of reasons, the most apparent being
an increase in detection of lysine-terminated peptides. Such an
increase could improve proteome coverage in peptide mass
ﬁngerprinting (PMF)12 studies and could allow for in-depth
analysis of single proteins. For example, guanidination allowed
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for pin-pointing of oxidation sites thought to be unique to
Parkinson’s disease.5
Guanidination can also prevent unwanted side-reactions to
lysine when the N-terminus is to be derivatized. N-Terminal
sulfonation, which promotes uniform fragmentation in MALDI-
TOF MS/MS, is arguably the most common derivatization to
combine with guanidination.14 Such a combination was used to
increase coverage of 2-D gel excised proteins1 and in de novo
sequencing of novel proteins.15−19 In quantitative proteomics,
guanidination was used directly as an isotopic tag20 or as a
protecting group prior to labeling the N-terminus with a
tag.21,22 Another advantage of guanidination is the mass shift of
42 Da which helps distinguish lysine from glutamine (Δ 0.04
Da).11
Salts from guanidination interfere with MALDI-TOF MS,
and desalting is required.23 Desalting is time-consuming, labor
intensive, and costly. Consequently, guanidination is often
performed as a second pass on protein spots that did not result
in a statistically signiﬁcant identiﬁcation.1,24 Relative quantita-
tion using isotope labeled guanidination reagents could be
automated except for the desalting step.20
Alternative guanidination methods do not require desalting;
however, there are disadvantages. Desalting is optional for a
commercial guanidination kit that uses a low concentration of
O-methylisourea-salt.25 However, potential problems include
incomplete derivatization, which complicates spectra and may
interfere with quantitation. Although in-gel guanidination of
proteins prior to digestion was assumed to be complete, it is
incompatible with in-solution digests.26,27 Sergeant et al.26
reported that trypsin has lower digest eﬃciency toward
homoarginine, resulting in longer peptides which tend to be
more diﬃcult to analyze.
The objective of this study was to develop freebase
guanidination, which is a simple and robust alternative to the
conventional guanidination procedure. Use of O-methylisourea-
freebase increases sensitivity and high-throughput capability of
the MALDI-proteomics workﬂow. In a simple reaction, O-
methylisourea-salt is reacted with barium hydroxide, the
products of which separate easily: O-methylisourea-freebase
goes to the aqueous phase and unwanted salts precipitate.28
The freebase guanidination reagent gives complete guanidina-
tion and does not leave behind interfering salts. This is
especially useful for applications, as demonstrated, for which
additional puriﬁcation steps are not desirable.
■ EXPERIMENTAL SECTION
Materials and Reagents. Trypsin Gold, MS grade, was
purchased from Promega (Madison, WI). Standard proteins:
BSA, ovalbumin (chicken), myoglobin (horse), and cyto-
chrome c (horse) (Sigma, St. Louis, MO) were used. The
MALDI matrix α-cyano-4-hydroxycinnamic acid (HCCA) and
Peptide Calibration Standard II were from Bruker (Billerica,
MA). C18 NuTips were from PolyLC (Columbia, MD). Other
reagents included O-methylisourea-hemisulfate (Sigma), ba-
rium hydroxide octahydrate (J.T. Baker Chemicals), ammo-
nium hydroxide (NH4OH) (Mallinckrodt, Inc.), and 2-
sulfobenzoic acid cyclic anhydride (Acros Organics, New
Jersey). Acetonitrile (LC−MS grade) and ammonium bicar-
bonate (NH4HCO3) were from Fisher Scientiﬁc. Water was
puriﬁed on a Milli-Q Advantage A10 system (Millipore,
Billerica, MA). Laemmli sample buﬀer, Bio-Safe Coomassie
Stain, and other gel electrophoresis supplies were purchased
from Bio-Rad (Hercules, CA). Rat lung tissues from 8 week-old
Sprague−Dawley Crj:CD 1GS male rats were provided by the
Korean Rural Development Administration (Gyeonggi-do,
Korea).
One-Dimensional Gel Electrophoresis (1-DGE). Mix-
tures of standard proteins were separated via 1-DGE in
triplicate.29 The mixtures consisted of 12.5, 25, or 50 pmol each
of BSA, ovalbumin, myoglobin, and cytochrome c. Proteins
were separated on a 12% polyacrylamide gel with a
MiniProtean apparatus (Bio-Rad) at a constant 15 mA for 2
h. The gel was stained with Bio-Safe Coomassie Stain according
to the Bio-Rad protocol.
2-DGE. Proteins were extracted from homogenized rat lung
tissues in rehydration buﬀer (Bio-Rad), and the concentrations
were determined with a Bradford assay.30 Lung proteins were
separated via 2-DGE according to the Bio-Rad protocol.31
Whole protein extract (200 μg) was applied to an immobilized
pH gradient strip (7 cm, pH 3−10, linear) using active
rehydration at 50 V for 16 h at 20 °C on a Protean i12
isoelectric focusing (IEF) cell (Bio-Rad). IEF consisted of rapid
ramping to 250 V (15 min), gradual ramping to 4 000 V (1 h),
and then rapid ramping at 4 000 V for 15 000 V h. The second
dimension was run on a precast gel (Any kD Mini-Protean
TGX, Bio-Rad) at a constant 200 V for 0.5 h. The gel was
stained with Bio-Safe Coomassie Stain as described for 1-DGE.
Spots were manually picked with a pipet tip, modiﬁed by
cutting oﬀ the end of the tip.
In-Gel Trypsin Digest. In-gel trypsin digestion was
conducted according to a protocol from Cold Spring Harbor32
with only slight modiﬁcation to peptide extraction. Following
reduction and alkylation, proteins were digested with trypsin
[12.5 (2-D gel spots) or 25 ng of trypsin (1-D gel bands) in 50
mM NH4HCO3] at 37 °C for 16 h. Peptides were extracted by
sonication for 5 min at ambient temperature in 25 mM
NH4HCO3, followed by addition of acetonitrile and repeated
sonication. After transferring the supernatant into fresh vials,
peptides were extracted in 0.05% triﬂuoroacetic acid (TFA) and
then 0.05% TFA, 50% acetonitrile. 1-D gel extracts were
divided into three aliquots for comparison of three guanidina-
tion methods (freebase, conventional, and conventional with
desalting) and then were dried via SpeedVac.
In-Solution Trypsin Digest. In-solution trypsin digestion
of BSA (200 pmol) was conducted in triplicate according to
Russell et al.,33 which was completed in 1 h by incorporating
80% acetonitrile into the digest solution. Reduction and
alkylation were also in 80% acetonitrile solution. Peptides
were dried via SpeedVac and resuspended in 100 μL of 5%
acetonitrile, 0.3% formic acid and stored at −20 °C.
Guanidination Reagent Preparation. The freebase
guanidination reagent was prepared with signiﬁcant modiﬁca-
tion to Imbeah et al.28 in order to make the ﬁnal product
suitable for downstream MS application. To prepare O-
methylisourea-freebase, 50 mg of O-methylisourea hemisulfate
was dissolved in 51 μL of water and then added to 64 mg of
barium hydroxide octahydrate to yield an 8 M O-methylisourea
and 4 M barium hydroxide solution. It is important to note that
barium hydroxide should be in a 1:1 (mol/mol) ratio with
sulfate. The freebase reaction was mixed by pulse vortexing (10
min) and then centrifuged (20 800g) at 4 °C for 5 min. The
clear supernatant (40 μL) was collected, avoiding the pellet.
Next, 112 μL of acetonitrile was added to bring it to ∼74%
acetonitrile. The solution was vortexed for 15 s and a
precipitate formed. The precipitate was pelleted as in the
previous step. The mixture separated into three phases, one
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solid precipitate and two liquid phases. An aliquot of 100 μL
(2.11 M O-methylisourea-freebase in 74% acetonitrile, pH 9−
10) was carefully collected from the top liquid layer and mixed
with 25 μL of 14.8 N NH4OH, 35 μL of acetonitrile, and 51 μL
of water to prepare a 1.0 M O-methylisourea-freebase solution
in 50% acetonitrile containing 1.75 N NH4OH (pH 11) as the
working solution. The conventional guanidination reagent was
prepared with slight modiﬁcation to Beardsley and Reily.23 O-
Methylisourea hemisulfate (50 mg) was dissolved in 119.3 μL
of water, 163.2 μL of acetonitrile, and 96.5 μL of 14.8 N
NH4OH, making a solution of 1.0 M O-methylisourea, 40%
acetonitrile, 3.5 M NH4OH (pH 11).
Guanidination. Dried peptides were dissolved in 5 μL of
O-methylisourea-freebase or O-methylisourea hemisulfate sol-
ution by sonication for 5 min. After guanidination at 65 °C for
20 min, the solution was dried via SpeedVac for approximately
5 min.
Sulfonation. Sulfonation was conducted with modiﬁcation
to Keough et al.14 Sulfonation solutions were prepared daily by
dissolving 20 mg of 2-sulfobenzoic acid cyclic anhydride in 1
mL of dry tetrahydrofuran. Dried guanidinated peptides were
dissolved in 2.5 μL of 25 mM triethylammonium bicarbonate,
50% acetonitrile. Next, 2.5 μL of the sulfonation solution was
added to bring it to pH 8−9, followed by sonication for 5 min
at ambient temperature. After the reaction, the solution was
evaporated via SpeedVac.
Sample Preparation for Mass Spectrometry. Freebase
guanidinated peptides (with or without sulfonation) were
dissolved in 5 μL of 0.25% TFA, 50% acetonitrile (pH 2).
Conventionally guanidinated peptides (with or without
sulfonation) were optionally desalted with C18 NuTips as per
the manufacturer’s instructions. After desalting, the sample was
eluted with 5 μL of 0.05% TFA, 60% acetonitrile into a clean
tube.
Samples were mixed 1:1 with the matrix (0.7 mg/mL HCCA
in 85% acetonitrile, 0.1% TFA, 1 mM ammonium phosphate,
monobasic), and 1 μL was deposited on the AnchorChip target
plate (Bruker) and allowed to air-dry. Alternatively, 0.5 μL of
Figure 1. MALDI-TOF spectra of BSA (25 fmol) tryptic peptides before (A) and after desalting (B), after conventional guanidination without
desalting (C) and with desalting (D), and after freebase guanidination (E). For reference, the m/z and peptide range (BSA; UniProt accession
P02769) are given for some peaks. Asterisks indicate peaks contributing to protein identiﬁcation, and red asterisks highlight the peaks that diﬀer
between parts D and E.
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the sample was deposited on a standard steel target followed by
0.5 μL of the matrix (20 mg/mL HCCA in 70:30 [v/v]
acetonitrile/5% formic acid) and allowed to air-dry. Peptide II
calibration standard, in the same matrix, was spotted adjacent to
the samples.
Mass Spectrometry. MALDI-TOF MS/(MS) was con-
ducted with an Ultra Flex III (Bruker) using Flex Control v. 3.4.
All spectra were acquired in positive reﬂectron mode and were
externally calibrated. For MS mode, 1 000 laser shots were
summed. For automated acquisition, 10 attempts were made
before aborting acquisition. Manual data acquisition was then
attempted for aborted acquisitions. Parent ions were
fragmented in LIFT mode.34 Data were sent to Flex Analysis
v. 3.4 for spectral processing. Peak picking and residue
assignments were manually veriﬁed.
Protein Identiﬁcation. Spectral data were subjected to a
Mascot search35 on a local Mascot server v. 2.2.7 (Matrix
Science, Boston, MA) via ProteinScape v. 3 (Bruker). For PMF,
the mass tolerance was 50 ppm and carbamidomethyl cysteine
was a global modiﬁcation. Upon veriﬁcation that no under-
ivatized lysines were detected, homoarginine was set as a global
modiﬁcation. Fragmentation spectra were submitted to a
Mascot MS/MS search with a mass tolerance of 50 ppm and
MS/MS tolerance of 0.3 Da. Carbamidomethyl cysteine and
homoarginine were global modiﬁcations, and N-terminal
sulfonation, listed as 3Sulfo, was a variable modiﬁcation.
Identiﬁcations were based on signiﬁcant matches at p < 0.05.
■ RESULTS AND DISCUSSION
O-Methylisourea-Freebase Preparation and Use. The
improved guanidination reagent, O-methylisourea-freebase, was
prepared in less than 30 min while waiting for gel peptide
extracts to dry. In a simple reaction between O-methylisourea
hemisulfate salt and barium hydroxide, O-methylisourea-
freebase separated into the aqueous phase while salts
precipitated. The salts are aqueous soluble to an extent
(barium sulfate [2.5 μg/mL], unreacted O-methylisourea
hemisulfate [100 mg/mL], unreacted barium hydroxide
octahydrate [38.9 mg/mL]) but are not soluble in organic
solvents. Upon agitation in 74% acetonitrile, residual salts
precipitated. The ﬁnal freebase guanidination solution includes
1.0 M O-methylisourea-freebase, which was eﬃcient for
complete guanidination of tryptic peptides,23 50% acetonitrile,
which aided in resolubilizing dried peptides, and 1.75 N
NH4OH, which maintained the reaction pH (pH 11). Drying
the peptides after the 20 min reaction eﬀectively removed
NH4OH. Dried freebase guanidinated peptides were dissolved
in 0.25% TFA, 50% acetonitrile prior to cocrystallization with
HCCA. Addition of 5 μL of that solution (which is equivalent
to 1 reaction volume) had little or no eﬀect on cocrystallization.
Freebase versus Conventional Guanidination of In-
Solution BSA Digests. Tryptic peptides from in-solution
digestion of BSA were used to optimize freebase guanidination
conditions and to examine the beneﬁts of freebase guanidina-
tion compared to conventional guanidination, which uses O-
methylisourea hemisulfate, with and without desalting. In the
present study, 25 fmol of BSA was the lowest amount for which
a positive identiﬁcation could be obtained for the tryptic
peptides via a database search (Figure 1A). The four peptides
used for identiﬁcation resulted in 7% sequence coverage.
Desalting and sample concentration with C18 NuTips improved
sequence coverage by more than 5-fold (39% sequence
coverage; Figure 1B). Conventional guanidination without
desalting resulted in a marked reduction in ion intensity and a
noisy background which prevented detection of all but 4
peptide ions (7% sequence coverage; Figure 1C). Desalting of
conventionally guanidinated peptides removed interfering salts,
increasing signal and lowering background noise (50%
sequence coverage; Figure 1D). With freebase guanidination,
interfering salts are removed prior to guanidination. After
freebase guanidination, there was minimal background noise
and the signal intensity was equivalent to that of desalted
samples (Figure 1B,D, and E). Both freebase guanidination and
the conventional procedure are alleviated from the “arginine
eﬀect,” whereas for tryptic peptides, one peak dominated the
spectrum (Figure 1B; m/z 927; YLYEIAR). Sequence coverage
after freebase guanidination was comparable to the conven-
tional method with desalting (46% sequence coverage).
Diﬀerences in peptide ions contributing to sequence coverage
were noted (red asterisks; Figure 1D,E). Peptide ions exclusive
to conventional guanidination with desalting were found in the
lower end of the mass range, whereas those exclusive to
freebase guanidination were larger. This is in line with the
observations that desalting with a C18 microcolumn leads to the
loss of more hydrophobic peptides.23,36 No underivatized
lysines were detected after freebase guanidination, indicating a
quantitative reaction.
Freebase versus Conventional Guanidination of
Standard Proteins Digested In-Gel. Guanidination is pH
sensitive. The reaction relies on the ε-amino group of lysine
being deprotonated. The optimal pH is 11.313 with a minimum
of pH 10.23 The freebase guanidination solution was adapted to
ensure that it is compatible with standard in-gel digest
procedures, which use acidic conditions to extract peptides. A
mixture of varying amounts of the four standard proteins was
separated by 1-DGE (Figure 2). At 12.5 pmol of each protein,
cytochrome c was barely detectable, so this amount was used in
the remainder of the study. The higher acid content of gel
extracts required 10-times more NH4OH than in-solution
digested peptides to achieve the optimal reaction pH. When a
lesser amount of base was used, guanidination was incomplete.
High-throughput capability with MALDI-TOF MS relies on
eﬃcient automated data acquisition. Samples were spotted on
an AnchorChip target, and data were collected in automated
mode. Sequence coverage and the Mascot score were about the
same for freebase guanidination and conventional guanidina-
tion with desalting (Table 1). The sequence coverage for these
Figure 2. 1-DGE of mixtures of standard proteins (50, 25, or 12.5
pmol). Boxes indicate bands excised for further experiments.
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was about 10 percentage points higher than conventional
guanidination without desalting for all proteins except
cytochrome c, which was more than 30 percentage points
lower. Only one replicate from conventional guanidination
without desalting was interpretable for cytochrome c, which was
near the limit of detection (LOD) for Coomassie staining
(Figure 2). These data indicate major advantages of freebase
guanidination over conventional guanidination with or without
desalting at low protein concentration conditions for
cytochrome c, potentially for other proteins as well. Freebase
guanidination is therefore eﬀective in increasing the dynamic
range of detection while decreasing the work needed in sample
preparation.
Repeatability measures how reliable a method is. A few
samples from freebase guanidination and conventional
guanidination with desalting failed during automated acquis-
ition, whereas most from conventional guanidination without
desalting failed. The missing data were collected manually. For
the four standard proteins and each of the replicates, a
signiﬁcant identiﬁcation could be obtained 100% of the time
when the freebase method or the conventional method with
desalting was used. Less than half of those examined after
conventional guanidination without desalting were successfully
identiﬁed (Table 1; repeatability). AnchorChip targets are the
most convenient for automated data acquisition.37 These
targets are also known for increasing sensitivity by concentrat-
ing the sample into a smaller area, which comes with the
consequence of other components concentrating as well.37 As a
result, an enhancement was not observed for freebase
guanidinated samples and the data quality for conventional
guanidination without desalting was critically reduced. Also,
sample drying time was increased with AnchorChip use. The
best compatibility was with the standard target plate, which can
be used for automated data acquisition.
Freebase versus Conventional Guanidination when
Combined with N-Terminal Sulfonation. In MALDI-TOF
MS/MS, fragmentation occurs through a charge-remote
mechanism, so spectra are not as readily interpretable as
those from electrospray (ESI)-MS/MS.38 N-Terminal sulfona-
tion facilitates unambiguous interpretation of MALDI-TOF
MS/MS fragmentation spectra wherein y-ions are almost
exclusively detected.14 A major advantage of guanidination is
that its coderivatization with N-terminal sulfonation gives no
side reactions.13
N-Terminal sulfonation with 2-sulfobenzoic acid could be
conducted without sample cleanup.26 Therefore, the three
guanidination methods were compared after N-terminal
sulfonation of the standard protein digests with this chemical
(Table 2). The 20 most intense peaks were subjected to MS/
MS fragmentation, and scores of signiﬁcant peptide identi-
ﬁcations were summed. For cytochrome c, which stained very
faintly after 1-DGE (Figure 2), a positive identiﬁcation from the
fragmentation spectra could only be obtained with freebase
guanidinated samples. Compared to conventional guanidina-
tion without desalting, freebase guanidination had more
peptides identiﬁed and higher scores from the Mascot MS/
MS search. For ovalbumin, conventional guanidination with
desalting is the preferred method since two additional peptides
were identiﬁed by MS/MS fragmentation analysis leading to a
higher score. Freebase guanidination well identiﬁed four out of
four proteins, whereas the conventional method with desalting
identiﬁed three out of four. This and previous studies showed
that desalting is needed for the conventional guanidination
method,23 and sample losses are an unavoidable concern when
desalting with C18 microcolumns.
23,36 Freebase guanidination
did not require desalting, which improved sensitivity of
detection (Table 2). This was particularly important since N-
terminal sulfonation decreases sensitivity.26 A more thorough
investigation demonstrating applicability to a wider range of
proteins is given in the following section.
Application of Freebase Guanidination and its Co-
Derivatization with N-Terminal Sulfonation to Analysis
of Rat Lung Proteins from 2-DGE. Lung diseases continue
to be challenging to diagnose and treat.39,40 Insights into the
biology of lung cancer4,6 as well as an understanding of
pulmonary development2 have been gained with the use of
proteomics. A major objective of the present study was to
implement freebase guanidination in the analysis of lung
proteins separated by 2-DGE. Successful implementation was
assessed by the capacity to yield statistically signiﬁcant protein
Table 1. Comparison of Freebase Guanidination to Conventional Guanidination with and without Desaltinga
freebase conventional without desalting conventional with desalting
proteinb MW (kDa) pI scorec sequence coverage (%) score sequence coverage (%) score sequence coverage (%)
BSA 66 5.6 227 45 226 35 267 45
ovalbumin 42 5.2 158 57 131 41 133 55
myoglobin 17 7.4 173 75 159 65 170 74
cytochrome c 12 9.6 160 56 56a 19a 145 53
repeatabilityd (%) 100 48 100
aResults are for samples from 1-DGE in Figure 2 and are representative of all replicates except cytochrome c from conventional guanidination
without desalting, which had only 1 replicate with interpretable results. b75 fmol per spot. cMascot PMF score. dThe % identiﬁed out of 48 (4
proteins × 3 replicates × 4 technical replicates).
Table 2. Comparison of Freebase Guanidination to Conventional Guanidination with and without Desalting When Combined
with N-Terminal Sulfonationa
BSA ovalbumin myoglobin cytochrome c
scoreb peptides score peptides score peptides score peptides
freebase 406 14 342 7 180 6 158 3
conventional without desalting 190 6 178 6
conventional with desalting 393 16 437 9 137 7
aResults for samples from 1-DGE (Figure 2). bSummed ions scores from Mascot MS/MS search.
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identiﬁcations regardless of protein characteristics or abun-
dance.
Whole protein extracts from rat lung were separated via 2-
DGE. A total of 20 spots, which captured a wide range of
molecular weight and isoelectric points with detection by
Coomassie staining, were chosen from the gel (Figure 3).
Identiﬁcation was achieved through PMF of freebase
guanidinated samples (Table 3). Further conﬁrmation was
achieved by coderivatization with N-terminal sulfonation and
MS/MS fragmentation of at least one peptide. For each of the
20 proteins, a signiﬁcant PMF identiﬁcation was obtained
regardless of protein characteristics (MW or pI) or abundance.
Fragmentation analysis after coderivatization with N-terminal
sulfonation allowed for successful identiﬁcation of 18 out of 20
spots. The two that were not identiﬁed (spots 10 and 19)
exhibited very low staining. The LOD by Coomassie staining
coincides with that of MALDI-TOF MS/MS (estimated
according to refs 31 and 34). For a 97.2 kDa protein,
phosphorylase b, 50−100 fmol was required for MS/MS
analysis34 and the lower LOD for Coomassie staining was 8−28
ng of protein,31 which is equivalent to 46−160 fmol of
phosphorylase b.
PMF results warranted MS/MS fragmentation analysis for
two main reasons: (1) the protein was not represented in the
Swiss-Prot database,41 which is manually annotated and
reviewed, or (2) the spot contained a mixture of proteins.
The mass spectrum of spot 2 after trypsin digestion and
freebase guanidination is shown (Figure 4A). An initial search
in the Swiss-Prot database41 returned no signiﬁcant hits. A
Mascot search using a larger database, NCBI nr, resulted in a
match to the predicted protein collagen α-1 (VI) for which
there is currently no protein level data available (UniProt
Knowledgebase42 entry last updated May 29, 2013 for accession
number D3ZUL3_RAT). A total of 20 peaks, within the mass
range of m/z 995−3257, were used in the identiﬁcation (Figure
4A). Of these, ﬁve were found to contain hydroxyproline (m/z
995, 1356, 1572, 1708, and 1724). Sulfonation with
sulfobenzoic acid cyclic anhydride results in a mass shift of
184 Da (O3S−C6H4−CO). After N-terminal sulfonation, eight
sulfonic acid derivatives were detected (Figure 4B). A red
dashed line indicates a shift of 184 Da for a peptide (m/z 1187,
Figure 4A) to its sulfonic acid derivative (m/z 1371, Figure
4B), which was selected for MS/MS fragmentation (Figure
4C). In the fragmentation spectrum, the highest peak was from
a loss of the aromatic sulfonic acid group and ammonia (Δ 201,
HO3S−C6H4−CO−NH2, Figure 4C). This and the observed
Figure 3. 2-DGE of rat lung tissues. Numbers indicate protein spots
excised from the gel and used for protein identiﬁcation (Table 3).
Table 3. List of Proteins from 2-DGE of Rat Lung Tissues Identiﬁed with Freebase Guanidination and Conﬁrmed by Co-
Derivatization with N-Terminal Sulfonationa
guanidination only guanidination + sulfonation
spot accessionb protein protein scorec sequence coverage (%) ions scored peptides
1 P12346 serotransferrin 233 31 49 1
2 D3ZUL3 predicted protein collagen α-1 (IV) 149 24 70 2
3 P06761 78 kDa glucose-regulated proteine 248 41 47 2
4 P63018 heat shock cognate 71 kDa proteine 125 23 47 1
5 P02770 serum albumin 356 62 238 8
6 P31000 vimentin 265 67 72 2
7 Q8VIF7 selenium-binding protein 1e 117 29 32 2
8 P20059 hemopexine 121 31 54 1
9 P69897 tubulin β-5 chain 114 44 39 1
9 P17475 α-1-antiproteinase 146 42 35 1
10 P18418 calreticulin 149 26
11 P85125 polymerase I and transcript release factor 58 12 61 2
12 P60711 actin, cytoplasmic 1 171 59 75 1
13 P25113 phosphoglycerate mutase 1f 99 51 19 1
14 P58775 tropomyosin β chain 91 37 53 1
15 B0BNN3 carbonic anhydrase 1f,g 100 56 60 2
16 P08010 glutathione S-transferase Mu 2f,g 126 51 23 1
17 O35244 peroxiredoxin-6 244 61 23 1
18 P01946 hemoglobin subunit α-1/2 62 37 47 1
19 P42930 heat shock protein β-1g 79 32
20 P02091 hemoglobin subunit β-1g 209 95 92 2
a2-DGE spot (Figure 3). bUniProt Knowledgebase accession number. cMascot PMF score. dSummed ions scores from MS/MS Mascot search.
eBackground proteins are serum albumin. fBackground proteins are hemoglobin subunit β-1. gBackground proteins are hemoglobin subunit α-1/2.
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y−17-ions are expected for sulfonic acid derivatives of peptides
containing an internal arginine or homoarginine.14,26
Diﬀerential post-translational modiﬁcation and proteolytic
cleavage of a highly abundant protein can result in occurrence
of that protein in more than one spot.39 This phenomenon may
obscure detection of low abundance and potentially relevant
proteins. Several such high abundance proteins were detected
in the present study, including serum albumin and hemoglobin.
Fragmentation spectra were instrumental in verifying low-
abundance components in various spots (3, 4, 7, 8, 13, 15, 16,
19, and 20; Figure 3 and Table 3). For example, PMF of spot 8
revealed that serum albumin peaks accounted for 75% of the
ion intensity, whereas those of hemopexin accounted for only
11%. Analysis of MS/MS fragmentation spectra conﬁrmed the
presence of hemopexin in the mixture.
■ CONCLUSIONS
Problems associated with guanidination using O-methylisourea
hemisulfate appeared to stem exclusively from the salts, making
use of O-methylisourea-freebase ideal. In the present study, no
underivatized lysines were detected, suggesting that freebase
guanidination is quantitative. This contributes to better
sensitivity and reproducibility. The beneﬁts of freebase
guanidination were most apparent under demanding sample
conditions as was seen after co-derivatization with N-terminal
sulfonation, which is known to negatively impact sensitivity. In
the 2-DGE workﬂow, sample preparation was streamlined by
avoiding time-consuming cleanup steps and PMF identiﬁcation
was obtained regardless of protein abundance.
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1. Introduction
Native chemical ligation is a strategic tool for the assembly of
poor yielding peptide and poly-peptide sequences. This simple
chemical approach makes possible the complete solution-phase
condensation of two individual fully deprotected peptide moieties
of varying lengths to form a site-directed native-state peptide bond
[3,4,6]. This approach enables sequential ‘block peptide’ elongation
in a selective and controlled manner. Native chemical ligation
deviates from the traditional convergent solid phase peptide
synthesis (SPPS) strategies, with the latter incorporating the
coupling of a fully orthogonally protected peptide fragment onto
an existing peptide–resin support, an approach typically directed
by extending normal amino acid coupling procedures [1,10].
Extensions of native chemical ligation now include the
chemical and semi-synthesis of large functional proteins
(>10 kDa). This includes ion channels [4,14,15,25,39] and the
incorporation of small synthetic peptide fragments into larger
recombinant proteins [17], which enables the introduction of
various non-native amino acids [23,38], ﬂuoro-derviatives (see Ref.
[25]) and afﬁnity labels [36]. These represent unique products to
the native chemical ligation strategy, with most unachieved via
convergent strategies.
Cysteine-rich peptide toxins provide ideal models for chemical
synthesis via native chemical ligation, as many are difﬁcult to
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synthesize or produce in high yields using standard linear SPPS
techniques due to their length, hydrophobic nature and multi-
cysteine content [37]. The requirements for native chemical
ligation peptide candidacy are: (i) an introduced C-terminal thiol
ester in the lead N-terminal peptide segment, and (ii) an N-
terminal Cysteine in the following C-terminal peptide segment
(see Fig. 1). The N-terminal cysteine of (ii) can be easily
accommodated by the relevant abundance and sequential
positioning of cysteine moieties throughout the length of many
classes of peptide toxins. We envisaged that synthesis of longer
(>40 amino acid) peptide toxins by native chemical ligation of20
amino acid fragments would offer potential advantages in yields
due to: (a) reduction of inherent cumulative stepwise SPPS
deletions, (b) relative ease of synthesizing and purifying shorter
peptides, and (c) avoiding problems of side reactions, disulﬁde
cross-linking and hydrophobic aggregation encountered during
acid cleavage of longer, hydrophobic, multiple cysteine-containing
peptides.
An important consideration in native chemical ligation synth-
esis is the kinetic dependence of the ligation reaction on the side
chain of the C-terminal amino acid thiol ester of the N-terminal
peptide segment (see ref. [16]). The success of ligation is
dependent on its selection. Some amino acids at this position
(e.g., Leu, Thr, Val, Ile, Pro) have slow reaction or coupling rates and
lead to poor yields of the ligated target species. In some cases,
substitution at this position may be required to give reasonable
yields of the ligated product. However, a single amino acid
substitution may also have signiﬁcant consequences on a toxin’s
speciﬁcity, targeting and overall pharmacological behavior, in
some cases rendering a toxin candidate biologically inactive (see
Refs. [33,34]). Here, careful design based on comparative structural
and pharmacological identity of similar peptide toxin sequences is
an important aspect of successful peptide toxin bioengineering.
In this paper, we illustrate the design and synthesis of a 37
amino acid scorpion toxin derivative, iberiotoxin V16A/D19-Cys-4-
MeOBzl, via native chemical ligation. The derivative’s retention of
pharmacological speciﬁcity and selectivity to the BKCa2+-activated
K+ channel (KCa 1.1) is veriﬁed by electrophysiological assay. The
native chemical ligation approach to increased synthetic yields
offers an alternative route to bioengineering cysteine stabilized a/
b motif containing scorpion toxins, which have numerous
applications for biological studies of ion channels such as KCa1.1.
2. Materials and methods
2.1. Synthesis of 3-Mercapto-Propionic Acid-Leucine (MPAL) base
resin
4-Methylbenzhydrylamine [MBHA] resin (0.79 mmole g1;
Peptides International) was pre-swollen overnight in dimethyl-
formamide (DMF) and 650mL N,N-diisopropylethylamine (DIEA).
After washing the swollen resin with DMF, Boc-Leu (2 mmole) was
activated with 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluro-
nium hexaﬂuorophosphate (HBTU) (0.5 M in DMF, 4 mL) and
347 mL of DIEA and allowed to couple for 40 min. After both DMF
and dichloromethane (DCM) washes (each 40 mL), the Boc group
was removed with 50% (v/v) TFA/DCM (2 min  5 min). 3,30
dithiopropionic acid (2 mmole) dissolved in HBTU (0.5 M in
DMF, 8 mL) was then mixed with sufﬁcient DIEA to both activate
and neutralize the resin and allowed to couple for 40 min. The resin
Fig. 1. Schematic representation of the chemical native ligation process involving two peptide fragments to produce a bioengineered Iberiotoxin derivative. Peptide A, the
leading fragment (16mer) contains both the C-terminal thiol ester, as well as the substituted Val16 to Ala to promote kinetic feasibility during the ligation reaction. Peptide B,
the Following Fragment (21mer) contains a free N-terminal cysteine to participate and regenerate its chemical functionality during and after ligation respectively – the latter
is required for sequential disulﬁde bond formation. Peptide B also contains an orthogonally protected Cys-4-MeOBzl at position 19 within the full ligated parent sequence.
This speciﬁc position has demonstrated to be a point for chemical bioconjugation or derivatization which does not greatly affect the biological activity or speciﬁcty of the
parent toxin. Sequential molecular masses, as determined by ESMS, illustrate the progressive chemical modiﬁcations that occur which result in the full length folded parent
toxin of 37 amino acids containing 3 disulﬁde bonds (oxidation is indicated by curved bar above peptide fragement A–B).
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was then washed with DMF and then treated with 650mL
ethanolamine and 200mL DIEA in 5 mL DMF for 40 min to cap
resin-bound-OBt esters. A DMFwash was followed by reduction of
the resin-bound disulﬁde with 2-mercaptoethanol (650 mL 2-
mercaptoethanol, 100 mL DIEA in 5 mL DMF) for 1 h. Following
another wash with DMF, Boc-Ala (2 mmole) was activated with
HBTU, as above, and immediately coupled for 20 min.
2.2. Boc SPPS of N-terminal portion of Iberiotoxin
Peptide A (ZFTDVDCSVSKECWSA16-[MPAL]) was manually
assembled via Boc SPPS using in-situ neutralization with 2 mmole
Boc-amino acid per 10 min single coupling, as described by
Schno¨lzer et al. [31], using the above described [MPAL]-loaded
resin. After each coupling step, yields were determined by
measuring residual free amine with the quantitative ninhydrin
assay [30] and maintained above 99.5 % or end-capped with Ac2O
(100mL in 5 mL DMF) if yield was not achieved. Side chain
protecting groups were Asp(cyclohexyl), Cys(4-methylbenzyl),
Glu(cyclohexyl), Lys(2-chlorobenzyloxycarbonyl), Ser(benzyl) and
Thr(benzyl). Tryptophan was unprotected. Pyroglutamic acid (Z)
was coupled in the same way as the other residues. Upon
completion of the synthesis, the resin was washed with DMF
followed by DCM and then dried under N2.
2.2.1. HF cleavage
Peptide-[MPAL]-resin was stirred with 20 mL HF and 1 mL p-
cresol for one hour at 0 8C. HF was removed in vacuo and the
residue treated with 100 mL of cold methyl tert-butyl-ether to
precipitate the peptide. The solids were collected onto a glass
sinter, washed twice with 50 mL methyl tert-butyl-ether, and the
peptide dissolved in 100 mL 50/50 (v/v) acetonitrile (MeCN)/H2O
containing 0.1% (v/v) TFA. The solution was lyophilized and stored
at 20 8C until required.
2.3. Preparative RP-HPLC/UV of N-terminal portion of Iberiotoxin:
Peptide A (ZFTDVDCSVSKECWSA16-[MPAL])
The crude peptide was dissolved in 50 mL unbuffered GnHCl
(pH 4) and loaded onto a Phenomenex 21.2 mm  250 mm C4
column (300 A˚, 10–15 mm) equipped with a 21.2 mm  60 mm
guard column packed with the same material. The initial mobile
phase was 100% Solvent A. The GnHCl was eluted from the column
using Solvent A at 10 mL min1, followed by elution of the peptide
using a two step gradient (0–20% Solvent B 0–20 min, 20–45%
Solvent B 20–80 min). Fractions were collected and analyzed by
infusion MS. Those containing the target peptide were pooled and
lyophilized.
2.4. Fmoc SPPS of C-terminal portion of Iberiotoxin
Peptide B [17CKC(4-MeOBzl)LFGVDRGKCMGKKCRCYQ37], 100mM
scalewas assembledautomatically via solidphase Fmoc coupling, at
KeckPeptideFacility (YaleUniversity) in the followingmanner: Peg-
Resin (0.18 mmol g1) was washed three times with DMF (2.5 mL),
deprotected twice with 20% (v/v) piperidine (2.5 mL, 2  0.5 min),
and then washed six more times with DMF (2.5 mL). Fmoc-amino
acids (0.5 mmole) were activated by 1.5 mL 0.4 M HBTU/DMF/N-
methyl-Morpholine and double coupled (20 min.). Upon coupling
completion, the peptide–resinwaswashedwithDMF (2.5 mL) three
times. Side chain protecting groups were: Cys(4-MeOBzl) [position
19 only], Cys(Trt), Lys(Boc) Asp(tBu), Arg(Pbf), and Gln(Trt). On
completion of the synthesis the resin was washed with DMF
followed by DCM and then dried under N2. The peptide was cleaved
and reverse-phase high performance liquid chromatography/ultra-
violet detection (RP-HPLC/UV) puriﬁed using a semi-preparative
Vydac C18 column (300 A˚, 5mm, 7.8 250 mm). Samples were
eluted using a linear 1% min1 gradient of organic (90/10 MeCN/
0.08%, v/v TFAaq.; Solvent B) against 0.1% (v/v) TFAaq. (Solvent A) at
a ﬂow rate of 1 mLmin1.
2.4.1. TFA cleavage
Resulting Fmoc peptides were subjected to a double cleavage
with 96% (v/v) TFA in the presence of Anisole (2%, v/v) and H2O
(2%, v/v), acting as protecting group scavengers, for 2 h at 24 8C.
The resulting cleaved peptidematerial was recovered as previously
described and stored at 20 8C as lyophilized powder until
required.
2.5. Analytical RP-HPLC/UV
Synthetic peptides were separated/quantiﬁed either by C18 or
C4 analytical RP-HPLC/UV (Vydac; 5mm, 300 A˚, 4.6  250 mm),
using the described conditions above. Eluants were monitored at
223 or 280 nm.
2.6. Native ligation
Typically N-terminal-peptide-[MPAL] (Peptide A) and 4-
MeOBzl containing C-terminal peptide (peptide B), in equal molar
ratios (30 mM), were dissolved in 4 mL 6 M GnHCl, 100 mM
sodium phosphate pH 7.9 and mixed with 30 mL each of
thiophenol and benzylmercaptan then allowed to stand at 40 8C.
After 18 h a sample was analyzed by LC/MS to conﬁrm the reaction
had taken place. After 21 h the solution was diluted with 50 mL
unbuffered 6 M GnHCl and extracted with three times 40 mL
methyl tert-butyl-ether. After removal of a sample for LC/MS
analysis, the ligated IbTx-V16A/D19C-4-MeOBzl (Lig-IbTx-
MeOBzl) was immediately puriﬁed by RP-HPLC (Vydac C4
10 mm  250 mm column, gradient 0–25% Solvent B 0–25 min,
25–37% Solvent B 25–85 min). Fractions were analyzed by infusion
MS, pooled and lyophilized.
2.7. Fmoc SPPS of IbTxD19C-Acm, IbTx-D19K-LC-biotin and linear
IbTx-V16A/D19C-4-MeOBzl
Three IbTx analogues were linearly synthesized (0.5 mmole
scale), all using the same automated Fmoc synthesizer and
cleavage protocols as described in Section 2.4. Here, the standard
Fmoc-amino acid and corresponding protecting groups were as
previously indicated, except for the use of Fmoc-Cys-Acm
in position 19 for IbTx-D19C-Acm [ZFTDVDCSVSKECWSVCKC(-
Acm)LFGVDRGKCMGKKCRCYQ], Fmoc-Lys(biotin-LC)-OH [N-a-
Fmoc-N-e-(D-biotin-6-amidocaproate)-L-lysine; Anaspec Inc.] in
position 19 for IbTx-D19K-LC-biotin [ZFTDVDCSVSKECWSVCKK(-
LC-biotin)LFGVDRGKCMGKKCRCYQ], and Fmoc-Cys(4-MeOBzl)-
OH in position 19 for linear IbTx-V16A/D19C-4-MeOBzl [ZFTD-
VDCSVSKECWSACKC(-4-MeOBzl)LFGVDRGKCMGKKCRCYQ].
2.8. Oxidation of IbTx analogues
Lig-IbTx-MeOBzl, IbTx-D19C-Acm and IbTx-D19K-LC-biotin
(10 mg) were sonicated in 20 mL of oxidation buffer of 2 M urea,
0.1 M NaCl, 0.1 M glycine, pH 7.8 in an effort to aid peptide
solubility and decrease peptide aggregation potential during
oxidation. Peptides were allowed to oxidize in air by stirring at
22 8C for 18 h. Slow oxidation of linear IbTx-V16A/D19C-4-MeOBzl
(10 mg) was aidedwith the introduction of 50% (v/v) 2-propanol in
to the above N2 purged oxidation buffer (20 mL) and allowed to stir
at 22 8C for 36 h. Peptides were immediately acidiﬁed (neat TFA),
ﬁltered (0.22 mm) and subjected to preparative RP-HPLC/UV
puriﬁcation, as described in Section 2.3.
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2.9. Puriﬁcation and characterization of folded peptides
Puriﬁcation of the folded toxin derivates was achieved by RP-
HPLC/UV—ﬁrst on a semi-preparative column, followed by
narrow-bore analysis, peptide co-elution and quantiﬁcation using
Vydac C18 columns both subjected to a linear 1% min
1 gradient of
0.1% (v/v) TFA aq. against 90% (v/v) MeCN in 0.08% (v/v) TFA aq.
over 60 min. UV absorption was monitored at 223 nm. Electro-
spray mass spectroscopy of the folded and puriﬁed peptides was
performed on a LQC Thermo Finnigan spectrometer.
2.10. Peptide quantiﬁcation
Peptide concentrations were determined by RP-HPLC/UV
integration of peptide samples [Peptide A and B; IbTx-D19K-LC-
biotin, standard linear IbTx-V16A/D19C-4-MeOBzl, Lig-IbTx-
MeOBzl and IbTx-D19C-Acm], which had previously undergone
quantitative amino acid hydrolysis and PTH derivatization and
quantiﬁcation (Keck Peptide Facility, Yale University).
2.11. MALDI TOF/TOF analysis
RP-HPLC/UV puriﬁed peptides fractions in aqueous 0.1% TFA
were mixed 1:1 with matrix solution (2,5-dihydroxybenzoic acid
[DHB] in 1:1 0.1% TFA:MeCN) and spotted onto a thin layer of dried
matrix (DHB) saturated in methanol on the target plate. The spots
were dried under a stream of N2 gas. Parent ions were identiﬁed on
theUltraﬂex IIIMALDI TOF/TOF (BrukerDaltonics), controlledby the
Compass 1.2 SR1 software package (Bruker), in positive reﬂector
mode. Parent ions were further selected in the LIFT-MS/MS mode.
Peptide II CalibrationMix (Bruker)was used for external calibration.
2.12. Planar bilayer assay of Lig-IbTx-MeOBzl
Single-channel recording of KCa1.1 channels from rat skeletal
muscle in planar lipid bilayers was performed as previously
described [7]. The recording solution was 200 mM KCl, 10 mM
Mops-KOH, pH 7.4 on both sides of the bilayer, with 0.2 mM CaCl2
on the intracellular side and 0.1 mM EDTA plus 0.1 mg mL1
bovine serum albumin on the extracellular side as deﬁned by
native asymmetry of the channel.
2.13. Electrophysiological assay of Lig-IbTx-MeOBzl
Lig-IbTx-MeOBzl was tested for blocking activity against
human KCa1.1 channels. An N-terminal Flag-BK version of the
human KCa1.1 channel (HSlo) was stably expressed in a human cell
line (HEK293) as previously described [2]. Channel activity was
monitored by the whole-cell patch clamp electrophysiological
technique [18] using an Axon 200B ampliﬁer and Clampex
software (Axon Instruments) for voltage pulse programming and
data acquisition. The pipette (intracellular) solution containing
0.5 mM free Ca2+ [35] was 100 mM KCl, 1 mM MgCl2, 1 mM CaCl2,
1.3 mM EGTA, 10 mM Hepes-KOH, pH 7.2. The standard bath
(extracellular) solution was 145 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mMMgCl2, 10 mMHepes-KOH, pH 7.4. Brieﬂy, macroscopic HSlo
currents were recorded from single HEK293-HSlo cells in whole-
cell mode by stepping the membrane voltage from a holding
potential of 80 mV to a series of consecutive test potentials
delivered in increments of +10 mV up to +100 mV for 100 ms.
Current records, low-pass ﬁltered at 5 kHz, were corrected for
capacitance transients and leak current using a negative P/5 pulse
protocol. Synthetic scorpion toxins and paxilline (Sigma–Alrich)
were applied to cells by continuous gravity perfusion of the bath
solution (0.5 mL min1) into a low volume cell recording chamber
(RC24E, Warner Instruments).
3. Results
Stepwise linear SPPS approaches failed to provide a free
‘spinster thiol’ D19C derivative of IbTx. Failure is suspected as a
result of incorrect disulﬁde pairing or intra-molecular disulﬁde
bonding. Possible conﬁrmation is provided by IbTx-D19C-Acm, an
orthogonally protected ‘spinster thiol’ derivative. This oxidized
biologically active derivative (Obs. MH+ 4265.4 Da, Calc. MH+
4265.8 Da) demonstrated a Kd of 1.6 nM via lipid bilayer (Table 1),
and demonstrated characteristic discrete long-lived blocked states
upon assay by single BKCa channels as observed in other aKTx1
toxins (see [11,2]; data not shown). Synthetic yields of IbTx-D19C-
Acm were 2% per 100 mg peptide oxidized. Selective thiol
deprotection using AgBF4, as described by Yoshida et al. [40],
resulted in a biologically inactive form of IbTx-D19C. Molecular
mass analysis indicated the presence of methionine sulfoxide (a
difference of +16 Da; Obs. MH+ 4211.2 Da, Calc. MH+ 4210.8 Da)
that accounted for biological inactivity by a structuralmodiﬁcation
of Met29 (see Ref. [32]). With these results, alternative approaches
were examined to construct an IbTx orthogonally protected
‘spinster thiol’ template derivative in high yields.
3.1. Peptide assembly
Synthesis of IbTx-D19K-LC-biotin (as discussed in Section 2)
provided 183 mg g1 of resin, with the target peptide representing
24% of total RP-HPLC/UV proﬁle at 223 nm of the crude cleaved
material. Typically upon oxidation and puriﬁcation, 2.8–3.3 mg of
folded bioactive material was recovered for each 100 mg oxidized
(2.8–3.3% yield).
Linearly synthesized IbTxV16A/D19C-4-MeOBzl provided
212 mg of material per gram of resin via double cleavage, with
the target peptide representing 15% of total RP-HPLC/UV proﬁle at
223 nm. Upon oxidation and puriﬁcation, 1 mg of folded material
was recovered for each 100 mg oxidized (1% yield).
For native chemical ligation, Peptide A, 16 amino acids in
length; IbTx [1–16]V16A-COSR (Obs. MH+ 1988.2 Da, Calc. MH+
1988.7 Da; Fig. 1), was manually assembled via Boc SPPS on the
described [MPAL] base resin. Typically single HF cleavage of one
gram of resin provided 260 mg of peptide material, with the target
peptide representing 37% of total RP-HPLC/UV proﬁle at 223 nm.
Upon puriﬁcation of the reducedmaterial,<99% purity, 14 mgwas
recovered for each 100 mg of crude peptide (14% yield).
Peptide B, 21 amino acids in length (Fig. 1), was assembled via
automated Fmoc SPPS. Single acid cleavage of Peptide B was
undertaken with 180 mg of peptide recovered from one gram of
resin. RP-HPLC/UV analysis indicated the presence of a dominant
peak (62% of the total RP-HPLC/UV proﬁle) correlating to the target
thiol-protected material. Molecular mass analysis conﬁrmed its
presence (Calc. MH+ 2546.2 Da and Obs. MH+ 2546.7 Da, see Fig. 1).
Upon puriﬁcation of the reduced orthogonally protected material,
<99% purity, 17.9 mg was recovered for each 100 mg of crude
peptide (18% yield).
3.2. Native ligation
Typically Peptide A and B, as observed in Fig. 1, were mixed in
approximately equal molar ratio (13 mM; i.e. 30.4 and 33.7 mg,
respectively), as described, with ligation completed after 21 h.
RP-HPLC/UV analysis illustrated a signiﬁcant decrease in starting
materials; Peptide A (Rt 26.1 min) and Peptide B (Rt 35.7 min),
together with an increase in a newly abundant peak, A–B (Rt
40.5 min), representing the reduced ligated target (see Fig. 2). LC/
MS illustrated the ligation process by the new ion species
[M + 4H]4+ 1079.9 and [M + 3H]3+ 1439.4 (Fig. 2); Calc. MH+
4314.8 Da and Obs. MH+ 4315.2 Da as illustrated in Fig. 2. Ligation
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yields were determined by weight to be 32%, providing a puriﬁed
unfolded ligated product of 20.5 mg. Upon batch-wise oxidation in
urea/50% (v/v) 2-propanol buffer, 2.5 mg of folded ligated material
was puriﬁed to <99% purity, which represents 12% per 100 mg of
ligated peptide.
The ligated reduced product demonstrated the same RP-HPLC/
UV retention time and molecular mass as the standard linear
synthesized IbTx-V16A/D19C-4-MeOBzl. Both oxidized and pur-
iﬁed ligated IbTx-V16A/D19C-4-MeOBzl (Lig-IbTx-MeOBzl) and
standard linear synthesized oxidized IbTx-V16A/D19C-4-MeOBzl
were RP-HPLC/UV co-injected in a 2:1 ratio, respectively, and
demonstrated identical retention of 33.3 min as illustrated in
Fig. 3. High resolution MALDI TOF/TOF of the ﬁnal target provided
the molecular mass of MH+ 4308.93 Da (Calc. MH+ 4308.9 Da),
conﬁrming both full oxidation and purity, as illustrated in Fig. 3.
3.3. Biological assay of Lig-IbTx-MeOBzl
To determine whether Lig-IbTx-MeOBzl has biological activity
against KCa1.1 channels, we tested its effect on the cloned human
KCa1.1 channel (HSlo) expressed in a human cell line. Fig. 4A shows
an example of HSlo channel activity recorded as macroscopic
current from an HEK293-HSlo cell using the whole-cell patch
clamp technique. Depolarization of the cell membrane with
0.5 mM free Ca2+ in the intracellular pipette solution gives rise
to outward K+ currents activated at membrane voltage more
Table 1
The sequential development of the bioengineered IbTx.
Sequence Kd
a (nM) Referenceb
ChTx (WT) ZFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS 8.8 [9]
17.6 This work
ChTxR19C ZFTNVSCTTSKECWSVCQCLHNTSRGKCMNKKCRCYS 8.8 [32]
ChTxV16E ZFTNVSCTTSKECWSECQRLHNTSRGKCMNKKCRCYS 18 [34]
IbTx (WT) ZFTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ <1 [11]
IbTxD19X ZFTDVDCSVSKECWSVCKXLFGVDRGKCMGKKCRCYQ 1.6c (X = Cys-Acm) This work
2.5c (X = K-LC-biotin) [2]
5.1 (X = K-LC-biotin) This work
2.5c (X = K-LC-biotin-streptavidin) [2]
IbTxV16A/D19X2 (Lig-IbTx) ZFTDVDCSVSKECWSACKX2LFGVDRGKCMGKKCRCYQ 1.9 (X2 = Cys-4-MeOBzl) This work
Detailed pharmacological examination of both native andmutant forms of ChTx provided key information for the introduction of non-native amino acids into the sequence of
IbTx. Initially ChTx – wild type (WT) was pharmacologically compared to two individual peptide mutants, ChTxR19C and ChTxV16E, which illustrated a maximal two-fold
decreasing in afﬁnity. Combining both mutations in a single sequence would likely not perturb toxin channel interactions. Given the structural and sequence similarities of
ChTx and IbTx, and to test this hypothesis, the ﬁnal combination of a double point mutation: (i) position 19 – this for later application derivatization, and (ii) position 16 –
speciﬁcally introduced to promote ligational kinetics to maximize peptide synthesis, supports the sequential development of IbTx bioengineering in providing the
biologically active parent template toxin ligated IbTxV16A/D19C-4-MeOBzl.
a As assigned via whole cell patch clamp.
b References as given in text.
c Kd is assigned by single channel analysis via lipid bilayer (see comments in Ref. [21]).
Fig. 2. Representative RP-HPLC/UV proﬁle obtained from the LC/MS run of the crude ligated products at 21 h. Peptide fragments A (Rt 26.1 min) and B (Rt 31.7 min) are
labeled as the remaining initial starting products, as determined bym/z and RP-HPLC retention, with the reduced ligated product A–B (Rt 40.5 min) presenting the major UV
contributor to the RP-HPLC proﬁle (Phenomenex C4). Molecular mass analysis of starting materials Peptide A and B are shown in their multiple charge states, as indicated,
with the ﬁnal unfolded target Peptide A–B as derived from the LC/MS proﬁle of crude ligated material.
J.-P. Bingham et al. / Peptides 30 (2009) 1049–1057 1053
positive than +30 mV. Perfusion of the cell with bath solution
containing 50 nM Lig-IbTx-MeOBzl inhibits HSlo current by 80% or
greater depending on the test voltage (Fig. 4B). Paxilline is a
tremorgenic fungal compound that has been characterized as a
potent inhibitor of mammalian KCa1.1 channels [21,35]. Addition
of 1mM paxilline to the bath solution inhibits greater than 95% of
the outward current, demonstrating that most of the K+ current
recorded under these conditions is attributable to paxilline-
sensitive KCa1.1 channels.
The kinetics of the interaction of Lig-IbTx-MeOBzl with HSlo
channels were also characterized by experiments illustrated in
Fig. 4C. Rapid perfusion of bath solution containing Lig-IbTx-
MeOBzl resulted in progressive time-dependent inhibition of
KCa1.1 current to a steady-state level reached several minutes after
onset. The time course of toxin inhibition is a measure of the
association rate of the toxin-channel binding reaction, since it is
not limited by the fast delivery rate of the solution to the recording
chamber. Similarly, slow recovery of K+ current observed after
perfusion with toxin-free bath solution is a measure of the time
course of the toxin-channel dissociation reaction. Association and
dissociation time courses for Lig-IbTx-MeOBzl, charybdotoxin
(ChTx), and IbTx-D19K-LC-biotin from experiments of Fig. 4C were
ﬁt to a single exponential and the resulting time constants were
used to calculate a second-order association rate constant (kon) and
a ﬁrst order dissociation rate constant (koff) for toxin binding
according to the standard kinetic model for one-site binding
reaction. Calculated kon values are: 4.6  105 s1M1 (Lig-IbTx-
MeOBzl), 1.3  105 s1 M1 (ChTx), and 9.9  104 s1 M1 (IbTx-
D19K-LC-biotin). Corresponding calculated koff values are:
8.7  104 s1 (Lig-IbTx-MeOBzl), 2.3  103 s1 (ChTx), and
5.1  104 s1 (IbTx-D19K-LC-biotin). The equilibrium dissocia-
tion constant for binding of the various toxins estimated from the
relationship, Kd = koff/kon, are: 1.9 nM (Lig-IbTx-MeOBzl), 17.6 nM
(ChTx), and 5.1 nM (IbTx-D19K-LC-biotin), see Table 1. The Kd
values calculated from the latter kinetic ratio compare favorably
with KI values of 2.9 nM for Lig-IbTx-MeOBzl and 13 nM for ChTx
as determined by ﬁtting the concentration dependence of steady-
state inhibition to a one-site binding isotherm (Fig. 4D). These
results show that synthetic Lig-IbTx-MeOBzl has high afﬁnity for
the human KCa1.1 channel and a slower dissociation rate than that
of ChTx formammalian KCa1.1 channels as previously described for
the native toxins [5,11,34].
4. Discussion
Chemical technologies of SPPS and bioconjugation facilitate
transformation of peptide toxins into biological probes. Investigat-
ing alternative methods of peptide assembly may provide avenues
for successful probe production in high yields. Our approach using
native chemical ligation can improve yields, but requires careful
due diligence in its design. The illustrated production of ligated
IbTx-V16A/D19C-4-MeOBzl extends from comparative analysis of
the structure activity relationships of ChTx (Table 1).
ChTx is a typicalmember of theaKTx1 family of scorpion toxins
characterized by: (i) a short a-helix (typically residues 13–21), (ii)
two stranded antiparallel b-sheets (typically residues 25–36; see
Ref. [19]), and (iii) a deﬁned channel-toxin interactive surface at
amino acid positions Ser10, Trp14, Arg25, Lys27, Met29, Asn30, Arg34
and Tyr36 [34,32]. ChTx exhibits broad pharmacological recogni-
tion of various Kv channels in contrast to the structural homolog
IbTx, which is a highly speciﬁc blocker of KCa1.1 (Kd < 1 nM; 9).
ChTx and IbTx, both 37mers, exhibit 68% sequence identity
(Table 1), including all the aforementioned essential toxin surface
interactive side chains except for Asn 30 ChTx/Gly 30 IbTx. These
structural features are compounded with identical positioning of
cysteine moieties that participate in a 7–28, 13–33 and 17–35
disulﬁde-bridging conﬁguration, providing a common fold of the
peptide backbone in the three-dimensional structure (see Ref.
[19]). A major difference between these two peptides is the overall
number of charged amino acids present, 13 for ChTx and 9 for IbTx,
which results in differing net charge of +4 and +2, respectively.
The derivative ChTx-R19C and the various labeled ﬂuorescent
[9] and radio-labeled [20] conjugates, coupled via a ‘spinster thiol’,
retain Kv channel selectivity, as the R19 modiﬁcation maps to the
‘backside’ of the toxin with respect to the channel-binding surface.
In IbTx-D19K-LC-biotin (Kd = 2.5 / 5.1 nM) and IbTx-D19C-Acm
(Kd = 1.6 nM), derivatives also retain potency and selectivity
towards KCa 1.1 (Table 1; 2), indicating functional and structural
conservation within the two toxins.
Combining the structure–activity proﬁles of ChTx [33,34], IbTx
[5,8,19], IbTx-chimeras [12], and our previous IbTx derivative
studies [2], a suitable thiol-ester ligation construct was designed,
containing an orthogonally protected ‘spinster thiol’. Native
chemical ligation requires a C-terminal peptide segment (Peptide
B) to contain an N-terminal Cys (see Fig. 1). In IbTx six cysteine
moieties are present, with position Cys17 providing a medial
sequence position (see Table 1). The next requirement is a
kinetically favorable amino acid for coupling at the C-terminal
MPAL thioester end of the N-terminal peptide segment (Peptide A,
Fig. 1). In IbTx Val16 provides a kinetic hindrance to the ligation
process. Hackeng et al. [16] showed that of all the neutral, aliphatic
amino acids, a C-terminal Ala-thioester peptide provided a useful
reaction rate in native chemical ligation. Other substitutions were
either unreactive or hindered ligation yields (see Ref. [16]). To
maximize chemical ligation of IbTx, Val16 was changed to Ala.
Pharmacological consequences of this mutation were considered;
substitution of Val16 by Glu in ChTx showed a two-fold decrease in
binding afﬁnity (see Table 1; [34]), indicating the absence of
essential channel-toxin interactions. This is compounded by the
amino acid 16-position also being on the non-interactive face,
neighboring the established 19-position of both toxins ([2], see
Fig. 5). Here we hypothesized that a neutral non-polar Val16 to Ala
substitution would not only lead to minimal alteration in channel-
Fig. 3. Analysis of the oxidized IbTx derivative. High-resolution molecular
mass analysis of the ﬁnal oxidized target ligated IbTxV16A/D19C-4-MeOBzl as
determined by MALDI-TOF/TOF. Insert: RP-HPLC/UV chromatograph (Vydac C18)
illustrating the 2:1 co-elution of the fully oxidized target peptide together with its
identical non-ligated linear synthesized folded counterpart.
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binding properties, but would in fact facilitate the production of
the target material by native chemical ligation.
Support for our hypothesis comes from the observed changes in
dissociation rates: Kd < 1 nM (wild type) versus 1.9 nM for Lig-
IbTx-MeOBzl as determined by whole-cell patch clamp (Table 1).
The use of these opposing faces provides for molecular bi-
functionality. We refer to these as ‘Janus-molecules’ since Janus
is the Roman god of gates and doors, usually depicted by a double-
faced head looking in opposite directions. Additional derivatiza-
tion at this non-interactive face and resulting changes in
pharmacology are illustrated in Table 1. Similar conclusions are
reiterated in other aKTx1 ‘Janus’ toxins, such as ChTx-R19C and
HgTx-A19C ([32,28] respectively) and reﬂect the conserved three-
dimensional structure observed within the aKTx1 toxin family
members [13,24,29]. This potentially provides an indication that
these and otheraKTx1 toxins, together with their pharmacological
resolving dipole moment, as discussed by Fre´mont et al. [8], can
tolerate limited changes in charge state, hydrophobicity and mass
additions. The extent of these tolerances at 19-positionwithin IbTx
and aforementioned aKTx1 toxins is presently unknown.
Further support for our hypothesis in IbTx bioengineering
comes from the 12-fold increase of yields by weight, of the folded
ligated target material, in comparison to the standard full linear
synthetic routewith a post-cleavage oxidation that yields1% (see
[37]). Increased yields are attributed to (i) enhanced ligated linear
production and (ii) improved yield in peptide folding. Initial yields
from standard linear synthesis of the 37mer IbTx-A16 V/D19C-4-
MeOBzl (31.8 mg of target peptide/ gram resin) are poor in
comparison to the smaller segmented construction of the 16mer-
Peptide A (96.2 mg of target/gram resin) and 21mer-Peptide B
(111.6 mg of target/resin gram), which are used for native
chemical ligation. With ligation production reaching 32%, a
100% increase in production of the unoxidized linear target is
achievable. Yet the major hurdle in both approaches is the folding
of the peptide-toxin. Standard linear synthesis of the IbTx-A16 V/
D19C-4-MeOBzl yielded 1%/100 mg, while native chemical ligated
oxidized target increased to 12%/100 mg. This increase is related to
the quality of linear starting material achievable, and puriﬁcation
steps prior to the ligation reaction. Minimization of thiol
containing peptide deletion or N-terminal terminated products
limits unwanted peptide polymerization.
Synthesis of a ligated bioactive derivative of IbTx suggests a
number of potential research applications. Giangiacomo et al. [12]
andMullmann et al. [27] described the pharmacological properties
ofaKTx1 toxin family chimeras using both IbTx and ChTx, and later
Noxiustoxin as peptide–toxin templates, respectively. The combi-
nation of different native-like N- and C-terminal sequence
segments resulted in non-native peptide toxins that exhibited
unique biological activity [12]. Our approach of segmented ‘block’
style synthesis and native chemical ligation readily lends itself to
toxin chimera production. Here, one could readily generate
libraries of full-length peptide chimeras combining various N-
Fig. 4. Comparison of the blocking effect of synthetic scorpion toxin derivatives on the human KCa1.1 channel. (A) Inhibition of HSlo current by ligated IbTx-A16 V/D19C-4-
MeOBzl (Lig-IbTx-OMeBzl) and paxilline. Records of HSlo current evoked by a series of voltage pulses from80 mV to +100 mV in steps of +10 mV are shown before (control)
and after addition of 50 nM Lig-IbTx-OMeBzl and 1 mM paxilline to the extracellular bath perfusion solution. (B) Current amplitudes measured at the end of the step pulse
from experiments in (A) are plotted versus the step voltage. Solid and dotted lines for control (ﬁlled circles) and Lig-IbTx-OMeBzl (open circles) data respectively correspond
to current values before and after subtraction of values measured in the presence of paxilline (ﬁlled triangles). (C) Time course of inhibition and recovery after addition of
toxin followed by perfusion with standard toxin-free bath solution. HSlo current was continuously monitored by voltage pulses from 80 to +50 mV (50 ms) delivered once
every 10 s. Values are normalized to peak current from each cell measured before addition of toxin. Overlaid data for three different experiments indicates current values
measured during addition and removal of 50 nM Lig-IbTx-OMeBzl (squares), 100 nM ChTx (upward triangles), and 200 nM IbTx-D19K-LC-biotin (downward triangles). Gray
lines correspond to exponential ﬁts of data as described in the text. (D) Concentration-dependence of toxin inhibition. Normalized currents taken after steady-state inhibition
by ChTx (ﬁlled triangles) or Lig-IbTx-OMeBzl (open triangles) as in (C) are plotted as a function of toxin concentration. Solid curves correspond to ﬁts of the data for each toxin
to: fN = KI/(KI + [Tx]), where fN is the fraction of normalized current, [Tx] is the toxin concentration, and KI is the equilibrium dissociation constant for the toxin. KI values are
13.0 nM for ChTx and 2.9 nM for Lig-IbTx-OMeBzl.
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and C-terminal peptide segments. This same approach may also
facilitate investigation of toxin structure–activity relationships.
Here an ‘alanine walk’ via ligation of various peptide block
segments wouldmitigate repetitive low-yields and could aid in the
generation of multi-point mutations within a single ligated toxin
sequence.
5. Conclusion
Native chemical ligation offers a powerful synthetic tool that
allows peptide elongation to go beyond the constraints of the
standard length of 50–60 amino acids of automated linear SPPS
(see Refs. [4,26]). This ligation scheme also opens new and varied
opportunities in peptide toxin studies, focusing on smaller
peptides 30–40 amino acids in length. These efforts will provide
a greater understanding of pharmacological interactions and how
these same peptides provides for an architectural foundation for
drug design, as articulated by Menez [22].
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Milked venom from cone snails represent a novel biological resource with a proven track
record for drug discovery. To strengthen this correlation, we undertook a chromato-
graphic and mass spectrometric study of individual milked venoms from Conus purpur-
ascens. Milked venoms demonstrate extensive peptide differentiation amongst
individual specimens and during captivity. Individual snails were found to lack
a consistent set of described conopeptides, but instead demonstrated the ability to
change venom expression, composition and post-translational modiﬁcation incorpora-
tion; all variations contribute to an increase in chemical diversity and prey targeting
strategies. Quantitative amino acid analysis revealed that milked venom peptides are
expressed at ranges up to 3.51–121.01 mM within single milked venom samples. This
provides for a 6.37–20,965 fold-excess of toxin to induce apparent IC50 for individual
conopeptides identiﬁed in this study. Comparative molecular mass analysis of duct
venom, milked venom and radula tooth extracts from single C. purpurascens specimens
demonstrated a level of peptide continuity. Numerous highly abundant and unique
conopeptides remain to be characterized. This study strengthens the notion that
approaches in conopeptide drug lead discovery programs will potentially beneﬁt from
a greater understanding of the toxinological nature of the milked venoms of Conus.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Cone snails represent a highly valuable natural resource
for drug-lead discovery programs. With an estimated
>75,000 individual bioactive peptides within the genus of
some þ500 species (Olivera, 2002), the venom peptides
from these carnivorous marine predators have provided
numerous highly selective ligands that target a myriad of
ion channels (as reviewed in Terlau and Olivera, 2004).
Several of these targets have direct implications in human
healthcare. As a result, cone snail peptides, commonly
referred to as conotoxins or conopeptides, are attracting
much attention from the medical research and pharma-
ceutical communities.
One peptide in particular, u-conotoxin MVIIA, also cited
as SNX-111 or Ziconotide has received US Food and Drug
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Administration approval as Prialt (Primary Alternative to
morphine), a potent neuropathic pain analgesic, speciﬁ-
cally targeting N-type voltage-gated calcium channels
(Miljanich, 2004). Other conopeptides have now transi-
tioned into clinical trials (see Han et al., 2008), providing
a clear indication attesting to their pharmaceutical and
therapeutic worth.
Unfortunately, suchdevelopments are often restrictedby
difﬁculties in accessing native cone snail venoms. This
problem is compounded by concerns regarding depletion of
the limitedmarine resource via bioprospecting (see Chivian
et al., 2003; Duda et al., 2004). To offset these concerns,
combined efforts encompassing genomic and proteomic
approaches have both increased the diversity of conopep-
tide sequences and minimized animal usage (Gayler et al.,
2005; Livett et al., 2006; Jakubowski et al., 2006). Sustain-
able research efforts have also been illustrated by utilization
of pooled milked venoms as an alternative source of novel
lead-compounds (see Shon et al.,1995; Hopkins et al.,1995).
Direct evidence of their success is established by themilked
venom-drug lead correlation, as illustrated with the
expression of u-conotoxin MVIIA (Prialt) in individual
specimens of Conus magus (see Bingham, 1998; Bingham
et al., 2010). Such observations necessitate the expansion
of our limited biological understanding of the milked
venoms of Conus. This in turn will maximize the drug-lead
potential of milked venoms and provide a platform to
ensure future biosustainable research supply.
Conus purpurascens (the purple cone; Fig. 1) represents
a unique research candidate within the cone snail genus.
Being an Eastern Paciﬁc piscivore (ﬁshing eating species),
its mammalian bioactive peptides have been well
described – from their isolation and characterization (Shon
et al., 1995, 1997; 1998a, 1998b; Jacobsen et al., 1998, 1999;
Teichert et al., 2007; Gowd et al., 2008), pharmacological
speciﬁcity (Shon et al., 1997; Jacobsen et al., 2000; Dowell
et al., 2003; Teichert et al., 2007; Lopez-Vera et al., 2007;
Gowd et al., 2008), to 3-Dimensional structural analysis
(Savarin et al., 1998; Mitchell et al., 1998; Van Wagoner
et al., 2003; Chi et al., 2005). What differentiates these
studies from previous conopeptide research is the source
of material; the majority of these conopeptides have
been isolated directly from the pooled milked venom
(see Table 1) and not from the crude dissected venom duct
gland. C. purpurascens presently represents the species
with the best-characterized milked venom of the genus.
Using this established knowledge base in turn provides:
(i) an avenue to further expand our general understanding
of milked venom biochemistry, and; (ii) a solid foundation
to examine alternative and novel approaches in conopep-
tide research.
To date, 15 peptides have been isolated, sequenced,
synthesized and pharmacologically classiﬁed from C. pur-
purascens (see Table 1). The majority of these peptides have
been found to selectively target sub-types of the acetyl-
choline receptor (a-, aA- and j-conotoxins; Lopez-Vera
et al., 2007; Teichert et al., 2007; Van Wagoner et al.,
2003); isoforms of the voltage-gated sodium channel
(m- and d-conotoxins; Shon et al., 1998a and 1995); block
potassium channels (k-conotoxin; Savarin et al., 1998) and
Fig. 1. Representative specimens of Conus purpurascens: Captive specimens 1–2 (representatives used in this study) and locality specimens 3–6. 1. Panama, long-
term captive specimen – notice chalky appearance, loss of shell color and gloss; 2. Panama, long-term captive specimen – notice growth ridges and bands, shell
was originally 23.9 mm in diameter and grew to 37.9 mm - at the broadest point; 3. Horseshoe Bay, Costa Rica, non-captive specimen; 4. Cocos Is. Costa Rica, non-
captive specimen; 5. Gobernadora Is. Panama, non-captive specimen; 6. Jaco, Panama, non-captive specimen. (A) Scan Electron Microscopy of C. purpurascens
radula harpoon showing apex, 1st and 2nd barbs – each radula is unique to each species of Conus; Insert (B) shows cross section of harpoon providing access to
lumen and peptide venom remnants within. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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antagonize the N-methyl-D-aspartate receptor (con-
antokins; Gowd et al., 2008). These peptides either inhibit
neuromuscular transmission, causing ﬂaccid paralysis, or
increase excitability at the target ion channel (see Terlau
et al., 1996). Interestingly enough, u-conotoxins have yet
to be isolated from C. purpurascens venom, further differ-
entiating this species from most other piscivorous species
studied to date; this provides the ﬁrst indication to phar-
macological diversiﬁcation within the envenomation and
prey immobilization strategies within Conus.
Toxinological characterization or quantitative biochem-
ical analysis of individual Conus milked venoms is absent
from current literature. Questions relating to venom
production (Newcomb et al., 1995; Tayo et al., 2010), duct
venomvariability (Vianna Braga et al., 2005) and synergistic
pharmacological strategieswithin Conus (Terlau et al.,1996)
have arisen. Those regarding the presence of peptides in the
venom organ/apparatus (see Biggs et al., 2008) and their
correlation within the envenomation process are further
compounded by comments surrounding the extent of
venom peptide differentiation amongst individual speci-
mens as well as the effects of captivity on this expression
(Jakubowski et al., 2005; Dutertre et al., 2010).
In this work, we lay a foundation for addressing some of
these questions by providing the ﬁrst comprehensive
quantitative analysis of milked venom peptides within
C. purpurascens. Their assignment represents a novel devel-
opment in theunderstandingof theenvenomationstrategies
within Conus. This work provides the proof-of-concept
working with a well-established and studied Conus species.
We commence with the examination of the expressive
nature of milked venom and its differentiation in individual
long-term captive animals via Reverse-Phase Liquid Chro-
matographic/Ultraviolet (RP-HPLC/UV) proﬁling. We then
undertakea comparativemolecularmass analysis, viaMatrix
Assisted Laser Desorption/Ionization Time of Flight Mass
Spectrometry (MALDI-TOF-MS), to identify milked venom
peptide constituents, speciﬁcally their presence within the
lumen of individual radula harpoons, and their expression
within whole crude dissected duct venom extracts. We
conclude with determining the precise concentration of
individual peptides delivered in a single envenomation.
Comparison of expressed milked venom concentrations
against previously reported IC50 (half maximal inhibitory
concentration) values indicates that highpotencycandidates
can be found in low abundance peaks. Combined, these
ﬁndingsprovide for auniquealternative route for identifying
and then correlating compounds/molecular masses of
potential pharmacological interest within Conus. These
ﬁndings add to our basic toxinological understanding of the
milked venoms of Conus.
2. Materials and methods
2.1. Materials
Chromatographic solvents used in this work were HPLC
grade or higher – these being subjected to high vacuum
Table 1
Conus purpurascens conopeptides: Potency, pharmacological targeting and source location.
Conopeptide Sequence IC50 Target Source Ref.
Neuromuscular aA-PIVA GCCGSYONAACHOCSCKDROSYCGQa 2.3 nM adult mouse muscle
nAChR
MV Hopkins et al., 1995
a-PIA RDPCCSNPVCTVHNPQICa 0.95 nM rat nAChR subtype
ra6/a3b2b3
cDNAb Dowell et al., 2003
a-PIB ZSOGCCWNPACVKNRCa 36 nM adult mouse muscle
nAChR
MV Lopez-Vera et al., 2007
m-PIIIA ZRLCCGFOKSCRSRQCKOHRCCa 44 nM mammalian Nav cDNAb Shon et al., 1998a
k-PVIIA CRIONQKCFQHLDDCCSRKCNRFNKCV 57  4 nM Kþ shaker channel MV Shon et al. 1998a,b
j-PIIIE HOOCCLYGKCRRYOGCSSASCCQR 127 nM
14 mM
torpedo nAChR
adult mouse muscle
nAChR
MV Shon et al., 1997
j-PIIIF GOOCCLYGSCROFOGCYNALCCRKa 19 mM–1 mM torpedo nAChR
adult mouse muscle
nAChR
MV Van Wagoner
et al., 2003
Excitotoxic d-PVIA EACYAOGTFCGIKOGLCCSEFCLPGVCFGa Excitatory
activityc
voltage-sensitive Nav MV Shon et al., 1995
kA-PIVE DCCGVKLEMCHPCLCDNSCKNYGKa Excitatory
activityc
– MV Teichert et al., 2007
kA-PIVF DCCGVKLEMCHPCLCDNSCKKSGKa Excitatory
activityc
– MV Teichert et al., 2007
Unclassiﬁed D-Trp
Contryphan-P
GCOWDPWCa – – DV Jacobsen et al., 1998
D-Leu
Contryphan-P
GCVLLPWC – – MV Jacobsen et al., 1998
PVA GCCPKQMRCCTL – – MV Jacobsen et al., 1998
P1.9 CRWLQHSCLQ – – cDNAb –
Conantokin-P GEggHSKYQgCLRgIRVNKVQQgC 0.3–2.3 nM NMDA Receptor
NR2A/NR2B
cDNAb Gowd et al., 2008
a C-terminal amidated; W, D-Tryptophan; L, D-Leucine; Z, pyroglutamic acid; O, 4-trans-Hydroxyproline; g, g-carboxylglutamic acid; MV, Milked Venom;
DV, Duct Venom.
b cDNA was prepared by reverse transcription of RNA isolated from the C. purpurascens venom duct.
c IC50 on target channel is unknown.
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ﬁltration to aid degassing prior to use. All buffers and
solvents were ﬁltered through 0.22 mm Nylon ﬁlters
(Millipore). Chemical reagents, including matrices,
ion-pairing agents were supplied from manufacturers, as
indicated – these being stored and used as per manufac-
turer’s recommendations.
2.2. Cone snail housing, feeding, milking and venom
extraction
Nine specimens of C. purpurascens were collected near
the Smithsonian Tropical Research Institute, Panama.
Specimens were transported to the USA, acclimated and
housed in a temperature controlled environment in a single
30-gallon artiﬁcial saltwater tank ﬁtted with a Fuval 402
biological ﬁltration system. Specimens were fed weekly,
using Carassius auratus auratus (goldﬁsh; weight 2–5 g) and
consequentially milked of venom using a modiﬁed method
previously described in Hopkins et al. (1995) and Bingham
et al. (2005). Individual milked venom volumes were
collected, measured, then lyophilized. Specimens were
later sexed upon dissection for duct venom and radula
harpoons. Milked venoms, together with radula harpoons
were stored at 20 C until required.
Secretory venom ducts were dried by Speed-Vac, then
homogenized into a ﬁne powder and weighed. Peptide
extraction was achieved with 95% Solvent A (0.1% v/v TFA/
aq.) and 5% Solvent B (90/10 v/v MeCN/0.08% v/v TFA/aq.),
with samples typically representing 1 mg mL1. Samples
were vortexed and then sonicated for 10min. Extracts were
then centrifuged at 12,000g for 10 min. The resulting
supernatant was removed, dried via Speed-Vac, weighed
and then stored at 20 C until required. All extracts were
resuspended in the above solvent at 1 mg mL1, sonicatio-
nated (5 min) and re-centrifuged (at 12,000g for 10 min)
prior to chromatographic separation and MS analysis.
2.3. RP-HPLC/UV – peptide puriﬁcation
Milked venom peptides and duct venom extracts were
separated and puriﬁed using C18 Narrow-bored RP-HPLC/UV
(Vydac; 5 mm, 300 Å, 2.1  250 mm) and later quantiﬁed
using a capillary-bore RP-HPLC/UV (Phenomenex; 5 mm,
300 Å, 1.0  250 mm). AWaters 2695 Alliance HPLC System
interfaced with a 996 Waters Photo Diode Array (PDA)
Detector was used for automated sample analysis and
detection. Data was acquired and analyzed using Waters
Millennium32 (v3.2) software. Samples were eluted using
a standard linear 1% min1 gradient of Acetonitrile (HPLC
grade, Fisher Scientiﬁc; MeCN; 90/10 MeCN/0.08% v/v aq.
TFA; Solvent B) against 0.1% v/v aqueous Triﬂuoroacetic acid
(Spectrophotometric grade, Sigma–Aldrich; aq. TFA; Solvent
A) at a ﬂow rate of 250 mL min1 (narrow-bore) or
100 mL min1 (capillary-bore) for a period of 65 min, as
shown inFigs. 2 and3. RP-HPLCcolumnwaspre-equilibrated
with 5% solvent B, prior to sample injection. Elutant proﬁles
were extracted at 214 nm. Samples for later amino acid
quantiﬁcationwere fractionated manually, and subjected to
repeated RP-HPLC/UV puriﬁcation when necessary.
2.4. Conopeptide reduction
Speed-Vac dried RP-HPLC/UV puriﬁed peptides were
resuspended in 100 mM Tris(2-carboxyethyl)phosphine
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Fig. 2. Representative RP-HPLC/UV proﬁle of time differentiated milked venoms obtained from a single Conus purpurascens specimen (Panama, specimen No. 2 –
Fig. 1): Proﬁles A and B represent a time difference of approximately 8 months in captivity. Peaks labeled correspond to the individual conopeptides observed and
their retentions (Rt), as listed in Table 2. Proﬁles demonstrate a level of chromatographic simplicity. Note: j-conotoxin PIIIF (Fig. 2B) is represented in two
separate, closely eluting forms. Molecular mass analysis assigns these two peptides a PTM variants differing by a single trans-4-hydroxyproline modiﬁcation.
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(TCEP; Pierce Chemicals) with 25 mM NH4OAc, pH 4.5. To
aid reduction, samples were heated at 60 C for 15 min.
Upon reduction, samples were either re-puriﬁed using
capillary-bore RP-HPLC/UV (as described above) or desal-
ted by using Millipore Zip-Tip, as described by the
manufacturer, prior to mass spectrometric analysis.
2.5. Conopeptide quantiﬁcation
Amino acid analyses of RP-HPLC/UV puriﬁed peptides
were performed at the W.M. Keck Foundation Biotech-
nology Resource Laboratory at Yale University. Samples
were hydrolyzed in vacuo with 6N HCl/0.2% v/v phenol for
16 h at 115 C. Analysis was undertaken using a Hitachi
L-8900 PH amino acid analyzer (ion-exchange separation,
post-column derivatization with ninhydrin for detection at
570 nm and 440 nm). Data was collected using EZChrom
Elite for Hitachi software and tabulated in a Microsoft Excel
spreadsheet.
2.6. Mass spectrometry conopeptide analysis
2.6.1. Electrospray ionization mass spectrometry (ESI-MS)
Speed-Vac dried RP-HPLC/UV puriﬁed peptides were
resuspended in 0.1% v/v aqueous Formic acid (LC/MS grade,
Sigma–Aldrich). Samples were delivered to the ionization
source of an API 3000 Mass Spectrometer (Thornhill,
Ontario, Canada) via a Redone 8125 Injector (20 mL external
loop; Rheodyne, Cotati, CA, USA) and infused with carrier
solvent (50% MeCN/0.1% v/v aq. Formic acid; 50 mL min1)
as provided by an ABI 140B Dual Syringe Pump. Full-scan
single MS experiments were typically obtained by scan-
ning quadrupole-3 (Q-3) from m/z 400–2200 in 2–3 s with
a scan step size of 0.1–0.5 Da. Data was acquired using
Analyst Software (v.1.4.1) (Applied Biosystems/MDS Sciex,
Thornhill, Ontario, Canada). ESI-MS system was calibrated
manually in positive mode with PPG 3000/Mass Standards
Kit (AB/MDS-Sciex), to achieve <5-ppm mass accuracy, as
per manufacturer’s protocol.
Collision Induced Dissociation (CID) was performed by
directly infusing the TCEP reduced RP-HPLC/UV puriﬁed
peptide into the ESI-MS at 5 mL min1, using the same
Formic acid/MeCN carrier solvent as mentioned above.
Bombardment was conﬁned to quadrupole-2 (Q-2) with
a collision cell gas thickness of 3  1014 atoms/cm2 and
a collision energy (Q-0 to Q-2 rod offset voltage) typically
set atw20–40 eV. The resulting CID (daughter ion) spectra
were obtained by scanning quadrupole-3 (Q-3) from m/z
50–3000 in 5 s with a step size of 0.1 Da. MS/MS data
analysis was assisted with the use of Mac BioSpec v1.01 (PE
Sciex, Thornhill, Ontario, Canada).
2.6.2. Matrix Assisted Laser Desorption/Ionization Time of
Flight/(Time of ﬂight) mass spectrometry [MALDI-TOF/(TOF)-
MS]
RP-HPLC/UV puriﬁed peptides fractions in 0.1% v/v aq.
TFA were mixed 1:1 with matrix solution (2,5-
dihydroxybenzoic acid [DHB] in 1:1 0.1% v/v aq. TFA:
MeCN; Ultra pure, Sigma–Aldrich) and spotted onto a thin
layer of dried DHB matrix saturated in methanol on the
target plate. The spots were dried under a stream of N2 gas.
Parent ions were identiﬁed on the Ultraﬂex III MALDI-TOF/
(TOF)-MS (Bruker Daltonics), controlled by the Compass 1.2
SR1 software package (Bruker Daltonics), in positive
reﬂector mode. Peptide II Calibration Mix (Bruker Dal-
tonics) was used for external calibration, with a <5-ppm
mass accuracy. Analysis of the spectra was done using
ﬂexAnalysis v3.0 (Bruker Daltonics).
2.7. Mass spectrometry radula harpoon analysis – MALDI-
TOF-MS
C. purpurascens radula harpoons were collected from
either (i) spent radula harpoons during themilking process,
or (ii) from dissected radula sacs. Radula harpoons were
prepared for MALDI-TOF-MS analysis in the following
manner: (a) externally dH2O washed-air dried radula
harpoons were repeatedly cut into sections in an eppendorf
and extracted with 100 mL extracting solution (1:1
MeCN:0.1% v/v aq. TFA), sonicated for 20min, centrifuged at
12,000g. The resulting solvent was Millipore Zip-Tip
(containing C18 reversed-phase media) desalted and the
elutemixed1:1withMALDI-MSmatrix solvent (40mgmL1
DHB in1:2MeCN:0.1%v/vaq. TFA)directlyon theMALDI-MS
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Fig. 3. Maximal milked venom complexity observed a single captive specimen Conus purpurascens (Panama, specimen No. 1 – Fig. 1): RP-HPLC/UV showing the
dominant peptide peaks being expressed in separate captive specimen of C. purpurascensmilked venom, MV #41. Six C. purpurascens conopeptides were observed
by retention and MS analysis (see Table 4). This speciﬁc proﬁle is used to illustrate quantitative amino acid analysis, as in reference to Table 2.
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target plate and allowed to air dry prior to analysis, or; (b)
externally dH2O washed-air dried whole radula harpoons
were cut in halves, taped onto the target plate via removable
double-coated Scotch Tape and then ﬂooded with matrix
solvent by dropping 1 mL at the luminal position of the
mounted radula harpoon.Matrix solventwas allowed to dry
with the assistance of a stream of N2 prior to analysis.
2.8. Scanning Electron-Microscopy of radula harpoons
Imaging by Scanning Electron-Microscopy (SEM) was
performed with a Hitachi S-4800 Field Emission Scanning
Electron Microscope with Oxford INCA X-Act EDS System.
Dissected radulaharpoonswereprepared for imagingbydip
washing in 100% methanol, followed by sub sequential
washes in dH20. Dry samples were mounted on aluminum
stubs with conductive silver paint. The samples were then
sputter-coated with 10–12 nm gold/palladium with a Cres-
sington 203 sputter coater. Imaging was performed at
a beamaccelerating voltageof 5 kV. Imageswereobtainedat
magniﬁcations ranging from 10 to 100; this was depen-
dent on the feature to be tracked.
3. Results
3.1. Comments on snail husbandry
A number of observations were made during long-term
C. purpurascens captivity: (i) Snails were able to consume
ﬁsh equal to their own shell size and had ability to feed
weekly; (ii) If snails were not fed regularly or did not
discharge their pre-loaded radula harpoons from the
proboscis (<2 times/month), theywould singularly lose the
ability to penetrate the receptacle membrane, resulting in
loss of milked venom – recovery occurred naturally with
‘spent’ radula harpoon expulsion and then re-arming; (iii)
Specimens seem to be sturdy and resilient to captive
conditions, as illustrated by the ability to produce viable
veliger upon mating – a situation that occurred twice
during 48 months of captivity. No specimen mortalities
were recorded during these experiments, until specimens
were terminated for duct venom extracts.
3.2. RP-HPLC/UV milked venom proﬁling
Milked venoms from C. purpurascens (n ¼ 100) were
measured to have volume ranges of 6–480 mL (Mean  Std
Dev.; 56.21 mL  105.21 mL). Chromatographically milked
venom differentiation was observed both in the expression
of individual conopeptides and in their peak area integra-
tion, the latter reﬂecting differences in concentrations –
given that the peaks of interest demonstrate peptide
homogeneity by LC/MS, this being in contrast to the crude
duct venom extracts (not shown). The maximal difference
in milked venom peptide expression within a single w8
month time differentiated captive individual is illustrated
in Fig. 2. This represented our most differentiated milked
venom proﬁle observed in this study. It was common to see
milked venom transition to a more complex constituent
containing proﬁle – this including the appearance and
disappearance of major proﬁle contributing peaks.
Expressional conopeptide differentiation in some indi-
vidual specimens was seen as a gradual process demon-
strating minor changes on a week-to-week basis (see
supplemental Fig. S1), this continued throughout the 48
months of captivity (see below). Oviposting females demon-
strated the absence of peptides within their milked venoms,
although the motions of venom capture were successful (i.e.
recorded milked venom volume, radula harpoon discharge
and prey engulfment). These proﬁles later recovered to re-
expressing conopeptides some weeks later. There were
a number of other unexplained instances in which dramatic
RP-HPLC/UV proﬁle changes were noted – in most revolved
aroundthesingleeventexpressionofnewlyabundantpeptide
peaks.Wealsoobserved ‘blank’milkings (w7%of allmilkings)
– in which ejaculate was collected with no apparent peptide
proﬁle being resolved chromatographically. These isolated
events demonstrated no correlation to animal sex, feeding
success, or season. They occurred between normal milkings
that exhibited typical elution patterns. Their occurrence may
represent a dynamicﬂuxof expressional or secretional events
that occur within the secretory venom duct itself.
The majority of captive milked venom peaks were
observed to chromatographically elute between 20 and 40%
MeCN. The presence of low to moderately abundant hydro-
phobic peaks (eluting>50%MeCN)were observed, these did
not equate to the hydrophobic d-conotoxins (see below).
Near baseline resolution was apparent for the majority of
individualmilkedvenomconstituents (seeFig.2A), this could
be further extended with TCEP reduction. Individual chro-
matographically resolvable peaks of interest, as examined in
this study, demonstrated a high level of peptide homoge-
neity, with minimal co-eluents being observed. Peak homo-
geneitywas assessed by: (i) UV spectrumextraction via PDA;
(ii) ESI-MS infusion of RP-HPLC/UV fractions; (iii) Liquid
Chromatography Interfaced Mass Spectrometry proﬁling
(LC/MS); (iv) TCEP reduction of whole milked venoms and
isolated fractions followed by RP-HPLC/UV analysis, and;
(v) MALDI-TOF-MS of RP-HPLC/UV venom fractions (not
shown).
The identiﬁed conopeptides previously isolated from C.
purpurascens, their presence being assigned by ESI-MS/
MALDI-TOF-MS molecular mass analysis and quantitative
aminoacid analysis– as reported in this study, demonstrated
an RP-HPLC/UV elution pattern of aA-conotoxin PIVA, a-
conotoxin PIB, j-conotoxin PIIIF, m-conotoxin PIIIA, k-con-
otoxin PVIIA and lastly a-conotoxin PIA (see Table 2, Fig. 3).
Individual Post-translational (PTM) variant forms of parent
conopeptide sequenceswere observedbut limited. Fromthis
single population of C. purpurascens, as throughout this
study, thehydrophobicd-conotoxinPVIA (‘lock-jawpeptide’;
Table 1) was absent, as determined by RP-HPLC/UV and by
molecularmassanalysis (seebelow). Its absencealsoextends
to the reported PTM variants – which represent differential
hydroxylated proline forms (see Shon et al., 1995).
3.3. Molecular mass comparison of crude duct extract, milked
venom and radula harpoon lumen
Zip-Tip processed venom source extracts from duct
venom,milked venom and radula harpoon lumen, obtained
from single C. purpurascens specimens, in part contained
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common m/z as observed by MALDI-TOF-MS (see Fig. 4).
Table 3 summarizes the molecular masses observed for
single C. purpurascens representative that typiﬁes this level
of molecular mass continuity in these extracts.
The observed molecular mass continuity was restricted to
27 m/z in total, and encompassed either 2 or all 3 of the
venom source extracts. These do not represent the onlym/z
observed within these venom source extracts, with
numerous relative abundant m/z being unassigned (Fig. 4).
Examining Fig. 4 revealed that different venom source
extracts demonstrated different clusters of molecular
masses and possess peptides of differing relative intensi-
ties, as seen speciﬁcally with the milked venom source
extract in the 2600–2750 m/z range. In the duct venom
source extract the most relative intense m/z was seen as
1119.72 Da, while in the milked venom source extract the
dominant m/z was assigned as 2633.07 Da. This speciﬁc
molecular mass corresponds to the previously reported
PTM variant (Hyp deletion) of [Pro13]aA-conotoxin PIVA
(see Hopkins et al., 1995). The parent sequence of aA-con-
otoxin PIVA is also observed, m/z 2649.07 Da (Calc. m/z
2649.94 Da). In this speciﬁc illustrated specimen, the
dominant ion present in the radula harpoon source extract
was observed as m/z 1809.16 Da. Of the all the observed
m/z, twomasses were shown to be common across all three
venom source extracts, m/z 961.7 and 1954.3 Da, as indi-
cated in Fig. 4 and Table 3. Examining common masses
between individual venom source extracts we see: (i)
Table 2
Identiﬁcation and assigned concentrations of Conus purpursacens conopeptides observed within a single milked venom.
Conopeptide Retention Time (min.) Conc. (pMoles)a [MV peptide] (mM)b IC50 (nM)c [MV peptide]/IC50d
aA-PIVA 24.61 359 48.22 2.3 20965.21
a-PIB 26.26 214 28.74 36 798.33
j-PIIIF 27.46 901 121.01 19000 6.37
m-PIIIA 30.06 450 60.44 44 1373.63
k-PVIIA 32.77 36 4.84 57 84.91
a-PIA 33.86 26.1 3.51 0.95 3694.73
a As observed by initial RP-HPLC/UV integration with peptide standards – without taking into consideration dilution factor (50%), amount loaded (100/
110 mL) and total volume of original milked venom (16.38 mL – speciﬁc sample, see Fig. 3).
b Corrected peptide concentration as observed in total milked venom sample.
c As reported in literature, see Table 1.
d Calculated from milked venom peptide concentrations present(b) and reported IC50.
Fig. 4. MALDI-TOF mass spectra of radula harpoon (top), captive milked venom (middle), and crude duct venom (bottom) obtained from a single specimen of
Conus purpurascens: Molecular Masses (m/z) common to all three are designated by a triangle (:). An asterisk (+) indicates peaks that correspond to previously
published conopeptides derived from C. purpurascens. 2,5-dihydroxybenzoic acid (DHB) was used as the matrix. One advantage of using DHB is that there is a low
occurrence of matrix peaks and matrix adducts. To further ensure that common masses observed are not matrix peaks, mass spectra were compared to ‘matrix
only’ mass spectra. No matrix peaks were detected.
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radula harpoon – milked venom source extract contains 10
common m/z; (ii) duct venom – milked venom source
extract contains 7 common m/z, while; (iii) duct venom –
radula harpoon source extract possesses the largest
number with 14 common m/z (see Table 3).
Of the previously published/patented C. purpurascens
conopeptides, 12 m/z were observed to correlate to known
conopeptides as indicated in Fig. 4 and illustrated in Table
4. The majority of these conopeptides, corresponding to 8
molecular masses, were observed in the milked venom
source – the original venom source for their isolation (see
Table 1).
3.4. Example of standardized procedure for quantitative
analysis of milked venom peak concentrations
A detailed and standardized procedure for determining
milked venom constituent concentrations is illustrated for
future reference. aA-conotoxin PIVA (Rt 24.61 min) from
MV #41 (Fig. 3) was quantiﬁed via assigning its peak area
integration and correlating this to a speciﬁc aA-conotoxin
PIVA concentration standard curve. The aA-conotoxin PIVA
standard was isolated and RP-HPLC/UV puriﬁed from
pooled milked venom. This peak demonstrated: (i)
molecular mass correlation to aA-conotoxin PIVA via ESI-
MS (Obs. MHþ 2647.85; Calc. MHþ 2647.93 Da; Obs.
Reduced MHþ 2653.79; Calc. Reduced MHþ 2653.93 Da);
(ii) partial sequence conformation via collision-induced
dissociation (CID) analysis (not shown), and; (iii) the cor-
responding amino acid composition to aA-conotoxin PIVA.
Quantitative amino acid hydrolysis was undertaken
using a 1/3 of this sample. Remaining (100 mL, 2/3) non-
hydrolyzed material was assigned the calculated concen-
tration – thus becoming the ‘aA-conotoxin PIVA standard’
stock. Five different concentrations of aA-conotoxin PIVA
(10, 50, 100, 500 and 1000 pMoles) resolved on a RP-HPLC
capillary C18 column and peak areas integrated to graphi-
cally establish a standard curve to then assign its unknown
concentrations, as observed in various milked venoms. aA-
Conotoxin PIVA milked venom proﬁle identiﬁcation was
achieved by RP-HPLC/UV retention time analysis, using the
same RP-HPLC capillary C18 column as above.
In our example, (Fig. 3 and Table 2) 359 pMoles of aA-
conotoxin PIVA was found to be present upon RP-HPLC/
UV proﬁle analysis of sample C. purpurascens MV #41.
Sample concentration correction was undertaken to give
the ﬁnal amount of peptide produced in whole milked
venom, as injected by the animal. This was achieved by
using our established protocol: (i) collected milked venom
is measured (16.38 mL), (ii) lyophilized and, (iii) resus-
pended in 100 mL of solvent A to make a standardized
milked venom working stock. 50 mL (50%) of this milked
venomworking solution was removed and further diluted
with 60 mL of solvent A, giving Tv ¼ 110 mL. A total of
100 mL of this sample was analyzed by RP-HPLC/UV, thus
representing 90.9% of total RP-HPLC sample volume
aliquot, or a physical representation of 45.45% of the
whole milked venom sample. This is then calculated to
represent an equivalent aliquot of 7.44 mL whole milked
venom (i.e. 45.45% of 16.38 mL). Thus 359 pMole of aA-
conotoxin PIVA, as determined by standard curve, was
equal to 7.44 mL equivalents of the original milked venom
volume. The total concentration of aA-conotoxin PIVA
present in sample MV #41 (Fig. 3) is calculated to be
48.22 pMoles mL1 ¼ 48.22 mM (359 pMoles/7.44 mL). This
same procedure was followed for RP-HPLC/UV puriﬁed
native milked venom peptide standards of a-conotoxin
PIB, j-conotoxin PIIIF, m-conotoxin PIIIA, a-conotoxin
PIA and k-conotoxin PVIIA; all demonstrated (i) correct
molecular mass correlation in native and TCEP reduced
state and (ii) expected amino acid composition. These
allowed for the expressed concentration to be assigned
to individual conopeptides within C. purpurascens (see
Table 2).
Table 3
Molecular masses shared between radula, milked venom, and duct venom
extracts derived from a single specimen of Conus puprpurasens.
Obs. m/z
Radula Extract Milked Venom Duct Venom
– 904.5 904.4
919.6 – 919.4
– 925.4 925.3
– 940.4 941.3
961.7a 961.5 961.4
976.6 – 976.4
998.6 – 998.4
1034.8 – 1034.6
1262.9 – 1262.7
– 1344.6 1344.6
1495.0 – 1495.7
1695.1 – 1695.7
1750.1 1749.8 –
1765.1 1764.8 –
1794.1 1794.8 –
1825.2 1825.8 –
– 1872.9 1872.3
1953.3 1954.9 1954.2
1965.3 1965.9 –
1968.3 1968.9 –
2004.3 2003.9 –
2174.4 – 2174.0
2343.5 – 2343.2
2382.5 – 2382.5
2490.6 2490.0 –
2836.9 – 2836.7
3330.3 – 3330.8
a Peaks common to all three are in bold; Common peaks have
a Dm/z ¼ 0  1 Da.
Table 4
Molecular masses identiﬁed in radula, milked venom, and duct venom
samples that correspond to known conopeptides from Conus
purpurascens.
Conopeptide Calc. m/z Obs. m/z
Radula MV DV
D-Leu Contryphan-P 888.4 887.01
Contryphan-P 976.34 976.61 976.38
P1.9 1271.57 1269.85
PVA 1336.52 1337.59
a-PIA 1980.82 1980.94
kA-PIVF 2594.05 2593.07
m-PIIIA 2604.11 2604.08
aA-PIVA 2649.94 2649.07
kA-PIVE 2656.03 2656.04
j-PIIIF 2665.06 2667.07
j-PIIIE 2717.06 2717.22
Conantokin-P 3152.31 3151.11
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3.5. Milked venom peptide concentrations and IC50 values
Within a single milked venom from C. purpurascens,
conopeptide concentrations are present within mM ranges,
i.e. from 3.51 mM (a-conotoxin PIA) to 121.01 mM (j-con-
otoxin PIIIF), as listed in Table 2. This speciﬁc milked venom
proﬁle exempliﬁes the greatest coverage of known indi-
vidual conopeptides quantiﬁed in our present studies of
C. purpurascens (see Fig. 3).
In this single milked venom sample, the ratios of indi-
vidual conopeptideconcentrations expressedwith respect to
their experimental IC50 values ranged from6.37 to 20,965.21
(Table 2). This data potentially provides an indication to the
observed pharmacological excess in venom production, as
examined with current IC50 data, and strengthens the
viability of milked venom as a source of potent bioactive
constituents. Within the gathered data, aA-conotoxin PIVA
(48.22 mM) demonstrates the highest ratio value, partially
attributed to its low IC50 value (2.3 nM), Table 2. This ratio is
in contrast to the highly concentrated j-conotoxin PIIIF
(121.01 mM), having a diminished ratio due to its relatively
high IC50 value (19 mM). The conopeptide with the second
lowest concentration in the milked venom, as an added
example to strengthen this seemingly inverse relationship,
a-conotoxinPIA (3.51mM),exhibited the secondhighest ratio
as a result of its low IC50 value (0.95 nM; Table 2).
4. Discussion
The pharmaceutical potential of cone snail venoms is
well recognized (as reviewed by Lewis, 2009). Venom
complexity and demonstrated isoform selectivity in ion
channel targeting makes these extracts a natural pharma-
copoeia for biological testing and drug lead discovery
programs. However, this is a limited marine resource, to
which few researchers have access. Novel approaches in
conopeptide research, including venom procurement, are
needed to maximize their full potential. Our approach has
been to emphasize the integration of traditional biochem-
ical and advanced mass spectrometric technologies,
together focusing on biosustainable resource management
– via animal husbandry and cone snail venom milking, in
an endeavor to place these rare commodities in the hands
of pharmacologists and neuroscientists alike.
We believe our ﬁndings provide a unique perspective
into the basic toxinology of the cone snail milked venoms.
As we have illustrated in this study, there are a number of
important observations that have signiﬁcant implications
in the transition potential of venom peptides to drugs. The
use of this information may impact how we view and use
cone snail milked venoms successfully as a primary source
of novel lead compounds.
4.1. Milked venoms demonstrate expressional variability
Venom peptide differentiation within C. purpurascens
has been previously alluded to with the expression of the
highly hydrophobic d-conotoxin PVIA (see Shon et al.,1995).
However, the nature and extent of peptide variability
within the time differentiated milked venom, as a whole,
was basically unrealized. Our evidence indicates that
hydrophobic d-conotoxins are not the only conopeptides
that demonstrate a high level of expressional regulation in
the milked venom, and that peptide differentiation is
compounded by captive conditions. Milked venom differ-
entiation increases the number of bioactive peptides
present; as seen in Figs. 2 and 3 individual specimens may
express different peptide proﬁles. Pooling vast quantities of
venoms may risk masking and/or diluting minor or unique
expressional constituents. Here, simplicity may be the best
approach, which may require treating individual snails or
individual populations of snails as unique venom producers.
4.2. Post-translational modiﬁcations increase the chemical
diversity of the milked venoms
In our study of C. purpurascens, we observe only a single
proline variant of aA-conotoxin PIVA, corresponding to the
[Pro13] derivative. This peptide was observed as a major
milked venom constituent (see Fig. 4), which may illustrate
a conservation of PTM expressional resources under
extended captive conditions, as suggested by Hopkins et al.
(1995). Whether the production of this PTM variant
represents a highly selective or random event remains to be
determined. However, the illustrated differential PTM
behavior adds an additional dimension to the chemical
diversity achievable within a single milking. Furthermore,
we believe that its expressional dominance, as seen by
MALDI-TOF-MS (Fig. 4), is not without toxinological
purpose, as the occurrence of differential hydroxylation has
been observed in other Conus venoms, as illustrated by
Franco et al. (2006) and Rivera-Ortiz et al. (2011).
PTM conopeptide variants potentially offer a combina-
torial-like approach to maximize phyla-selective pharma-
cological efﬁcacy via increase functional group complexity,
without the need to change the genetic sequence of the
parent toxin sequence. PTM variants can possess differen-
tial pharmacological selectivity and targeting (Hopkins
et al., 1995; Chi et al., 2003; Nevin et al., 2007). Within
the milked venoms of C. purpurascens differential hydrox-
ylation of proline moieties has the potential to affect 7
different classes of conopeptides (Table 1). Yet to date only
2 pharmacological classes, the d- and aA-conotoxins, have
been affected by this natural occurrence (Shon et al., 1995;
Hopkins et al., 1995). Unlike previous reports, our obser-
vations of PTM variants within C. purpurascens are limited.
This occurrence potentially reﬂects the small and localized
population of snails examined in this study. This may infer
that the ability to undertake such modiﬁcations relates to
unique and possibly localized environmental pressures,
similar observations have been observed in the milked
venom of Conus ermineus (see Rivera-Ortiz et al., 2011).
4.3. A number of different pharmacological strategies are
represented within the milked venoms derived from C.
purpurascens
Not all published C. purpurascens conopeptides are
observed in a single milked venom proﬁle- initially or
over its entire time in captivity. Similar observations of
differential peptide expression are observed in Conus
striatus (Jakubowski et al., 2005), Conus consors (Dutertre
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et al., 2010) and C. ermineus (Rivera-Ortiz et al., 2011). To
ensure predatory success, C. purpurascens must possess
a minimal pharmacological strategy. In this study, we see
this with the combination of aA-conotoxin PIVA, j-con-
otoxoin PIIIF and m-conotoxin PIIIA (see Fig. 2A and Table 1).
These toxins target a combination of nAChR isoforms (Shon
et al., 1997; Van Wagoner et al., 2003) and NaV ion channels
(Shon et al., 1998a). aA-Conotoxin PIVA and j-conotoxoin
PIIIF provide for a potent and independent targeting of the
acetylcholine mediated synaptic transmission system
(Hopkins et al., 1995; Shon et al., 1997). This is then com-
pounded with Nav targeting by m-conotoxin PIIIA, ensuring
inhibition of any post-synaptic action potential propagation.
This illustrates the most basic neuromuscular ‘motor cabal’
as deﬁned by Terlau and Olivera (2004). Long-term captive
milked venoms show expression of additional peptides in
also varying concentration levels, as phenomena illustrated
by the co-expression of a-conotoxin-PIA (Fig. 2B) and
a-conotoxin-PIB (Fig. S1). Their expression synergistically
complements the differential AChR targeting strategy
illustrated above.
The expression of excitotoxic peptides kA-conotoxins
PIVE and PIVF (m/z 2656.04 and 2593.07 Da, respectively),
as seenwithMALDI-TOF-MS, Fig. 4 and Table 4, conforms to
the proposed synergistic ‘lighting strike cabal’ or excito-
toxic shock inducement as detailed by Terlau and Olivera
(2004). While the expression of excitotoxic kA-conotoxins
provides an effective route for rapid prey immobilization
(Terlau et al., 1996), members of the aforementioned
neuromuscular ‘motor cabal’ dominate via concentration
(see Table 5). However, throughout this study the absence
of d-conotoxin PVIA, a member of the excitotoxic peptide
family, and its PTM variants, is noted andwe ﬁnd that this is
not a result of peptide handling or storage.
Combined, these observations indicate that individual C.
purpurascens specimens can use different pharmacological
strategies to ensure successful prey capture and immobi-
lization. What represents the quintessential pharmacolog-
ical envenomation strategy for C. purpurascens remains to
be determined. This is complicated by many uncharac-
terized milked venom peptides, including dominant
peptide peaks, which may contribute to the completion of
this pharmacological strategy.
4.4. Milked venoms represent a highly reﬁned source of
bioactive constituents
Crude duct venom extracts contain cellular debris that
can complicate any aspect of pharmacological assessment –
whether using a competitive binding assay or electrophysi-
ological evaluation. Milked venoms offer a simple and direct
route to those constituents of biological intent and resulting
pharmacological interest. The observed chromatographic
resolution provides a major incentive for its use (see Figs. 2
and 3), as well as the peptide concentrations achievable
from a single milking – namely milked venom peptide
production being within the mM range for this speciﬁc
species (see Table 5). However, the presence of seawater
within the expelled venom may effect pharmacological
assessment, an issue corrected by chromatographic desalt-
ing. Alternatively, venom sample dilutionmayminimize any
potential changes in solution osmolarity during the venom-
assay applicationprocess (Huang andBingham, unpublished
results). Thus the direct use of the milked venoms then
provides for a biosustainable resource of bioactive peptides
that are highly amenable to pharmacological testing such as
seen with whole cell patch clamping, and later to chro-
matographic isolation and MS characterization.
In this study, we illustrate the extent of molecular mass
continuity between the whole duct venom extract and
milkedvenom, and thedetecteddifferences in conopeptides
that are expressed (Fig. 4). We equate these differences in
part to the previously observed constituent changes seen
with traversing the secretory duct (see Tayo et al., 2010). The
combination of these duct sections masks the true
complexity of the duct venom extract. These occurrences
may be attributed to incomplete and/or differential PTM
processing, which would result in diluting the level of
peptide continuity observed in themilked venom.However,
we would expect that closer comparative inspection of
a small duct section that terminates into the pharynx of the
cone snailwoulddemonstratea strongermass correlation to
the milked venom upon dissection, this being due to its
anatomical proximity – to be illustrated and discussed
elsewhere.
4.5. Dominant RP-HPLC/UV milked venom proﬁle peaks do
not necessarily correlate to the most pharmacologically potent
constituents
Attention is drawn to those conopeptides of low
expressional abundance in the individual milked venoms,
as illustrated with a-conotoxin PIA (Fig. 2B; Table 2). This
conopeptide has the lowest IC50 of any of the C. purpur-
ascens peptides reported. We observed the opposite with
the highly abundant RP-HPLC/UV peaks, as illustrated with
j-conotoxin PIIIF, which is reported to have an IC50 of
19 mM or w1 mM, depending on which nAChR isoform is
Table 5
Conopeptide concentration assignment within time captive milked venoms of Conus purpurascens.
aA-PIVA a-PIA a-PIB m-PIIIA k-PVIIA j-PIIIF
IC50 (nM) 2.3 0.95 36 44 57 19,000
Milking No. Concentration (nM) Tv (mL)a
14 6348 2146 3242 12,006 795 17,243 46.8
34 33,550 26,400 – 21,175 – 57,200 8
36 178,200 – – 35,200 – 134,200 5
40 138,600 – 39,600 323,400 13,200 305,800 3
46 215,600 360,800 105,600 308,000 66,000 567,600 3
a Total milked venom volume.
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being evaluated (Table 1). Concentrating on the abundant
peaks within the duct and milked venom extracts has been
a common trend in conopeptide research.
The relative abundance of uncharacterized low intensity
molecular masses within the milked venom indicates that
C. purpurascens still has much to offer investigators. These
observations indicate that each individual peptide needs
equal pharmacological consideration. This process is
potentially complicated with speciﬁc target isoform or
phyla speciﬁcity. This is illustrated with j-conotoxin PIIIE
having IC50 of 127 nM for Torpedo AChR subtype, compared
to an IC50 of 14 mM for adult mouse muscle nAChR (see
Table 1; Shon et al., 1997). Many such examples of this
pharmacological phenomenon exist in Conus. Combining
this with low peptide abundance may provide a reliance on
synthetic production for their analysis.
4.6. Mass spectrometric surveying demonstrates peptide
abundance in radula harpoon extracts
A novel idea being introduced in this study is the
correlation of molecular masses that are present in the
radula harpoon extracts with those found in duct and milk
venoms (Fig. 4 and Table 3). The majority of observed
radula harpoon masses are likely a result of radula sac
speciﬁc expression of conopeptides. Evidence for radula sac
speciﬁc expression of conopeptide-like mRNA was previ-
ously characterized (see Biggs et al., 2008). While the
molecular mass continuity observed potentially represents
an accumulated ‘back-wash’ or leakage into the radula sac
itself, as milked venom expulsion is undertaken with great
velocity and pressure (Schultz et al., 2004).
Deﬁning these molecular mass correlations may have
a number of interesting research implications. As we
observed there are unidentiﬁed molecular masses present
in the radula harpoon (see Fig. 4 and Table 3), which
represents a new highly reﬁned source of conopeptides of
potential biological interest. As not all cone snails can be
milked successfully, this established correlation between
radula harpoon extracts and milked venom may assist in
streamlining efforts to identifying lead-compound candi-
dates. These assigned molecular masses could be isolated
from crude duct venoms, if no milked venom source were
available, or correlated to sequence information derived
from cDNA-derived libraries. The relative abundance of
these same radula harpoon molecular masses could allow
for direct sequence analysis by MALDI-TOF/TOF-MS. The
MS analysis of the radula harpoon represents another
dimension to conopeptide discovery.
4.7. The number of bioactive peptides within Conus may
exceed present estimations
Use of mass spectrometric technology, providing
molecular mass correlation within Conus, opens an alter-
native perspective into the venom complexity and the
adopted chemical strategies to enhance pharmacological
diversity. All these factors indicate the extent of biodiver-
sity observable within Conus – an area that remains poorly
addressed toxinologically. We believe that our initial mass
spectrometric observations within the milked and duct
venoms, as well as radula harpoon extracts (see Fig. 4),
together with the combined ability to differentially express
venom constituents (see Fig. 2), illustrates that the present
75,000–100,000 individual conopeptide constituents may
represent a conservative estimate to the true abundance of
biologically active peptides within these gastropods. This
same statement is echoed by Davis et al. (2009), Biass et al.
(2009) and Rivera-Ortiz et al. (2011), noting that these
authors also utilize a mass spectrometric approach in their
investigations. Along similar lines, additional analysis of
other cone snail species, as we have illustrated here, will
add to the debate regarding the actual physical size of the
native conopeptide library.
5. Concluding remarks and outlook
Enhancement of natural resource management,
increased knowledge about venom production and secre-
tion provides for a focused approach in maximizing the
venom potential of Conus. Understanding these natural
trends enhances our ability to ﬁnd novel lead compounds
of potential therapeutic use – based on their biochemical
and predatory use. Without investigative investments into
the basic toxinological understanding of Conus, we are
potentially missing important biological aspects of their
venom, as it is these facets that differentiate cone snails
from other venom producers.
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a b s t r a c t
“Snails can kill” is a statement that receives much disbelief. Yet the venom from Conus
geographus, as delivered by a disposable hypodermic-like needle, has indeed killed many
unsuspecting human victims. Our understanding of their milked venom the essence of
these fatalities, is in itself non-existent. Here, we present the molecular mass analysis of
the milked venom of C. geographus, providing the ﬁrst insight into the composition of its
deadly cocktail.
 2012 Elsevier Ltd. All rights reserved.
Twenty-ﬁve peptide sequences have been derived from
the secretory venom duct of Conus geographus (Table 1;
Fig. 1 – insert). This represents a culmination over some
w80 years of biochemical, genetic and pharmacological
research.1 Some of these bioactive peptides, commonly
called conotoxins or conopeptides, have led to the
pharmacological re-classiﬁcation of ion channels, based on
work exploiting isoform selectivity and phyla differentia-
tion characteristics (see Terlau and Olivera, 2004; Table 1).
Yet, toxinologicallywhatwe knowabout the composition of
these injected venoms remains mostly a mystery, particu-
larly in this species which is known to be lethal to humans.
Potent biological activity has been correlated to the
individually isolated secretory duct venom (DV) con-
opeptides; these have offered some insight into their
deadly nature. But there remain a number of compelling
issues: Do the complex crude dissected DV extracts repre-
sent what the snail uses in prey capture? Are all known DV
conopeptides observed within a single milked venom (MV)
collection? What makes a ‘killer’ cone snail lethal to
humans? Here we address some of these questions using
the MV of a known lethal cone snail, C. geographus – this
species being responsible for at least 18 human fatalities
(see Yoshiba, 1984).
Using a similar method as described by Hopkins et al.
(1995), we obtained MV by allowing C. geographus
Abbreviations: Acetonitrile, CH3CN; DHB, 2, 5-Dihydroxybenzoic acid;
DV, Duct venom; MALDI-TOF MS, Matrix Assisted Laser Desorption/
Ionization-Time of Flight Mass Spectrometry; m/z, Mass to charge ratio;
MV, Milked venom; Obs. m/z, Observed Mass to charge ratio; RP-HPLC,
Reverse Phase-High Performance Liquid Chromatography; TFA aq., Tri-
ﬂuoroacetic acid/aqueous; UV, Ultra-violet detection.
q This paper is dedicated to a mentor, friend and fellow shell collector,
Associate Professor Bruce G. Livett, formerly of the Department of
Biochemistry & Molecular Biology at the University of Melbourne,
Australia, in celebration of his retirement and contribution to the ﬁeld of
conopeptide research.
* Corresponding author. Fax: þ1 808 965 3542.
E-mail address: jbingham@hawaii.edu (J.-P. Bingham).
1 Much of this research has been reported in Toxicon over the last 50
years.
Contents lists available at SciVerse ScienceDirect
Toxicon
journal homepage: www.elsevier .com/locate/ toxicon
0041-0101/$ – see front matter  2012 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.toxicon.2012.07.014
Toxicon 60 (2012) 1166–1170
Table 1
The conopeptide sequences derived from C. geographus – pharmacological targeting, afﬁnity, origin and expression within the milked venom.
Name Amino acid sequence Target Afﬁnity
IC50 [nM]
Original
source
Monoisotopic
mass (Da)
Observed
m/z in MV
RP-HPLC
Rt (min)a
Ref.b
Lys-conopressin G CFIRNCPKG* Vasopressin
Receptor
N.D. DV 1033.49 1034.48 N.D. [1]
a-GII ECCHPACGKHFSC* nAChRb N.D. DV 1415.5 1416.43 32.3d [2]
a-GI ECCNPACGRHYSC* (LD50 12
mg/kg; mouse)
DV 1436.48 1437.41 32.3 [2]
nAChR
(mouse)
20
Site 1 (ad) 1.3  0.3
G5.1 QGWCCKENIACCV N.D. N.D cDNA 1451.54 – – [3]
a-GIC GCCSHPACAGNNQHIC* nAChR
(human)
cDNA 1608.58 – – [4]
ha3b2 1.1
ha3b4 775
ha4b2 309
G1.1 ECCNPACGRHYSCKG nAchRb N.D cDNA 1622.58 1622.55 N.D. [3]
a-GIA ECCNPACGRHYSCGK nAchRb N.D DV 1622.58 1622.55 31.0 [2]
Contulakin-G ZSEEGGSNATKKPYIL Neurotensin
Receptor
DV 2068.97 2068.11 N.D. [5]
NTR2
(human)
960
NTR3
(mouse)
250
a-GID IRDgCCSNPACRVNNOHVC nAchR
ra7(rat)
4.5 DV 2185.86 – – [6]
ha3b2 3.1
ha4b2 152
Conantokin-G GEggLQgNQgLIRgKSN* NMDA
Receptor
DV 2262.94 – – [7, 8]
NR2B 480
Brain
(human)
21–69
m-GIIIC RDCCTOOKKCKDRRCKOLKCCA* NaVc N.D. DV 2595.2 2595.02 26.4d [9, 10]
m-GIIIA RDCCTOOKKCKDRQCKOQRCCA* NaV1,4 DV 2610.14 2610.08 26.4 [10, 11,
12]Brain (rat) 69.2  0.8
Brain
(chicken)
>1000
Skeletal
muscle (rat)
0.97  0.17
Electroplax
(eel)
3.48  0.09
m-GIIIB RDCCTOORKCKDRRCKOMKCCA* NaV1,4 DV 2641.16 – – [10, 13,
14]NaV1.4
(human)
1065
NaV1.4
(rat)
49
NaV1.4
(eel)
1.1  0.1
u-GVIC CKSOGSSCSOTSYNCCRSCNOYTKRC NaVb N.D. DV 2875.99 – – [10]
u-GVIA CKSOGSSCSOTSYNCCRSCNOYTKRCY* CaV 2.2
(chick brain)
0.15 DV 3038.17 3038.09 32.8 [10, 15]
CaV 2.2
(mouse brain)
0.07
u-GVIB CKSOGSSCSOTSYNCCRSCNOYTKRCYG CaVb N.D. DV 3096.13 3096.02 33.5 [10]
u-GVIIB CKSOGTOCSRGMRDCCTSCLSYSNKCRRY CaVb N.D. DV 3289.34 – – [10]
Scratcher peptide KFLSGGFKgIVCHRYCAKGIAKEFCNCPD* N.D. N.D. DV 3301.53 – – [15]
u-GVIIA CKSOGTOCSRGMRDCCTSCLLYSNKCRRY CaV 2.2 3.7 DV 3315.39 3315.25 36.8 [10, 16]
G6.1 DDECEPPGDFCGFFKIGPPCCSGWCFLWCA N.D. N.D. cDNA 3322.24 3322.13 N.D. [3]
Conotoxin-GS ACSGRGSRCOOQCCMGLRCGRGNPQKC
IGAHgDV
NaV Skeletal
muscle (rat)
880 DV 3617.5 – – [17]
Sequence 401 from
Patent EP1852440
SDGGNAAAKESDVIALTVWKCCTIPSC
YEKKKIKACVF
N.D. N.D. cDNA 4071.99 – – [18]
Sequence 323 from
Patent EP1852440
SDGRNAAANDQASDLMAATVRGCC
AVPSCRLRNPDLCGGGR
N.D. N.D. cDNA 4143.86 – – [18]
(continued on next page)
J.-P. Bingham et al. / Toxicon 60 (2012) 1166–1170 1167
specimens to impale a condom-covered receptacle. The
stimulated snails inject venom, under pressure and with
velocity, directly into the vial at w5–20 mL per milking
(n ¼ 20). Interestingly, not all C. geographus specimens
demonstrated this proboscis extension-envenomation
behavior. We collected specimens (n ¼ 4) repeatedly from
one speciﬁc site, Boult Reef (234503200S 1521602200E) in the
Capricorn andBunkerGroupofAustralia’sGreat Barrier Reef,
which solely demonstrated this unusual predatory behavior.
As we have observed, most C. geographus prey envenoma-
tions occurwithin the safety of the rostrum/mouth upon full
prey engulfment (n ¼ 22 specimens; 5 locations). The
Fig. 1. (A) RP-HPLC/UV proﬁle of the milked venom from C. geographus (Insert: C. geographus specimen from Boult Reef, GBR, Australia). (B) The MALDI-TOF-MS
analysis of the milked venom from C. geographus. Illustrated is the unexpected molecular mass simplicity of milked venom. Labeled peaks (*) correspond to
known conopeptides listed in Table 1. Method: MV was RP-HPLC/UV proﬁled using a C18 Phenomenex capillary column (5 mm, 300 A, 1.0  250 mm, ﬂow
100 mL min1) eluted with a linear 1% min1 gradient of organic [90/10% v/v Acetonitrile (CH3CN)/0.08% v/v TFA aq.] against 0.1% v/v TFA aq. for 80 min, as
delivered by a Waters 2695 Alliance HPLC system. Elutant was monitored by photodiode array UV detection from 200 to 300 nm and extracted at 214 nm (A). For
MALDI-TOF MS MV analysis, ZipTip desalted MV was mixed 1:1 with matrix solution (2, 5-dihydroxybenzoic acid [DHB] in 1:1 0.1% v/v TFA aq.: CH3CN) and
spotted onto dried matrix saturated in methanol on the MTP 384 polished target plate, and dried under N2. Parent ions were identiﬁed on the Ultraﬂex III MALDI-
TOF-MS (Bruker Daltonics), controlled by the Compass 1.2 SR1 software package in positive reﬂector mode (B). Peptide II Calibration Mix (Bruker Daltonics) was
used for external calibration, with a <5-ppm mass accuracy. Spectra analysis was undertaken using FlexAnalysis v3.0 (Bruker Daltonics).
Table 1 (continued )
Name Amino acid sequence Target Afﬁnity
IC50 [nM]
Original
source
Monoisotopic
mass (Da)
Observed
m/z in MV
RP-HPLC
Rt (min)a
Ref.b
s-GVIIIA GCTRTCGGOKCTGTCTCTNSSKCGC
RYNVHPSGWGCGCACS*
5-HT3 53  3 DV 4189.43 – – [19]
Sequence 321 from
Patent EP1852440
SDGRNDAAKAFDLISSTVKKGCCSHPAC
AGNNQHICGRRR
N.D. N.D. cDNA 4238.98 – – [18]
*¼ C-terminal amidation; Z¼ pyroglutamic acid; S¼ O-linked glycosylated serine; w¼ D-tryptophan;W¼ bromotryptophan; O¼ 4-trans-hydroxyproline;
T ¼ glycosylated threonine; g ¼ gamma-carboxy glutamic acid; Y ¼ sulfotyrosine.
a RP-HPLC retentions are in reference to Fig. 1A.
b Corresponding references listed in Supplemental Materials.
c Targeting assigned based on sequence homology; N.D., Not Determined, DV, Duct Venom; MV, Milked Venom; cDNA, complementary DNA; nAChR,
nicotinic Acetylcholine Receptor; NMDA, N-Methyl-D-aspartate; CaV, Voltage gated calcium channels; NaV Voltage gated sodium channels; 5-HT3, Serotonin
5-HT3-receptor.
d Observed as shoulder in primary peak.
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physical environment at Boult Reef may inﬂuence C. geo-
graphus’ predatory behavior. Specimens are only found in
a narrow corridor of fused cavernous coral substrate under
largedeadplate coral, this provides a Labyrinth for smallﬁsh.
Full expansion of the rostrum to ‘net’ ﬁsh would be spatially
difﬁcult, making proboscis extension more feasible for
predatory success. Observations in captivity show partially
opened rostrums during hunting, with a brilliant red
proboscis cautiously deployed mid-air a few centimeters
ahead, and not as an extended probing appendage as seen in
other species. The snail actively pursues the ﬁsh; contact
between prey and predator is ‘calculated’ targeting the
lateral side away from the head and gills; the proboscis is
immediately withdrawn upon envenomation leaving the
imbedded radula without tethering. The subdued ﬁsh,
displays a dulled response to physical stimulus and shows
labored gill movement, within a fewminutes the ﬁsh looses
the ability to maintain an upright posture. Once on its side,
the cone snail moves in with rostrum fully expanded
engulﬁng the ﬁsh headﬁrst, without issue. Milking of C.
geographus then becomes a simple intervention once
proboscis is visibly extended. Use of whole ﬁsh as a milking
stimulus increases rate of success.
A representative Reverse Phase-High Performance
Liquid Chromatography/Ultra-violet detection (RP-HPLC/
UV) proﬁle of non-captive MV (milked within <24 h after
ﬁeld collection) is shown in Fig. 1A. This multi-peak proﬁle,
which contains w12 distinguishable peaks, far contrasts
the complexity observed in the crude DV extract (see
Olivera et al., 1990; Bingham et al., 1996). A number of C.
geographus peptides were isolated and Edman sequenced
(not shown), conﬁrming their sequence identity, post-
translational amino acid content and expression – these
include, in order of RP-HPLC elution: m-conotoxin GIIIA
(26.4 min), a-conotoxin GI (32.3 min), and u-conotoxin
GVIA (32.8 min). Matrix Assisted Laser Desorption/
ionization-Time of Flight Mass Spectrometry (MALDI-TOF
MS) analysis (positive mode) of the representative single
MV sample of C. geographus provided the assignment of 18
molecular masses, of which 12 correlated to known con-
opeptide sequences (Table 1; Fig. 1B). This was the highest
number of known C. geographus conopeptides seen in
a single MV from this population. In this example the
observed MV mass range encompasses 990–3400, Fig. 1B.
The peptide with the highest relative intensity was m/z
1090.21 – an uncharacterized MV constituent. In a number
of instances we observed þ1 m/z with some of the known
conopeptides, as illustrated in Table 1. This potentially
represents C-terminal processing, the difference being
between the amidated and carboxylated form. This has
been a somewhat unexpected observation in this and other
Conus MVs (Bingham unpublished results).
Examining the MV molecular mass proﬁle, the domi-
nance of the a-conotoxin family becomes apparent, with 4
individuals identiﬁed (a-conotoxins GI, GII, GIA/G1.1; see
Table 1). This parallels the common observation of a-
neurotoxins in the MV of snakes (Phui Yee et al., 2004).
Pharmacologically in C. geographus this is compounded by
the co-expression of m-conotoxins GIIIA, GIIIC (obs. m/z
2610.08, and 2595.02 respectively) and u-conotoxins GVIA
and GVIB (obs. m/z 3038.09, 3096.02 respectively), which
completes a predictable peptide toxin ‘motor cabal’ as
proposed byOlivera and Cruz (2001). This C. geographusMV
‘cabal’ targets the functionality of pre- and post-synaptic
ion channel targets which include: (i) the acetylcholine
receptor (a-conotoxins); (ii) the voltage gated sodium
channel (muscle type; m-conotoxins), and; (iii) voltage
gated calcium channels (N-type; u-conotoxins). Here their
synergistic pharmacological actions would lead to a rapid
and persistent ﬂaccid paralysis – a common observation in
both native prey capture (Olivera, 1997) and human enve-
nomations (see Flecker, 1936; Rice and Halstead, 1968).
The expression of Lys-conopression G (calc. m/z
1033.49; obs. m/z 1034.48 – indication of differential C-
terminal processing, see above) in the MV raises additional
speculation to its biological/pharmacological intention in
prey. Suggestions of minimizing prey escape response have
been proposed (Dutertre et al., 2008). This has merit as
typically C. geographus specimens take to a net-casting-like
prey capture response using their rostrum, with the
seemingly oblivious ﬁsh unaware of the danger it faces
while being engulfed alive – a possible indication of prey
sedation frommaterial ‘leaking’ from the venom apparatus
(see Johnson and Stablum, 1971).
But what of the other conopeptides derived from C.
geographus? Or the unidentiﬁedm/z observed, as indicated
in Fig. 1B? This brings a new level of intrigue and possible
explanation of why different outcomes in human enveno-
mation, lethal vs. non-lethal, are reported for this speciﬁc
species (Cruz and White, 1995). Furthermore, the illus-
trated MV RP-HPLC (Fig. 1A) may not represent a lethal
human dose, as materials recovered are induced by pred-
atory response, are small in relative concentration,
and derived from smaller then normal C. geographus
specimens – which are typical of Boult Reef. Further
investigation is required to see if a ‘defensivemilked venom
proﬁle’ can be achieved. Our previous observations indicate
Conus’ ability to produce ‘dry-milking’s’ and undergo MV
differentiation (Chun et al., 2012), which indicates an
ability to differentiate and/or control venom secretion.
The presence of additional highly abundant peptides
that illustrate unknown or unassigned compounds, i.e.
w40% of the observed MV m/z, provides an indication that
even within this well-studied cone snail, C. geographus
contains many uncharacterized venom constituents,
speciﬁcally those observed with a m/z <1100, similar
observations are seen in MV from Conus purpurascens
(Chun et al., 2012). The primary m/z data provided here
may assist in future genomic endeavors using this species
and aid in peptide sequence characterization. While with
the advancement of low-level peptide detection methods,
as too the use of their MVs, as seen here with mass spec-
trometric incorporation, brings further validation to
decades of previous works and now provides direct tox-
inological insight regarding these lethal predators.
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a b s t r a c t
Cone snail venoms provide a largely untapped source of novel peptide drug leads. To enhance the dis-
covery phase, a detailed comparative proteomic analysis was undertaken on milked venom from the
mollusk-hunting cone snail, Conus textile, from three different geographic locations (Hawai’i, American
Samoa and Australia’s Great Barrier Reef). A novel milked venom conopeptide rich in post-translational
modiﬁcations was discovered, characterized and named -conotoxin TxIC. We assign this conopeptide
to the 4/7 -conotoxin family based on the peptide’s sequence homology and cDNA pre-propeptide
alignment. Pharmacologically, -conotoxin TxIC demonstrates minimal activity on human acetylcholine
receptor models (100M, <5% inhibition), compared to its high paralytic potency in invertebrates,
PD50 =34.2nMol kg−1. The non-post-translationally modiﬁed form, [Pro]2,8[Glu]16-conotoxin TxIC,
demonstrates differential selectivity for the 32 isoform of the nicotinic acetylcholine receptor with
maximal inhibition of 96% and an observed IC50 of 5.4±0.5M. Interestingly its comparative PD50
(3.6Molkg−1) in invertebrates was ∼100 fold more than that of the native peptide. Differentiating
-conotoxin TxIC from other -conotoxins is the high degree of post-translational modiﬁcation (44% of
residues). This includes the incorporation of -carboxyglutamic acid, two moieties of 4-trans hydroxy-
proline, two disulﬁde bond linkages, and C-terminal amidation. These ﬁndings expand upon the known
chemical diversityof-conotoxins and illustrate apotential driverof toxinphyla-selectivitywithinConus.
© 2013 Elsevier Inc. All rights reserved.
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1. Introduction
The genus Conus (Family: Conidae, Subfamily: Coninae) has
maintained a position of predatory superiority within tropi-
cal marine ecosystems for some 50 million years. The genus
attributes its evolutionary success to the development and deliv-
ery of a venomous cocktail. The cone snail injects this venom
through a hypodermic needle-like radula harpoon that can
penetrate deep into the dermis of its prey [19]. These ven-
oms comprise a potent pharmacopeia of individual bioactive
peptide constituents, commonly referred to as conotoxins or
conopeptides. New estimates indicate that half-a-million distinct
biologically active molecules are expressed within this genus alone
[17,38,49].
Stemming from their intended predatory use as potent neu-
rotoxic agents for prey immobilization [12,21], the chemical
complexity and functional side-chain variability of conopep-
tides has been studied, whereby providing tools for prob-
ing ion channel function and structure-activity relationships.
The majority of research has focused on the clinical sig-
niﬁcance and therapeutic potential of conopeptides. This is
evident by the number of conopeptide derived molecules
in pre-clinical development or clinical phase trials for the
treatment of a broad spectrum of conditions ranging from
neuropathic pain and Alzheimer’s, to Parkinson’s and epilepsy
[5,20,22,30,47,55].
Early investigations using milked venom from piscivorous
species has fuelled rapid identiﬁcation of a number of novel
bioactive peptides includingA-conotoxin OIVA from Conus obscu-
rus [50] and -conotoxin SIIIA from Conus striatus [48]. Most
notably, in 2004, the United States Food and Drug Administration
(FDA) approved PrialtTM (-Conotoxin MVIIA), a peptide naturally
expressed in themilked venomofConusmagus, for the treatment of
chronic neuropathic pain [7,26]. Unfortunately, due to this height-
enedmedical interest, in conjunctionwith intensiveexploitationby
the ornamental shell-trade industry, the over-harvesting of Conus
has the potential to result in the depletion of population densi-
ties [9,16]. Subsequently, the need for a rapid and biosustainable
approach to identifynovel, clinically signiﬁcant conopeptideswhile
simultaneously reducing pressure on native snail populations has
emerged.
In order to increaseourunderstandingofmolluscivorousmilked
venoms, the current study was initiated to perform a comprehen-
sive investigation into the venomic multiplicity of Conus textile
using Reverse-Phase High Performance Liquid Chromatographic
(RP-HPLC2) proﬁling and mass spectral analysis of both duct (DV)
and milked venoms (MV) collected from non-captive specimens
representing diverse locations throughout the Paciﬁc. This widely
distributed tropical species currently represents one of the most
well-studiedmolluscivore conesnailwith countlessmolecular con-
stituents, including 77 fully characterized conopeptides (see Table
S1).
Our results from the combined ‘conovenomic’ approach
revealed an unexpected level of diversity within the venom
proﬁles of geographically unique populations of C. textile,
and further demonstrated molecular consistency within indi-
viduals between the proﬁles of (i) MV, (ii) dissected whole
DV, and (iii) Radula lumen Extract (RE). The comparison
of geographically diverse venom proﬁles led to the identi-
ﬁcation of a previously uncharacterized peptide, -conotoxin
TxIC, which exhibits extensive post-translational modiﬁcations
(PTMs). Here we demonstrate how PTM amino acids act as
determining factors for selective targeting of the nicotinic
acetylcholine receptor (nAChR)—a well-documented therapeu-
tic target for the treatment of chronic neuropathic pain
[8,31,44,51,52].
2. Materials and methods
2.1. Snail milking
MV from non-captive C. textile was obtained within 24hours
of ﬁeld collection. Envenomation was stimulated by the pres-
ence of live gastropods Morula marginalba, Strombus luhuanus or
Cypraea caputserpentis. On extension of the cone snail’s proboscis,
a pipette ﬁtted with a 5000L tip was depressed and placed near
the upturned aperture, close to the foot of the prey. On subsequent
ﬁring of the radula, envenomation was observed by the release of
excess venom, typically as a visible ‘cloud’, which was carefully
aspirated to avoid dispersion. The collected MV was acidiﬁed (1%
v/v TFA) and either frozen (−20 ◦C) or lyophilized for later analysis.
Aliquots of seawater (blanks) were collected and processed in the
identical manner.
2.2. Dissected duct venom extract preparation
Whole venom ducts were dissected from live specimens, indi-
vidually dried by Speed-Vac, weighed and homogenized to obtain
a ﬁne powder. A mixture of (1000L) 95% Solvent A (0.1% v/v
TFA/aq.) and 5% Solvent B (90/10 v/v CH3CN/0.08% v/v TFA/aq.)
was used as the extracting solvent at a standardized concentration
(1mgmL−1). Samples were vortexed (30 s), sonicated (10min) and
then centrifuged (4,500 g for 10min.). The resulting supernatant
was decanted, dried via Speed-Vac, weighed and then stored at
−20 ◦C until required. All materials were dissolved in 500L of the
above solvent, sonicated (5min), ﬁltered (0.2m membrane) and
then centrifuged (12,000× g for 10min) prior to chromatographic
separation and analysis.
2.3. Chromatographic separation and analysis, RP-HPLC
Representative MV peptides and DV extracts were individu-
ally separated as follows: (i) Capillary Scale (Phenomenex; C18,
5m, 300 A˚, 1.0×250mm, ﬂow 100Lmin−1)—used for com-
parative RP-HPLC/UV proﬁling, quality control of peptide purity,
peptide quantiﬁcation and peptide co-elution experiments. (ii)
Analytical Scale (Vydac; C18, 5m, 300 A˚, 4.2×250mm, ﬂow
1mLmin−1)—used for the isolation and puriﬁcation of native
peptides for MALDI-TOF-(TOF)-MS and Edman Degradation (Sec-
tions 2.4 and 2.5). (iii) Preparative Scale (Vydac; C18, 10m,
300 A˚, 22×250mm, ﬂow 5mLmin−1)—used for the desalting and
preparative separation of native MV peptides for sequencing and
pharmacological assay (Sections 2.9 and 2.12). Systems (i) and
(ii) used a Waters 2695 Alliance RP-HPLC System interfaced with
a 996 Waters Photo Diode Array Detector for automated sam-
ple analysis and detection. Data was acquired and analyzed using
Waters Millennium32 (v3.2) software. Samples were eluted using
a linear 1%min−1 gradient of organic (90/10% v/v CH3CN/0.08%
v/v aq. TFA) Solvent B against aqueous (0.1% v/v TFA aq.) Sol-
vent A for 65min, excluding a terminating high organic wash (80%
Solvent B for 5min), and pre-equilibration step (5% Solvent B)
for 10min prior to sample injection. Eluent was monitored from
200–300nm and extracted at 214nm. Preparative RP-HPLC/UV,
system (iii), used a 625 Waters HPLC pump and controller inter-
faced with a 996 Waters Photo Diode Array Detector. Both gradient
control and data acquisition were facilitated by the use of the
Waters Millennium32 software. Filtered (Nylon 0.22m) crude
MV and DV peptide extracts were manually loaded and eluted
from the preparative scale column using the same 1% gradient
at 5mLmin−1 and monitored at 214 and 280nm. Fractions were
collected manually and stored at −20 ◦C or freeze-dried until
required.
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2.4. Direct ESI-MS infusion
AB/MDS-Sciex API 3000 triple quadrupole mass spectrometer
(Thornhill, Ontario, Canada) was used in this investigation as pre-
viously described by Chun et al. [10]. The ESI-MS system was
calibrated manually in positive mode with PPG 3000 (AB/MDS-
Sciex) to achieve <5-ppm mass accuracy, as per manufacturer’s
protocol.
2.5. MALDI-TOF MS venom analysis
ZipTipTM or RP-HPLC/UV puriﬁed venom fractions in Solvent A
(0.1% v/v aq. TFA) were mixed 1:1 with matrix solution (40g L−1
2,5-dihydroxybenzoic acid (DHB) in 1:1 0.1% v/v aq. TFA: CH3CN)
and 1L was spotted on a MTP 384 polished steel target plate
(Bruker Daltonics). The spots were dried under a stream of N2 gas.
Mass spectra were acquired on the Ultraﬂex III (Bruker Dalton-
ics), controlled by the Compass 1.2 SR1 software package (Bruker
Daltonics), in positive reﬂector mode from m/z 500 to 5000. Mass
spectra were summed (400 to 1200 laser shots) until no further
improvement to the signal to noise ratio of peaks was achieved.
Peptide II Calibration Mix (Bruker Daltonics) was used for external
calibration, with a mass accuracy of approximately 50-ppm. Anal-
ysis of the spectra was completed using FlexAnalysis v3.0 (Bruker
Daltonics).
2.6. MALDI-TOF/TOF MS peptide sequencing and PTM
characterization
The reduced venom peptide, -conotoxin TxIC, was desalted
via ZipTipTM (C18 reversed-phase media, Millipore) or RP-HPLC/UV
isolated and spotted onto the target plate with DHB matrix, as
described above (Section 2.5). Tandem mass spectra (MS/MS) were
acquired in reﬂector positive LIFT mode on the UltraﬂexIII (Bruker
Daltonics), externally calibrated with Peptide Calibration Mix II
(Bruker Daltonics) with a MS/MS accuracy of 0.04Da. FlexAnaly-
sis v3.0 (Bruker Daltonics) was used for manual inspection and
annotation of the LIFT-spectra. TheRapiDeNovomodule in BioTools
(Bruker Daltonics) was used to make additional assignments to the
amino acid sequence.
2.7. MALDI-TOF MS radula analysis
Conus textile radulae were collected from dissected radula sacs.
Harpoons were prepared for MALDI-TOF MS analysis as described
previously by Chun et al. [10].
2.8. Peptide reduction and thiol alkylation
For complete peptide reduction, Conus extracts and peptide(s)
(typically 0.02–3mg) were exposed to 100L of 200mM Tris(2-
carboxyethyl)phosphine (TCEP; Pierce Chemicals, USA) in 25mM
NH4OAc (pH 4.5) and heated for 5–30min at 50 ◦C. Alkylation of
the RP-HPLC puriﬁed, reduced peptide(s) was achieved by dissolv-
ing thepeptide in 90–150L of 25mMNH4OAc (pH4.5) and adding
100mM N-phenylmaleimide or Maleimide (Fluka, Switzerland) in
isopropanol. Typically 20–40 fold excess (w/w) of the alkylating
agent was used. Alkylation was allowed to proceed at 50 ◦C for
15min, prior to RP-HPLC/UV puriﬁcation.
2.9. Sequencing–Edman degradation
Non-alkylated and Maleimide alkylated derivatives were
applied to Polybrene-treated glass ﬁber support ﬁlters for auto-
mated Edman degradation on a gas-phase sequencer (Model 470A;
Applied Biosystems, Foster City, CA, USA). Assignment of the amino
acid sequencewas essentially as describedbyAtherton et al. [2] and
Matsudaira [34].
2.10. Peptide synthesis
-Conotoxin TxIC [ROQC4CSHOAC10NVDHPIC-NH2;  -
carboxyglutamic acid (Gla), O 4-trans hydroxyproline (Hyp)] was
manually assembled using a 0.5mmole scale and Fmoc SPPS via in-
situ neutralization with 2mmole Fmoc-amino acid per 10–30min
single coupling, as adapted from Schnölzer et al. [46] and described
in detail in Kapono et al. [26]. A Fmoc-Cys(Trt)-Rink-Amide MBHA
Resin (0.55meq. g−1; Peptides International, Louisville, KY, USA)
wasused for peptide assembly to give thedesiredC-terminal amide
function. Side chain protecting groups were: Cys(Trt), Asp(tBu),
Arg(Pbf) and Gln(Trt). Gla(otBu)2, His(Trt), Asn(otBu) and Hyp(tBu)
(as supplied by Peptides International, Louisville, KY, USA). An
additional 0.5mmole scale synthesis of -conotoxin TxIC was
undertaken using orthogonally protected Cys(Acm) being placed
in positions 4 and 10 in the above sequence. This synthesis used
the same synthetic strategy as previously mentioned, but deviated
using an alternative directive/sequential oxidation process (see
below). Finally, a non-PTM amino acid variant of-conotoxin TxIC,
(i.e. [Pro]2,8[Glu]16-conotoxin TxIC), was produced and folded
using the same orthogonally Cys(Acm) protected scheme as above.
Incorporated were the Fmoc amino acids Pro and Glu(OtBu) used
as PTM substituents.
2.11. TFA cleavage
Fmoc peptidyl-resins were subjected to a cleavage with 82.5%
v/v TFA in the presence of thioanisole (5% v/v), Phenol (5% v/v) H2O
(5% v/v) and TIPS (2.5% v/v), acting as protecting group scavengers,
for 2.5h at 24 ◦C. The resulting cleaved peptide material was recov-
ered by ﬁltration and cold t-butyl ether precipitation. Resulting
crude peptide was stored at −20 ◦C, as lyophilized powder, until
required.
2.12. Random disulﬁde bond formation
Peptide oxidation was achieved with 15mg of TCEP reduced C18
RP-HPLC puriﬁed peptide, using 0.1M NH4HCO3 pH 8.7 (5 days
stirring; room temp.). The oxidized peptide was preparative RP-
HPLC/UV isolated and re-puriﬁed, and the oxidizedmolecularmass
was veriﬁed by ESI-MS.
2.13. Directed disulﬁde bond formation
Cleaved -conotoxin TxIC and [Pro]2,8[Glu]16-conotoxin TxIC,
both containing Cys(Acm) in positions 4 and 10, were RP-HPLC/UV
puriﬁed, and then air oxidized, as above. Partially oxidized mate-
rials, as conﬁrmed by ESI-MS, were then subjected to spontaneous
thiol deprotection and disulﬁde bond formation. Deprotection was
achieved by dissolving the partially folded peptide in 50% v/v acetic
acid (1mgmL−1) and by adding a solution of freshly saturated I2 in
50% v/v acetic acid to the stirring peptide (25% reaction vol.). Reac-
tion was quenched after 5min with the addition of 10L aliquots
of 1M Na2S2O3 until the stirring solution became clear, which was
then followed by the addition of 200L TFA. Resulting acidiﬁed
material was centrifuged (12,000× g, 5min) and directly puriﬁed
bypreparativeRP-HPLC/UV (as above)withmass conﬁrmationpro-
vided by ESI-MS.
2.14. Genetic analysis of ˛-conotoxin TxIC
The venom duct and bulb of C. textile specimens (Great Barrier
Reef, Australia) were removed by dissection and snap frozen in
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liquid N2. The secretory venom duct and bulb were ground
and mRNA was extracted using a Dynabeads mRNA direct kit
(Dynal, Norway). A cDNA library was created from this mRNA
using a Marathon cDNA ampliﬁcation kit (Clontech) as previously
described [44]. All PCRs utilized the primers Uni -1 (universal
-conotoxin primer) 5′ ATGGGCATGCGGATGATGTT 3′; and Uni -
2 (universal -conotoxin primer) 5′ CGGAAAGTGAAGCAGGTCAG
3′, designed against conserved sequences found on the 5′ and
3′ conserved regions of known conotoxins. Reaction mixtures
contained Taq polymerase (Roche) and deoxynucleotides in a
buffer supplied by the manufacturer. Samples were incubated at
94 ◦C for 2min; followed by 30 cycles of 94 ◦C for 30 s, an annealing
step for 30 s, 72 ◦C for 45 s; concluding with a ﬁnal step of 72 ◦C
for 5min. Ampliﬁcation products were puriﬁed after separation
on a 1.5% agarose gel using a Qiaquick gel extraction kit (Qiagen).
The puriﬁed PCR products were transformed into competent
INVF′ Escherichia coli cells in accordance with the manufacturer’s
speciﬁcations (Invitrogen, Netherlands). Recombinant plasmids
containing inserts of approximately 250bp were sequenced by the
di-deoxy chain termination method using the ABI PRISM Big-Dye
Terminator Cycle Sequence Ready Reaction Kit (Perkin Elmer,
USA). Sequences were analyzed on a Perkin Elmer 377 sequencer
at the Australian Genome Research Facility (AGRF).
2.15. Pharmacology
2.15.1. Expression of voltage-gated ion channels in Xenopus
laevis oocytes
For the expression of nAChR (1, 3, 4, 5, 2, 4, ; ; )
in Xenopus oocytes, the linearized plasmids were transcribed using
the T7 or SP6 mMESSAGE-mMACHINE transcription kit (Ambion®,
Carlsbad, CA, USA). The harvesting of stage V–VI oocytes from
anaesthetized female Xenopus laevis frog was previously described
by Liman et al. [29]. Oocytes were injected with 50nL of cRNA at
a concentration of 1ngnL−1 using a micro-injector (Drummond
Scientiﬁc®, Broomall, PA, USA). The oocytes were incubated in a
solution containing (in mM): NaCl, 96; KCl, 2; CaCl2, 1.8; MgCl2, 2
and HEPES, 5 (pH 7.4), supplemented with 50mgL−1 gentamycin
sulfate.
2.15.2. Electrophysiological recordings
Two-electrode voltage-clamp recordings were performed at
room temperature (18–22 ◦C) using a Geneclamp 500 ampliﬁer
(Molecular Devices®, Downingtown, PA, USA) controlled by a
pClamp data acquisition system (Axon Instruments®, Union City,
CA, USA). Whole cell currents from oocytes were recorded 1–4
days after injection. Bath solution composition was (in mM): NaCl,
96; KCl, 2; CaCl2, 1.8; MgCl2, 2 and HEPES, 5 (pH 7.4). Voltage
and current electrodes were ﬁlled with 3M KCl. Resistances of
both electrodes were kept between 0.5 and 1.5M. During recor-
dings, the oocytes were voltage-clamped at a holding potential of
−70mVandsuper fusedcontinuouslywithND96buffer via gravity-
fed tubes at 0.1–0.2mLmin−1, with 5min incubation times for the
bath-appliedpeptides. Acetylcholine (ACh)was appliedvia gravity-
fed tubes until peak current amplitude was obtained (1–3 s), with
1–2min washout periods between applications. Data was sampled
at 500Hz and ﬁltered at 200Hz. Peak current amplitude was mea-
sured prior to and following incubation of the peptide.
To assess the concentration-response relationships, data points
were ﬁtted with the Hill equation: y=100/[1 + (EC50/[toxin])h],
where y is the amplitude of the toxin-induced effect, EC50 is the
toxin concentration at half maximal efﬁcacy, [toxin] is the toxin
concentration and h is the Hill coefﬁcient. Comparison of two sam-
ple means was made using a paired Student’s t test (p<0.05). All
data is presented asmean± standard error (S.E.M) of at least 4 inde-
pendent experiments (n≥4). All data was analyzed using pClamp
Clampﬁt 10.0 (Molecular Devices®, Downingtown, PA, USA) and
Origin 7.5 software (Originlab®, Northampton, MA, USA).
2.16. Whole animal bioassay
Standardized concentrations of native -conotoxin TxIC (2.5,
5, 10, 20, 40, 80, 160, 320 and 640pMol g−1) and synthetic
[Pro]2,8[Glu]16-conotoxin TxIC (0.16, 0.32, 0.64, 1.28, 2.56, 5.12
and 10.24nMol g−1) in 10L volumes (PBS), were injected intra-
muscularly (IM - foot) into Hawaiian snakehead cowries (Cypraea
caputserpentis) using a Hamilton 10L syringe at a depth of 2mm.
Following injection, animals were placed in glass Petri dishes ﬁlled
with fresh aerated seawater, where paralysis was determined by
the inability of the animal to cling to the substrate. Dosage and
paralysiswere recorded and plotted according to Reed andMuench
[40], and thePD50 wasextrapolatedusingGraphPadPrismSoftware
(v5.02). All dose experiments were repeated in triplicate or greater
(n≥3).
3. Results
3.1. Conformational analysis of ı-conotoxin TxVIA
The MH+ 3035.4Da was identiﬁed by ESI-MS from RP-HPLC/UV
fractions of DV, conﬁrming the identity of -conotoxin TxVIA (Calc.
MH+ 3035.3Da). TCEP reduction, RP-HPLC/UV separation and ESI-
MS analyzed demonstrated a mass shift of 6Da (Obs. Red. MH+
3041.5Da), which reﬂects disulﬁde content. This same material
(∼300nmole) was then subjected to 27 cycles of Edman degra-
dation, and a single unambiguous sequence that corresponded
to -conotoxin TxVIA W(-)KQSGEM(-)NLLDQN(-)(-)DGY(-)IVLV(-
)T was obtained. ‘Blanks’ (-) were observed at degradative cycles
2, 9, 16, 17, 21 and 26. These corresponded to the 6 underivatized
cysteine moieties as predicted within this speciﬁc sequence. This
conﬁrmed the expression of -conotoxin TxVIA—a species-speciﬁc
duct venom ‘biomarker’ for all specimens examined in this study.
The methionine sulfoxide derivative (+16Da) of this peptide was
also observed by MALDI-TOF MS (m/z 3051.3; Fig. 2A and B).
3.2. Geographic biodiversity - RP-HPLC/UV non-captive milked
venom proﬁling
Typical representative MVs from non-captive specimens of C.
textile demonstrate an abundance of chromatographic peaks ran-
ging from 20–70 per MV proﬁle (Fig. 1). Multiple MV samples from
Hawai’i (n=30 specimens) and the Great Barrier Reef (n=50 speci-
mens; GBR), Australia contained similar chromatographic content,
with varying relative peptide concentrations as observed in the
moderately hydrophilic region (25–40% CH3CN, 25 to 40min; see
Fig. 1A and C, respectively). No observable RP-HPLC/UV correlation
to cone snail sex or collection/milking season could be established
from the MV proﬁles from any of the three locations examined (not
shown).
The moderate to hydrophobic RP-HPLC/UV proﬁle region
(40–80%CH3CN, 40 to 80min) accounted for >30% ofmilked venom
variability, with the highest proportion of peak variability seen in
the representative MV of non-captive specimens from American
Samoa (n=20 specimens) (Fig. 1B). The hydrophobic -conotoxin
TxVIA (Rt 65.3min) was observed in both non-captive Hawai’ian
and American Samoan representative samples (see arrow in Fig. 1A
and B respectively), but was absent in non-captive GBR Australian
MV (Fig. 1C). One previously undocumented peak (underlined),
with a retention time (Rt) = 26.6min (-conotoxin TxIC), was
observed in all three locations (n=100, total specimens examined)
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Fig. 1. RP-HPLC/UV comparison of peptides from the milked venom of representative non-captive C. textile specimens sampled from different geographic locations in the
South Paciﬁc: (A) Hawai’i; (B) American Samoa; and (C) the Great Barrier Reef, Australia. The expression of -conotoxin TxVIA (arrow), was detected in MV samples from
Hawai’i (n=30, from 5 sites) and American Samoa (n=20, from 5 sites), but was absent from those from GBR, Australia (n=50, from 32 sites). -Conotoxin TxIC (underscore)
was detected in MV from all three locations, indicating its importance in the envenomation strategy of C. textile. MALDI-TOF MS analysis of these MV samples is shown in
Fig. 2. In each map, indicated are cone snail collection sites (ﬁlled circle) and individual representative samples (arrow).
(Fig. 1A–C). This observed geographic commonality lends credence
to the importance of that particular conopeptide.
3.3. Geographic biodiversity - Molecular mass proﬁling of
non-captive milked venom
MALDI-TOFMSproﬁles ofMV from5 randomspecimens of non-
captive C. textile fromeach geographic location cover the entirety of
the examined mass range (Fig. 2A–C). In the examples illustrated,
a combined total of 178 non-overlapping peaks were observed in
the three MVs (Table 1 & Table S2). Of these, 42 peaks (∼24%) were
common to two collection sites, with only 11 (∼6%) being common
to all three. Importantly, 27 of the 178non-captiveMVconstituents
(∼15%) correlated to known C. textile peptides (Table 1; Tables
S1 & S2), excluding potential PTM variants including C-terminal
processing ( ±1.0Da for free-acid vs. amide). Expression of 2 of
these known conopeptides, TxIA and TxIIIC, were previously con-
ﬁrmed by Edman degradation sequencing [4].
3.4. Single specimen venom source consistency–Non-captive
RP-HPLC/UV proﬁling
RP-HPLC/UV venom peptide proﬁles from a single non-captive
specimenofC. textile (Oahu,Hawai’i) is shown in Figs. 3A–C. Results
illustrate a high level of peptide Rt consistency between the whole
duct venom (DV) extract, the milked venom (MV), and the Radula
lumen Extract (RE). The relative abundance of peptides in the
different venom extracts was highly variable as seen with the rel-
ative intensity of the hydrophobic -conotoxin TxVIA (Rt 65.3min;
Fig. 3B and C).
3.4.1. Duct venom (DV) extracts
In the DV, -conotoxin TxVIA was one of the major components
(Fig. 3C). The presence of -conotoxin TxIC in DV (underscored,
Fig. 3C)was observed at Rt = 26.6min, corresponding to an identical
elution proﬁle from the MV of the same specimen (Fig. 3B) as well
as in the representatives from geographic MV sampling (Fig. 1).
3.4.2. Milked venom (MV) extracts
In contrast to the DV, MV proﬁles naturally correspond to a
more accurate representation of bioactive constituents used in
prey immobilization. -Conotoxin TxVIA was one of only a few
hydrophobic peptides observed in the MV (Fig. 3B), which exhib-
ited direct correlation to the DV. These results are reiterated in
the geographic specimens that exhibit few hydrophobic peptides
(Fig. 1); most notably, Australian specimens–which may reﬂect
venom processing. Highly abundant hydrophilic peptides within
bothDVandMVvenomextract proﬁleswere examined (Fig. 3B and
C), which identiﬁed -conotoxin TxIC (underscored, Rt = 26.6min).
3.4.3. Radula lumen (RE) extracts
Analysis of the RE demonstrated poorly resolved peaks with
limited abundance (Fig. 3A), yet the two major peaks correlated
with the two highly abundant peaks in the MV (Fig. 3B). Both peaks
showed marked differences in the DV extract.
3.5. Single specimen venom source consistency–Non-captive
molecular mass proﬁling
MALDI-TOF-MS was used to detect and compare identiﬁable
peptide masses in extracts of the RE, MV and DV, from a single
non-captive representative specimen of C. textile (Fig. 4). A total of
159 unique molecular masses were observed (Table S3). Common
to all three extracts were 16 individual masses (∼10%). Showing
the greatest similarity were the MV and DV proﬁles that shared 38
masses (∼24%). The RE mass spectrum, exhibiting masses within
m/z 945 to 3850, contained fewer masses than the MV and DV. The
MV mass spectrum was the most complex in peak number of the
three.
Most notable are the high intensity masses observed in both the
DV and MV extracts which correspond to important and previously
characterized conopeptides (Table 2 and Fig. 4). The dominant peak
in the MV and DV mass spectra (m/z 2488.2±0.3) corresponds to
the C. textile Convulsant peptide. This peak is also present in the
RE mass spectrum. Other identiﬁed peptides (i.e., TxIA and TxIIIC)
were alsoobservedasmajor contributors in thegeographic analysis
(Table 1, Fig. 2).
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Fig. 2. MALDI-TOF MS mass spectra of of representative non-captive milked venoms from C. textile specimens obtained from: (A) Hawai’i; (B) American Samoa; and (C)
the Great Barrier Reef, Australia. Peaks corresponding to known conopeptides (*) and peaks common to all 3 spectra () are indicated Table S2 provides an extensive list
comparing all peaks observed in these venom proﬁles.
3.6. Mass spectrometric analysis of ˛-conotoxin TxIC disulﬁde
bonds
A geographically consistent peptide (Rt = 26.6min; Fig. 3) was
isolated from MV by RP-HPLC/UV. A single parent mass of MH+
2080.8Da was assigned by ESI-MS (Obs. [M+3H]+3 694.6Da; data
not shown). After TCEP reduction, the observed parent mass was
MH+2084.7Da,which indicated thepresence of 2 disulﬁdebridges.
This was conﬁrmed by alkylation of the reduced material with N-
phenylmaleimide, after which an increase in 692Da was observed,
Fig. 3. RP-HPLC/UV comparison of venom obtained from (A) Radula Lumen Extract; (B) Milked Venom; and (C) Duct Venom from a representative specimen of C. textile. (A)
The RE revealed limited similarity of peptides within the hydrophilic region to those in the hydrophilic regions of MV and DV. Note that -conotoxin TxIC (underscore) and
-conotoxin TxVIA (arrow) were not detected in the RE. Both (B) MV and (C) DV demonstrated a high level of peptide abundance and continuity. These samples were proﬁled
via MALDI-TOF MS (Fig. 4).
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Fig. 4. MALDI-TOF MS proﬁles of peptide extracts from a single representative Conus textile specimen obtained from: (A) Radula Lumen Extract; (B) Milked Venom and (C)
Whole Duct Venom. Peptides exhibiting common peaks are listed in Table 2 and indicated () in each proﬁle. These data illustrate expressional consistency, although some
unique peaks are observed from each venom source. Absence of -conotoxin TxIC is apparent, but is suspected to be present as an in-source decay fragment. -Conotoxin
TxVIA was observed at m/z 3035.6±0.2. Peaks corresponding to other known C. textile peptides are indicated by asterisk (*). Table S1 provides an extensive list of observed
peaks corresponding to known C. textile venom peptides.
corresponding to 4 alkylation groups ( 173Da for each free thiol
[6]).
3.7. CID analysis of ˛-conotoxin TxIC
The parent ion of-conotoxin TxIC was not observed in MALDI-
TOF MS analyses of geographic and source extracts (Figs. 2 and 4).
This indicated decay of the parent ion, which is common in MALDI-
TOF MS of peptides containing labile PTMs. Direct observation of
this suspected decay was achieved via MALDI-TOF MS of the puri-
ﬁed material in its reduced form (Fig. 5A). Two well resolved peaks,
with a difference of 44Da, indicated the presence of a carboxyl
group. Similardecayof theparent ioncouldbe reproducedwithESI-
MS, a softer ionization method, by increasing the oriﬁce potential
voltage outside of the normal operating range (data not shown).
MALDI-TOF/TOF MS/MS fragmentation spectra of the suspected
decarboxylated (m/z 2041.06; Fig. 5B) and ‘intact’ form (m/z
2805.07; data not shown) of TCEP reduced -conotoxin TxIC were
nearly indistinguishable. In both cases MS/MS fragmentation dis-
played a 44Da deﬁcient a-, b-, and y-ion series. Analysis of the
overlapping ion series allowed for interpretation of the amino
acid sequence as R-[I/L/O]2-Q-C-C-S-H-[I/L/O]8-A-C-N-V-D-H-P-E-
[I/L/O]17-C. The isobaric nature of isoleucine and leucine (I and
L) and their similarity in mass to 4-trans-hydroxylproline (O) (
0.036Da) resulted in ambiguities at positions 2, 8 and 17, which
were resolved with Edman degradation (Section 3.8).
The CID fragment ions also indicated heterogeneity of the C-
terminus, the predominant form being amidated. The presence
of low abundant C-terminal free acid form was veriﬁed using a
narrowprecursor ionselectionwindowof±0.5Da. TheMS/MS frag-
mentation spectrum was interpreted to have the same amino acid
sequence as the amidated form (data not shown). Additional veriﬁ-
cation was obtained by comparing predicted and observed isotopic
distribution patterns for the respective parent ions.
3.8. Edman degradation of ˛-conotoxin TxIC
RP-HPLC/UV puriﬁed N-phenylmaleimide thiol alkylated -
conotoxin TxIC, ∼300nmole, was subjected to 20 cycles of
automated Edman degradation. PTH-4-trans-hydroxylproline was
added to the amino acid standard mixture to aid identiﬁcation.
Sequential degradation provided an unambiguous 18 amino acid
sequence: RO2QCCSHO8ACNVDHP(-)16IC. Cycle 16 indicated a low
recovery level PTH-Glu (<1nmole) and was designated as a ‘blank
cycle’ based on the expected sequential cycle yields observed
within the normal degradative process.
Edman degradation assigned 17 of the 18 amino acids conclu-
sively, including positions 2 and 8 as 4-trans-hydroxylproline and
17 as isoleucine. The presence of low levels of glutamic acid in cycle
16, combined with the observed mass difference of 44Da (-CO2)
under variousmass spectrometric conditions, provided further cor-
roborated the presence of a -carboxylated glutamic acid within
-conotoxin TxIC at position 16.
3.9. Genetic analysis of ˛-conotoxin TxIC
The peptide sequence was conﬁrmed genetically by iden-
tifying the -conotoxin transcript in C. textile venom duct
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Fig. 5. (A) The decarboxylation of TCEP Reduced -conotoxin TxIC as seen by MALDI-TOF MS. Observed molecular masses differ by 44 Da. The ratio could be inﬂuenced by
choice of MALDI-MS matrix (not shown). (B) CID analysis of -conotoxin TxIC. Using overlapping a-, b-, and y-ion series, the sequence was interpreted to be R-[I/L/O]-Q-C-
C-S-H-[I/L/O]-A-C-N-V-D-H-P-E-[I/L/O]-C. Fragment ions also indicated decarboxylation and heterogeneity of the C-terminal amino acid.
cDNA (GBR, Australia) using oligonucleotides based on regions
of conserved sequence in the pre-region and C-terminal ﬂank-
ing region of -conotoxins [44]. The resulting 19 amino acid
toxin- or mature-sequence region was deduced: RPQCCSHPAC-
NVDHPEIC[R] (see Fig. 6). A C-terminal arginine was absent
following Edman analysis; its inclusion would also be at vari-
ance with native molecular mass as observed by either ESI-MS,
MALDI-TOF MS or by sequence analysis using MALDI-TOF/TOF MS
LIFT.
The N-terminal pro-region of -conotoxin TxIC also possesses
an argininase site for mature conopeptide cleavage, an occurance
common to conotoxin processing [24]. In -conotoxin TxIC the
pro-peptide cleavage site is located between two neighboring
arginine moieties–see Fig. 6. This is conﬁrmed by the recov-
ery/identiﬁcation of an N-terminal arginine in -conotoxin TxIC
both by MALDI-TOF/TOF MS LIFT and Edman Degradation. Inde-
pendent identiﬁcation of [Glu]16, via genetic analysis, conclusively
conﬁrmed the original parent PTM amino acid assignment.
3.10. Peptide synthesis of ˛-conotoxin TxIC
Based on the assigned C-terminal amide sequence above,
-conotoxin TxIC was synthetically constructed and folded by ran-
dom air oxidation. Upon completion, the correct target molecular
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Fig. 6. Genetic analysis of -conotoxin TxIC and its comparison to -conotoxins MII and Vc1.1. The Pre/Pro region of -conotoxin TxIC demonstrates a high level of amino
acid identity to established members of the 4/7 -conotoxin family. N-terminal processing of -conotoxin TxIC shares similarities with the processing of -conotoxin Vc.1.1
required to produce themature toxin. Similarmechanisms operate to process-conotoxinMII. C-terminal brackets [] represent stop codonswithin the formal cDNA sequence.
mass was observed by ESI-MS: Obs. MH+ 2080.9Da (Calc. MH+
2080.8Da). RP-HPLC/UV demonstrated the presence of 3 peaks,
with the two dominant peaks separated by <0.3min (Fig. 7A).
All three peaks were determined to be disulﬁde isomers of -
conotoxin TxIC, as conﬁrmedbyESI-MS. Separationof the twomain
isomers proved difﬁcult. Changes to gradient, ion pair agents and
column failed to achieve their full separation (data not shown).
A second synthesis was performed using the established
disulﬁde connectivity pattern reported for the 4/7 -conotoxin
family [31]. This was achieved by incorporation of differential
orthogonally protected cysteine moieties at positions 4 and 10
(Fig. 7B). This allowed for the step-wise production of a sin-
gle oxidized peptide peak that retained target characteristics of
mass (Obs. MH+ 2080.9Da) and RP-HPLC/UV using a slower chro-
matographic gradient (0.5%min−1), without production of the
previously observed isomeric materials (Fig. 7A). Co-injection of
the RP-HPLC/UV puriﬁed synthetic material with-conotoxin TxIC
isolated fromthenativemilkedvenom, in a ratioof 1:2 respectively,
demonstrated chromatographic homogeneity at 33.3min, Fig. 7B.
RP-HPLC/UV co-injection of the TCEP reducedmaterial also demon-
stratedchromatographichomogeneity (not shown). This conﬁrmed
the original peptide sequence assignment, including C-terminal
assignment, and provided an independent synthetic standard for
RP-HPLC/UV.
3.11. Pharmacological assessment
Native -conotoxin TxIC (≤100M) had minimal inhibitory
action on human nicotinic acetylcholine receptor (nAChR) subunit
combinations42 (brain),44 (neuronal),7 (neuronal),
(muscle),  (muscle) or the human peripheral nAChR sub-
types 32, 325 and 34. Biological activity was observed
with [Pro]2,8[Glu]16-conotoxin TxIC, the synthetic non-PTM form
(Fig. S1A & B). This analogue inhibited the human nAChR subtypes
Fig. 7. (A) Random folding of synthetic-conotoxin TxIC. Production of isomeric materials was achieved upon random peptide folding, which when resolved by RP-HPLC/UV
demonstrated difﬁculties in puriﬁcation. (B) Selective folding of -conotoxin TxIC and its co-elution with native material. Undertaking a separate synthetic, together with a
step-wise directed folding strategy, allowed for the production of a single peak/isomer upon full oxidation. RP-HPLC/UV co-elution in oxidized and TCEP reduced from (not
shown), demonstrated identical chromatographic behaviors.
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Table 1
Conus textile peptides identiﬁed by molecular mass analysis from three different
geographic locations.
Obs. m/z HI AS GBR Mass correlation
879.309
√
Leu-contryphan-Tx
1091.051
√
TeAr193
1238.410
√
TeAr151
1239.434
√
1305.405
√
TxIIIC (Tx3.4)
1305.443
√
1357.499
√
Tx10b or Tx10c
1357.537
√
1392.411
√
TxXIIIA
1447.593
√
Tx5b
1448.557
√
1474.604
√
Tx5c
1474.620
√
1592.509
√
Tx3d
1656.531
√
Tx1c
1657.754
√
TxIA
1678.968
√
Tx-D0111
1679.718
√
1712.485
√
TxIIIA
1712.570
√
1723.566
√
TxMLKM-021
1723.636
√
1757.642
√
TxMMSK-03
1756.444
√
1761.518
√
TxMRCL-D012
1779.609
√
TxMMSK-04
1844.578
√
Tx3e
1889.753
√
Tx3f (Tx3.5)
1889.808
√
2151.783
√
Tx3h (TxMLKM-011)
2487.917
√
Convulsant Peptide
2488.002
√
2488.044
√
2642.073
√
Tx6.3
2942.164
√
TxMKLT1-015
2961.308
√
Tx05
2995.234
√
Tx6.2
2995.311
√
3035.342
√
TxVIA (King-Kong 0)
3066.942
√
TxMLKLT1-0111
3067.313
√
3067.339
√
Obs. m/z are within ±1.0Da of the identiﬁed peptide mass to account for possible
amide and free acid variants.
(32, 352 and 34), with the 34 isoform demonstrat-
ing the highest sensitivity (IC50 2.1±0.2M) and exhibiting a 77%
maximuminhibition. Isoform32demonstrated thehighest level
of inhibition (96%) with an IC50 of 5.4±0.5M (Table 4). No sig-
niﬁcant inhibition was observed at the remaining isoform targets
(42, 44, 7, , ) at concentrations up to 100M
(Table 4).
3.12. Whole animal bioassay
Whole animal bioassay using the native -conotoxin TxIC
demonstrated a dose-dependency in its ability to produce animal
paralysis (see Fig. S2).-Conotoxin TxIC produced total paralysis at
640pMol g−1 (n=14), this dose did not cause lethality in test ani-
mals. A PD50 of 34.2pMol g−1 (34.2nMol kg−1; whole snail weight)
was determined for the native toxin (Table 4). The synthetic non-
PTM analogue of -conotoxin TxIC demonstrated an inability to
cause paralysis at same PD50 concentration (n=15). Total paralysis
was achieved with 10.24nMol g−1 (n=7), this being ∼16× that of
the native. A similar dose-dependent trend was observed (see Fig.
S2), with the maximal dose used not causing animal lethality. A
PD50 of 3.6nMol g−1 (3.6Molkg−1; whole snail weight) was cal-
culated (Table 4), this PD50 concentration being ∼100× more than
observed with the native PTM toxin.
Table 2
Comparative analysis of MALDI-TOF MS C. textile data from different venom sources
(RE, MV and DV).
Obs. m/z RE MV DV Mass correlation
1305.460
√
TxIIIC
1305.528
√
1305.689
√
1357.487
√
Tx10b/Tx10c
1357.660
√
1357.801
√
1392.422
√
TxXIIIA (TxMRCL-02)
1392.533
√
1447.628
√
Tx5b
1447.747
√
1447.879
√
1474.753
√
Tx5c
1474.906
√
1521.536
√
TxIIIB
1592.538
√
Tx3d
1592.716
√
1592.896
√
1642.756
√
Tx5d
1642.927
√
1643.013
√
1657.766
√
TxIA
1657.914
√
1658.034
√
1679.701
√
Tx-D0111
1679.850
√
1710.766
√
TxIIIA
1723.635
√
TxMLKM-021
1723.787
√
1757.609
√
TxMMSK-03
1757.801
√
1757.981
√
1844.824
√
Tx3e
1889.819
√
Tx3f
1889.980
√
1890.178
√
1931.063
√
TxVA
2151.757
√
Tx3h
2151.973
√
2152.196
√
2488.586
√
Convulsant Peptide
2488.269
√
2487.992
√
2557.971
√
Tx02
2558.240
√
2558.667
√
2642.027
√
Tx6.3
2642.319
√
2944.225
√
TxMKLT1-015
2944.594
√
3011.221
√
King-Kong 2
3035.290
√
TxVIA (KK-0)
3035.647
√
3035.892
√
3067.747
√
TxMKLT1-0111
3107.684
√
Tx04
Obs. m/z are within ±1.0Da of the identiﬁed peptide mass to account for possible
amide and free acid variants.
4. Discussion
This study is the ﬁrst reported analysis comparing the venom
proﬁle of a single specimen of Conus from milked venom (MV), to
duct venom (DV), and ﬁnally to radula lumen extract (RE) by RP-
HPLC/UV analysis and molecular mass proﬁling. This has provided
greater insight into the complexity ofmolluscivorous venom froma
single specimen through to thegross variationobservedat a species
level from wide-ranging geographical locations.
The importance of Conus textile to conopeptide research can-
not be underestimated. Early studies on C. textile [21,27,36] made
major contributions to the present understanding of conopeptide
processing and expression [11,23,45,54], and led to the discovery of
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Table 3
Sequence comparison of -conopeptide 4/7 family members to -conotoxin TxIC.
All 31 peptides, including -conotoxin TxIC, share a conserved cysteine pattern framework. Peptides most similar in sequence are those derived from C. textile and other
molluscivores, while -conopeptides from piscivores and vermivores share less sequence similarity. The overall sequence similarity to -conotoxin TxIC is displayed
graphically. This calculation is based on the total number of peptides similar to -conotoxin TxIC and the number that exhibits conservation of the same speciﬁc amino acid
and position in the sequence. For example, 3 peptides have a Pro in position 3; this is divided by 17 peptides that possess an amino acid in the equivalent position 3 of the
-conotoxin TxIC sequence; this gives a consensus of 18% for that position. Note that the -4/7 cysteine pattern framework is solely used as the point of sequence alignment.
bReferences listed are Supplemental Information – References II.
novel PTM amino acids [14,37,41] and unique biological activities.
The specie’s relative abundance, population distribution and access
has allowed for an intensive level of research, covering specimens
collected from the Philippines [28], Red Sea [21], South China Sea
[33], Japan [27,36] and the GBR, Australia [15,25]. In the present
study, we have expanded this geographic range to include speci-
mens collected from Hawai’i and American Samoa (Figs. 1 and 2),
making this the largest geographic study of a single Conus species
to date–this provides an indication to their regional biodiversity,
an area poorly addressed in Conus research.
A ‘conovenomic’ comparison of MV from distant geographic
locations, illustrates the true extent of venom peptide diversity
present within C. textile, as alluded to by Lu et al. [33]. Our evidence
further demonstrates the intraspeciﬁc venom variability identiﬁed
in DV of other members of the genus [1,15,42,43]–a characteris-
tic that now extends to MV. This may increase earlier estimates of
bioactive venom constituents [18,35,36,49], and expand the thera-
peutic potential of Conus [5,7,20,30,47].
This is only further demonstrated with the identiﬁcation of
a novel, highly PTM-modiﬁed conopeptide, -conotoxin TxIC,
despite the intensive level of research thatC. textilehas receivedhis-
torically. Thenewlyobserved-conotoxindemonstrateshomology
to Vc1.1 (∼66%; Table 3), and an experimentally conﬁrmed level of
selectivity (in its non-PTM form) to human isoforms of neuronal
type nAChR (Table 4), a well-documented target for the treatment
of chronic neuropathic pain [8,31,44,51].
WithinC. textile, considerablediversity is foundprimarilywithin
the hydrophobic region of the RP-HPLC/UV venom proﬁles (Fig. 1),
andprominently in specimens fromAmericanSamoa.Mass spectral
analysis revealed a level of molecular mass consistency across all
locations, however the relative proportion of venom constituents
varies markedly (Fig. 2; Table 1; Table S2). Peptide expressional
variability supports an important biological role in the predator
envenomation strategy, a factor that may aid the discovery of a
novel conopeptides, as illustrated with -conotoxin TxIC.
To further reﬁne this approach, the analysis of a single C. textile
specimen facilitated the tracking of integral venom constituents
from DV to MV and then RE. This strengthens the proteomic cor-
relation, end-point detection and characterization of the essential
secretory venom constituents used during envenomation [51].
It is these identiﬁed end-point MV peptides that have shown
the strongest correlation to both potential biological activity and
proven drug potential in piscivores [7,26]. Using RP-HPLC/UV we
established that -conotoxin TxIC is represented in DV extract
(Fig. 3C), and that expressional continuity continues through the
MV (Fig. 3B). Interestingly -conotoxin TxIC was absent from the
RE (Fig. 3A). For this species at least, the radula lumen extract
is not representative of the venom content as a whole–however
some level of conopeptide continuity, bym/z comparison, is clearly
observable (Table 2; Fig. 4).
-Conotoxin TxIC represents a novel toxin that highlights some
of the issues thathaveplaguedconopeptidediscoveryand sequenc-
ing, necessitating a combined ‘conovenomic’ approach to obtain
a thorough and accurate sequence analysis. The sole use of mass
spectrometry for Conus venom analysis can lead to misidentiﬁca-
tion of sequence and molecular mass arising from inconsistencies
associated with sample preparation, matrix selection and the ion-
ization technique used. However we are unsure of the extent of
PTM ‘miss assignment’ that may exist in the 1000s of conopep-
tides already documented in the publically available conopeptide
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Table 4
Pharmacological analysis of -conotoxin TxIC and [Pro]2,8[Glu]16-conotoxin TxIC.
nAChR subtypea IC50b [M] Maximum inhibition % PD50c [nMol kg−1]
-Conotoxin TxIC 34.2
32, 352, 34 100 <5
42, 44, 7, ,  50 0
[Pro]2,8, [Glu]16-Conotoxin TxIC 3600
32 5.4±0.5 96
352 4.9±0.8 91
34 2.1±0.2 77
42, 44, 7, ,  ≥100 <10
a Human variants.
b Half-maximal inhibitory concentration (human).
c Paralytic dose (mollusk).
database (http://www.conoserver.org). Yet, such errors are highly
possible given the relative abundance and differential incorpora-
tion of PTM amino acids in conotoxins/conopeptides [10].
The ability to detect the presence of -conotoxin TxIC only by
its decarboxylated and fragmented products, and not its parent
molecular mass, illustrates the susceptibility of the parent peptide
to in-source decay. This process was exacerbated for -conotoxin
TxIC by thepresence of the PTMamino acid-carboxyglutamic acid
(Gla). Similarobservationshavebeendescribed involving the lossof
the PTM Tyr-SO4 desulfation (−80Da) in-conotoxins PnIA (Conus
pennaceus) and EpI (Conus episcopatus) [32,53]. Although ESI-MS
is less harsh, a similar degree of peptide degradation can occur if
working outside normal operating parameters. Our observations
highlight the necessary awareness that needs to be undertaken
when dealing with complex and highly PTM processed DV extracts
and native MVs.
Irrespective of MS technique, each method has advantages and
disadvantages in the performance of mass detection and sequenc-
ing. If suspicion of PTMs arise, it is best to employ a combined
approach for analysis and veriﬁcation; this would include the use
of molecular biology techniques along with more traditional bio-
chemicalmethods suchas Edmandegradation. The latter technique
becomes a necessity when considering the isobaric CID fragments
generated from Hyp and Ile and Leu (±0.04Da). Three such unam-
biguous assignments were observed in the de-novo sequencing
analysis of -conotoxin TxIC (Fig. 5B). Residues were later con-
ﬁrmed and assigned by Edman degradation (Section 3.8) and via
genetic analysis, as shown in Fig. 6 (Section 3.9).
Comprising of 18 amino acids with two disulﬁde bonds, 44% of
residues display one or more forms of modiﬁcation, -conotoxin
TxIC is one of the most highly PTM conopeptides documented to
date. This novel 4/7 conopeptide (as represented by its cysteine
framework) shares sequence homology with other -conotoxins
[18,31] and demonstrates sequence commonality to other mollus-
civorous conopeptides, speciﬁcally Ai1.2 (C. ammiralis) and Vc1.1
(C. victoriae) (Table3). Thishomology is seenexplicitly inVc1.1 in its
native PTM form: [Hyp]6[Gla]14Vc1.1 [24], and more so within the
last cysteine loop (89% homology; Table 3). Both C. ammiralis (Ai)
and C. victoriae (Vc) are close relations of C. textile–with C. victoriae
being endemic to Australia. Genetic analysis of -conotoxin TxIC
strengthens its relationship to the established 4/7 -conotoxins,
as seen by the homology of the pre/pro-peptide regions of -
conotoxins MII and Vc1.1 (Fig. 6) [17,33,39,44].
As the majority of these illustrated -conotoxin sequences
are deduced from genomic sequences, the current inclusion of
the observed PTMs at positions [Pro→Hyp]2, [Pro→Hyp]8 and
[Glu→Gla]16 in Table 3 increases the known chemical diversity
of -conotoxin TxIC. Modiﬁcations may be affecting in vivo char-
acteristics including kinetic properties and/or pharmacological
selectivity of conotoxins. The absence of these PTMs in piscivo-
rous 4/7 -conotoxins, such as -conotoxin MII (Conus magus),
potentially indicates a phyla-selective targeting differentiation. By
examining both the native -conotoxin TxIC, as well as a syn-
thetic unmodiﬁed isoform ([Pro]2,8[Glu]16-conotoxin TxIC), we
have here substantiated these claims, highlighting the role of PTMs
in vivo. While remaining biologically active in whole animal bioas-
say, native-conotoxin TxIC is inactive when tested human nAChR
channel isoforms (Table 4). The synthetic unmodiﬁed -conotoxin
TxIC (i.e. [Pro]2,8[Glu]16-conotoxin TxIC) however remains active
at the nAChR, demonstrating isoform selectivity (Table 4). These
features highlight the importance of PTMs in the selective target-
ing of -conotoxins. This is further illustrated at a phylogenic level
with the observed switching in potency in invertebratemodels that
represents the native prey target (Fig. S2).
The phyla-selectivity and reduced potency of the native -
conotoxin TxIC towards human nAChR isoforms demonstrates an
underlying differentiation between receptor selectivity and phar-
macodynamic properties in ion channels from different phyla. This
is an area reiterated by the PTM of the nAchR in the Egyptian mon-
goose (Herpestes ichneumon) that provides a level of resistance to
-bungarotoxin [3]. Here, genomic and proteomic investigation
into invertebrate nAchR isoforms, as well as other receptors (e.g.
N-type (Cav2.2) calcium channels and GABAB [13]), may provide
insight into the determinants for pharmacological potency and
phyla selective characteristics observed commonly with Conus.
Such information will provide insights into toxin target speciﬁcity
enhancement though peptide bioengineering and the potential
manipulation/incorporation of PTMs.
5. Conclusions
The complexity of MV proﬁles from specimens of C. textile
revealed in this study serve to remind us of the extent we
have underestimated the biodiversity and value of these unique
venomous marine snails. The analysis of venoms necessitates a
speciﬁcally tailored approach, requiring special attention to the
analyticalmethods employed, and further accentuating the need to
employ a combined ‘conovenomic’ approach. The lessons learned
and approaches outlined will facilitate peptide prospecting, toxi-
nological correlations and the future discovery of new, clinically
relevant conopeptides.
Conﬂict of interest
Authors state that there is no conﬂict of interest.
Acknowledgements
We are indebted to Mr. David Bingham, the members of the
Malacological Society of Australasia (Brisbane Branch), Mr. Harold
“JJ” Jackson (Hawai’ian Malacological Society) and Mr. Don Barclay
Z.L. Bergeron et al. / Peptides 49 (2013) 145–158 157
(American Samoa) for assistance in obtaining species described in
this study. We wish to acknowledge the ﬁnancial support from
the American Heart Association (Scientist Development Award
0530204N to J.-P.B.) and the University of Hawai’i Sea Grant Col-
lege Program (J.-P.B.) and USDA TSTAR (# 2009-34135-20067)
(J.-P. B.) & HATCH (HAW00595-R) (J.-P.B.). This project in-part
was supported by grants from the National Center for Research
Resources (5 G12 RR003061-26) and the National Institute on
MinorityHealth andHealthDisparities (8G12MD007601-26) from
the National Institutes of Health. JT was supported by the following
grants: G.0433.12, G.A071.10N and G.0257.08 (F.W.O. Vlaanderen),
EU–FP7–MAREX, A portion of this work was submitted to The
University of Queensland, Australia, (J.-P.B.), The University of
Melbourne, Australia (D.W.S.) and The University of Hawai’i, USA
(Z.L.B.) as fulﬁllment for awarding a doctoral degrees.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.peptides.2013.
09.004.
References
[1] Abdel-Rahman MA, Abdel-Nabi IM, El-Naggar MS, Abbas OA, Strong PN.
Intraspeciﬁc variation in the venom of the vermivorous cone snail Conus vexil-
lum. Comp Biochem Physiol C Toxicol Pharmacol 2011;154:318–25.
[2] Atherton D, Fernandez J, DeMott M, Andrews L, Mische SM. Routine protein
sequence analysis below ten picomoles: one sequencing facility’s approach.
San Diego, California: Academic Press, Inc. (Harcourt Brace and Co.); 1993.
[3] BarchanD, Kachalsky S, NeumannD, Vogel Z, OvadiaM, Kochva E, et al. How the
mongoose can ﬁght the snake: the binding site of the mongoose acetylcholine
receptor. Proc Natl Acad Sci USA 1992;89:7717–21.
[4] Bingham J-P. Novel toxins from the genus Conus- from taxonomy to toxins.
Brisbane: University of Queensland; 1998.
[5] Bingham JP, Andrews EA, Kiyabu SM, Cabalteja CC. Drugs from Slugs. Part II -
Conopeptide bioengineering. Chem Biol Interact 2012;200:92–113.
[6] Bingham JP, Broxton NM, Livett BG, Down JG, Jones A, Moczydlowski EG. Opti-
mizing the connectivity in disulﬁde-rich peptides: alpha-conotoxin SII as a case
study. Anal Biochem 2005;338:48–61.
[7] Bingham JP, Mitsunaga E, Bergeron ZL. Drugs from slugs–past, present
and future perspectives of omega-conotoxin research. Chem Biol Interact
2010;183:1–18.
[8] Carstens BB, Clark RJ, Daly NL, Harvey PJ, Kaas Q, Craik DJ. Engineering of
conotoxins for the treatment of pain. Curr Pharm Des 2011;17:4242–53.
[9] Chivian E, Roberts CM, Bernstein AS. The threat to cone snails. Science
2003;302:391.
[10] Chun JB, Baker MR, Kim DH, Leroy M, Toribo P, Bingham JP. Cone snail
milked venom dynamics - a quantitative study of Conus purpurascens. Toxicon
2012;60:83–94.
[11] Conticello SG, Gilad Y, Avidan N, Ben-Asher E, Levy Z, Fainzilber M. Mecha-
nisms for evolving hypervariability: the case of conopeptides. Mol Biol Evol
2001;18:120–31.
[12] Cruz LJ, Ramilo CA, Corpuz GP, Olivera BM. Conus peptides: phylogenetic range
of biological activity. Biol Bull 1992;183:159–64.
[13] Cuny H, de Faoite A, Huynh TG, Yasuda T, Berecki G, Adams DJ. -Aminobutyric
acid type B (GABAB) receptor expression is needed for inhibition of N-
type (Cav2.2) calcium channels by analgesic -conotoxins. J Biol Chem
2012;287:23948–57.
[14] Czerwiec E, Kalume DE, Roepstorff P, Hambe B, Furie B, Furie BC, et al. Novel
gamma-carboxyglutamic acid-containing peptides from the venom of Conus
textile. FEBS J 2006;273:2779–88.
[15] Davis J, Jones A, Lewis RJ. Remarkable inter- and intra-species complexity of
conotoxins revealed by LC/MS. Peptides 2009;30:1222–7.
[16] Duda TFJ, Bingham JP, Livett BG, Kohn AJ, Massilia GR, Schultz JR, et al. How
much at risk are cone snails. Science 2004;303:955–7.
[17] Dutertre S, Jin AH, KaasQ, Jones A, Alewood PF, Lewis RJ. Deep venomics reveals
the mechanism for expanded peptide diversity in cone snail venom. Mol Cell
Proteomics 2013;12:312–29.
[18] Dutertre S, Ulens C, Büttner R, Fish A, van Elk R, Kendel Y, et al. AChBP-targeted
alpha-conotoxin correlates distinct binding orientations with nAChR subtype
selectivity. EMBO J 2007;26:3858–67.
[19] Endean R, Rudkin C. Further studies of the venoms of conidae. Toxicon
1965;69:225–49.
[20] Essack M, Bajic VB, Archer JA. Conotoxins that confer therapeutic possibilities.
Mar Drugs 2012;10:1244–65.
[21] Fainzilber M, Gordon D, Hasson A, Spira ME, Zlotkin E. Mollusc-speciﬁc toxins
from the venom of Conus textile neovicarius. Eur J Biochem 1991;202:589–95.
[22] Halai R, Craik DJ. Conotoxins: natural product drug leads. Nat Prod Rep
2009;26:526–36.
[23] Hillyard DR, Olivera BM, Woodward S, Corpuz GP, Gray WR, Ramilo CA, et al.
A molluscivorous Conus toxin: conserved frameworks in conotoxins. Biochem-
istry 1989;28:358–61.
[24] Jakubowski JA, Kelley WP, Sweedler JV. Screening for post-translational modi-
ﬁcations in conotoxins using liquid chromatography/massspectrometry:
an important component of conotoxin discovery. Toxicon 2006;47:
688–99.
[25] Jones J, Bingham JP, Gehrmann J, Bond T, Loughnan M, Atkins A, et al. Isolation
and characterization of conopeptides by high-performance liquid chromatog-
raphy combined with mass spectrometry and tandem mass spectrometry.
Commun Mass Spectrom 1996;10:138–43.
[26] Kapono CA, Thapa P, Cabalteja CC, Guendisch D, Collier AC, Bingham JP.
Conotoxin truncation as a post-translational modiﬁcation to increase the
pharmacological diversity within the milked venom of Conus magus. Toxicon
2013;70:170–8.
[27] Kobayashi J, Ohizumi Y, Nakamura H, Hirata Y. Pharmacological study on the
venom of the marine snail Conus textile. Toxicon 1981;19:757–62.
[28] Lev-RamV, Olivera BM, Levitan IB. A toxin from the venomof the predator snail
Conus textile modulates ionic currents in Aplysia bursting pacemaker neuron.
Brain Res 1994;640:48–55.
[29] Liman ER, Tytgat J, Hess P. Subunit stoichiometry of a mammalian K+ channel
determined by construction of multimeric cDNAs. Neuron 1992;9:861–71.
[30] Livett BG, Gayler KR, Khalil Z. Drugs from the sea: conopeptides as potential
therapeutics. Curr Med Chem 2004;11:1715–23.
[31] Livett BG, Sandall DW, Keays D, Down J, Gayler KR, Satkunanathan N, et al.
Therapeutic applications of conotoxins that target the neuronal nicotinic
acetylcholine receptor. Toxicon 2006;48:810–29.
[32] Loughnan M, Bond T, Atkins A, Cuevas J, Adams DJ, Broxton NM, et al.
Alpha-conotoxin EpI, a novel sulfated peptide from Conus episcopatus that
selectively targets neuronal nicotinic acetylcholine receptors. J Biol Chem
1998;273:15667–74.
[33] Lu BS, Yu F, Zhao D, Huang PT, Huang CF. Conopeptides from Conus striatus and
Conus textile by cDNA cloning. Peptides 1999;20:1139–44.
[34] Matsudaira PT. Introduction A practical guide to protein and peptide puriﬁca-
tion for microsequencing. San Diego, California: Academic Press, Inc. (Harcourt
Brace Jovanovich); 1989.
[35] McIntosh JM, Santos AD, Olivera BM. Conus peptides targeted to speciﬁc nico-
tinic acetylcholine receptor subtypes. Annu Rev Biochem 1999;68:59–88.
[36] Nakamura H, Kobayashi J, Ohizumi Y, Hirata Y. The occurrence of arachi-
donic acid in the venom duct of the marine snail Conus textile. Experientia
1982;38:897.
[37] Nakamura T, Yu Z, Fainzilber M, Burlingame AL. Mass spectrometric-based
revision of the structure of a cysteine-rich peptide toxin with gamma-
carboxyglutamic acid, TxVIIA, from the sea snail, Conus textile. Protein Sci
1996;5:524–30.
[38] Olivera BM, Rivier J, Clark C, Ramilo CA, Corpuz GP, Abogadie FC, et al. Diversity
of Conus neuropeptides. Science 1990;249:257–63.
[39] Price-CarterM,GrayWR,GoldenbergDP. Foldingof omega-conotoxins. 2. Inﬂu-
ence of precursor sequences and protein disulﬁde isomerase. Biochemistry
1996;35:15547–57.
[40] Reed LJ, Muench S. A simple method of estimating ﬁfty percent time points.
Am J Hyg 1938;27:493–7.
[41] Rigby AC, Lucas-Meunier E, Kalume DE, Czerwiec E, Hambe B, Dahlqvist I,
et al. A conotoxin from Conus textile with unusual posttranslational modi-
ﬁcations reduces presynaptic Ca2+ inﬂux. Proc Natl Acad Sci USA 1999;96:
5758–63.
[42] Rivera-Ortiz JA, Cano H, Marí F. Intraspecies variability and conopeptide pro-
ﬁling of the injected venom of Conus ermineus. Peptides 2011;32:306–16.
[43] Romeo C, Di Francesco L, Oliverio M, Palazzo P, Massilia GR, Ascenzi P, et al.
Conus ventricosus venom peptides proﬁling by HPLC-MS: a new insight in the
intraspeciﬁc variation. J Sep Sci 2008;31:488–98.
[44] Sandall DW, Satkunanathan N, Keays DA, Polidano MA, Liping X, Pham V, et al.
A novel alpha-conotoxin identiﬁed by gene sequencing is active in suppress-
ing the vascular response to selective stimulation of sensory nerves in vivo.
Biochemistry 2003;42:6904–11.
[45] Sasaki T, Feng ZP, Scott R, Grigoriev N, Syed NI, Fainzilber M, et al. Synthesis,
bioactivity, andcloningof theL-typecalciumchannelblockeromega-conotoxin
TxVII. Biochemistry 1999;38:12876–84.
[46] Schnölzer M, Alewood P, Jones A, Alewood D, Kent SBH. In situ neutraliza-
tion in Boc-chemistry solid phase peptide synthesis. Int J Peptide Protein Res
1992;40:180–93.
[47] SchroederCI, CraikDJ. Therapeuticpotential of conopeptides. FutureMedChem
2012;4:1243–55.
[48] Schroeder CI, Ekberg J, Nielsen KJ, Adams D, Loughnan ML, Thomas L, et al.
Neuronally micro-conotoxins from Conus striatus utilize an alpha-helical motif
to target mammalian sodium channels. J Biol Chem 2008;283:21621–8.
[49] Tayo LL, Lu B, Cruz LJ, Yates JR. Proteomic analysis provides insights on venom
processing in Conus textile. J Proteome Res 2010;9:2292–301.
[50] Teichert RW, Rivier J, Dykert J, Cervini L, Gulyas J, Bulaj G, et al. AlphaA-
Conotoxin OIVA deﬁnes a new alphaA-conotoxin subfamily of nicotinic
acetylcholine receptor inhibitors. Toxicon 2004;44:207–14.
[51] Townsend A, Livett BG, Bingham JP, Truong HT, Karas JA, O’Donnell P,
et al. Mass spectral identiﬁcation of Vc1.1 and differential distribution of
conopeptides in the venom duct of Conus victoriae. Effect of post-translational
158 Z.L. Bergeron et al. / Peptides 49 (2013) 145–158
modiﬁcations and disulﬁde isomerisation on bioactivity. Int J Peptide Res
Therap 2009;15:195–203.
[52] Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, McIntosh JM. Molec-
ular mechanism for analgesia involving speciﬁc antagonism of alpha9alpha10
nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 2006;103:17880–4.
[53] Wolfender JL, Chu F, Ball H, Wolfender F, Fainzilber M, Baldwin MA, et al.
Identiﬁcation of tyrosine sulfation in Conus pennaceus conotoxins alpha-PnIA
and alpha-PnIB: further investigation of labile sulfo- and phosphopeptides by
electrospray, matrix-assisted laser desorption/ionization (MALDI) and atmo-
spheric pressure MALDI mass spectrometry. J Mass Spectrom 1999;34:
447–54.
[54] Woodward SR, Cruz LJ, Olivera BM, Hillyard DR. Constant and hypervariable
regions in conotoxin propeptides. EMBO J 1990;9:1015–20.
[55] Xiao WH, Bennett GJ. Synthetic omega-conopeptides applied to the site
of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther
1995;274:666–72.
 129 
 
REFERENCES 
 
Alpeeva, I. S.; Niculescu-Nistor, M.; Leon, J. C.; Csöregi, E.; Sakharov, I. Yu. Palm tree 
peroxidase-based biosensor with unique characteristics for hydrogen peroxide 
monitoring. Biosensors and Bioelectronics 2005, 21, 742–748. 
Armougom, F.; Moretti, S.; Poirot, O.; Audic, S.; Dumas, P.; Schaeli, B.; Keduas, V.; 
Notredame, C. Expresso: automatic incorporation of structural information in multiple 
sequence alignments using 3D-Coffee. Nucleic Acids Research. 2006, 34, W604–W608. 
Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISS-MODEL workspace: a web-
based environment for protein structure homology modelling. Bioinformatics 2006, 22, 
195–201. 
Baker, M. R.; Zhao, H.; Sakharov, I. Yu.; Li, Q. X. Amino acid sequence of anionic 
peroxidase from the windmill palm tree Trachycarpus fortunei. Journal of Agricultural 
and Food Chemistry 2014, 62, 11941–11948. 
Barba-Espin, G.; Dedvisitsakul, P.; Hagglund, P.; Svensson, B.; Finnie, C. Gibberellic acid-
induced aleurone layers responding to heat shock or tunicamycin provide insight into the 
N-glycoproteome, protein secretion, and endoplasmic reticulum stress. Plant Physiology 
2014, 164, 951–965. 
Bernardes, A.; Textor, L. C.; Santos, J. C.; Cuadrado, N. H.; Kostetsky, E. Y.; Roig, M. G.; 
Bavro, V. N.; Muniz, J. R. C.; Shnyrov, V. L.; Polikarpov, I. Crystal structure analysis of 
peroxidase from the palm tree Chamaerops Excelsa. Biochimie 2015, 111, 58–69. 
Bordoli, L.; Kiefer, F.; Arnold, K.; Benkert, P.; Battey, J.; Schwede, T. Protein structure 
homology modeling using SWISS-MODEL workspace. Nature Protocols 2008, 4, 1–13. 
Capone, S.; Pletzenauer, R.; Maresch, D.; Metzger, K.; Altmann, F.; Herwig, C.; Spadiut, O. 
Glyco-variant library of the versatile enzyme horseradish peroxidase. Glycobiology 2014, 
24, 852–863. 
Caramyshev, A. V.; Evtushenko, E. G.; Ivanov, V. F.; Barceló, A. R.; Roig, M. G.; Shnyrov, 
V. L.; van Huystee, R. B.; Kurochkin, I. N.; Vorobiev, A. K.; Sakharov, I. Yu. Synthesis 
of conducting polyelectrolyte complexes of polyaniline and poly(2-acrylamido-3-methyl-
1-propanesulfonic acid) catalyzed by pH-stable palm tree peroxidase. Biomacromolecules 
2005, 6, 1360–1366. 
Caramyshev, A. V.; Firsova, Y. N.; Slastya, E. A.; Tagaev, A. A.; Potapenko, N. V.; 
Lobakova, E. S.; Pletjushkina, O. Y.; Sakharov, I. Yu. Purification and characterization 
of windmill palm tree (Trachycarpus fortunei) peroxidase. Journal of Agricultural and 
Food Chemistry 2006, 54, 9888–9894. 
 130 
 
Caramyshev, A. V.; Lobachov, V. M.; Selivanov, D. V.; Sheval, E. V.; Vorobiev, A. K.; 
Katasova, O. N.; Polyakov, V. Y.; Makarov, A. A.; Sakharov, I. Yu. Micellar peroxidase-
catalyzed synthesis of chiral polyaniline. Biomacromolecules 2007, 8, 2549–2555. 
Chambers, M. C.; Maclean, B.; Burke, R.; Amodei, D.; Ruderman, D. L.; Neumann, S.; 
Gatto, L.; Fischer, B.; Pratt, B.; Egertson, J. A cross-platform toolkit for mass 
spectrometry and proteomics. Nature biotechnology 2012, 30, 918–920. 
Chen, S.; Yuan, R.; Chai, Y.; Hu, F. Electrochemical sensing of hydrogen peroxide using 
metal nanoparticles: a review. Microchimica Acta 2013, 180, 15–32. 
Cooper, C. A.; Gasteiger, E.; Packer, N. H. GlycoMod–a software tool for determining 
glycosylation compositions from mass spectrometric data. Proteomics 2001, 1, 340–349. 
Damerell, D.; Ceroni, A.; Maass, K.; Ranzinger, R.; Dell, A.; Haslam, S. M. The 
GlycanBuilder and GlycoWorkbench glycoinformatics tools: updates and new 
developments. Biological Chemistry 2012, 393. 
Dasari, S.; Chambers, M. C.; Slebos, R. J.; Zimmerman, L. J.; Ham, A.-J. L.; Tabb, D. L. 
TagRecon: high-throughput mutation identification through sequence tagging. Journal of 
Proteome Research 2010, 9, 1716–1726. 
Desaire, H. Glycopeptide analysis, recent developments and applications. Molecular & 
Cellular Proteomics 2013, 12, 893–901. 
Deutsch, E. W.; Lam, H.; Aebersold, R. Data analysis and bioinformatics tools for tandem 
mass spectrometry in proteomics. Physiological Genomics 2008, 33, 18–25. 
Domon, B.; Costello, C. E. A systematic nomenclature for carbohydrate fragmentations in 
FAB-MS/MS spectra of glycoconjugates. Glycoconjugate Journal 1988, 5, 397–409.  
Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale 
protein identifications by mass spectrometry. Nature Methods 2007, 4, 207–214. 
Fanata, W. I. D.; Lee, K. H.; Son, B. H.; Yoo, J. Y.; Harmoko, R.; Ko, K. S.; Ramasamy, N. 
K.; Kim, K. H.; Oh, D.-B.; Jung, H. S.; Lee, K. O. N-Glycan maturation is crucial for 
cytokinin-mediated development and cellulose synthesis in Oryza sativa. The Plant 
Journal 2013, 73, 966–979. 
Farré, M.; Kantiani, L.; Barceló, D. Advances in immunochemical technologies for analysis 
of organic pollutants in the environment. TrAC Trends in Analytical Chemistry 2007, 26, 
1100–1112. 
Gajhede, M.; Schuller, D. J.; Henriksen, A.; Smith, A. T.; Poulos, T. L. Crystal structure of 
horseradish peroxidase C at 2.15 Å resolution. Nature Structural Biology 1997, 4, 1032–
1048. 
 131 
 
Gaspar, S.; Popescu, I. C.; Gazaryan, I. G.; Gerardo Bautista, A.; Sakharov, I. Yu.; 
Mattiasson, B.; Csöregi, E. Biosensors based on novel plant peroxidases: a comparative 
study. Electrochimica acta 2000, 46, 255–264. 
Gasteiger, E.; Hoogland, C.; Gattiker, A.; Wilkins, M. R.; Appel, R. D.; Bairoch, A. Protein 
identification and analysis tools on the ExPASy server. In The proteomics protocols 
handbook; Springer, 2005; pp 571–607. 
Gomord, V.; Fitchette, A.-C.; Menu-Bouaouiche, L.; Saint-Jore-Dupas, C.; Plasson, C.; 
Michaud, D.; Faye, L. Plant-specific glycosylation patterns in the context of therapeutic 
protein production: PMP-specific glycosylation patterns. Plant Biotechnology Journal 
2010, 8, 564–587. 
Gray, J. S. S.; Montgomery, R. Asymmetric glycosylation of soybean seed coat peroxidase. 
Carbohydrate Research 2006, 341, 198–209. 
Hanisch, F.-G. Top-down sequencing of O-glycoproteins by in-source decay Matrix-Assisted 
Laser Desorption Ionization Mass Spectrometry for glycosylation site analysis. Analytical 
Chemistry 2011, 83, 4829–4837. 
Hart-Smith, G.; Raftery, M. J. Detection and characterization of low abundance 
glycopeptides via higher-energy C-trap dissociation and orbitrap mass analysis. Journal 
of The American Society for Mass Spectrometry 2012, 23, 124–140. 
Henriksen, A.; Welinder, K. G.; Gajhede, M. Structure of barley grain peroxidase refined at 
1.9-A resolution: a plant peroxidase reversibly inactivated at neutral pH. Journal of 
Biological Chemistry 1998, 273, 2241–2248. 
Henriksen, A.; Smith, A. T.; Gajhede, M. The structures of the horseradish peroxidase c-
ferulic acid complex and the ternary complex with cyanide suggest how peroxidases 
oxidize small phenolic substrates. Journal of Biological Chemistry 1999, 274, 35005–
35011. 
Henriksen, A.; Mirza, O.; Indiani, C.; Teilum, K.; Smulevich, G.; Welinder, K. G.; Gajhede, 
M. Structure of soybean seed coat peroxidase: a plant peroxidase with unusual stability 
and haem-apoprotein interactions. Protein Science 2001, 10, 108–115. 
Hu, C.; Lee, D.; Chibbar, R. N.; Huystee, R. B. Ca
2+
 and peroxidase derived from cultured 
peanut cells. Physiologia Plantarum 1987, 70, 99–102. 
Huddleston, M. J.; Bean, M. F.; Carr, S. A. Collisional fragmentation of glycopeptides by 
electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of 
glycopeptides in protein digests. Analytical Chemistry 1993, 65, 877–884. 
 132 
 
Johnson, K. D.; Chrispeels, M. J. Substrate specificities of N-acetylglucosaminyl-, fucosyl-, 
and xylosyltransferases that modify glycoproteins in the Golgi apparatus of bean 
cotyledons. Plant Physiology 1987, 84, 1301–1308. 
Kang, J. S.; Frank, J.; Kang, C. H.; Kajiura, H.; Vikram, M.; Ueda, A.; Kim, S.; Bahk, J. D.; 
Triplett, B.; Fujiyama, K.; Koiwa, H. Salt tolerance of Arabidopsis thaliana requires 
maturation of N-glycosylated proteins in the Golgi apparatus. Proceedings of the 
National Academy of Sciences 2008, 105, 5933–5938. 
Klibanov, A. M.; Tu, T.-M.; Scott, K. P. Peroxidase-catalyzed removal of phenols from coal-
conversion waste waters. Science 1983, 221, 259–261. 
Kolarich, D.; Jensen, P. H.; Altmann, F.; Packer, N. H. Determination of site-specific glycan 
heterogeneity on glycoproteins. Nature Protocols 2012, 7, 1285–1298. 
Krainer, F. W.; Pletzenauer, R.; Rossetti, L.; Herwig, C.; Glieder, A.; Spadiut, O. Purification 
and basic biochemical characterization of 19 recombinant plant peroxidase isoenzymes 
produced in Pichia pastoris. Protein Expression and Purification 2014, 95, 104–112. 
Léonard, R.; Costa, G.; Darrambide, E.; Lhernould, S.; Fleurat-Lessard, P.; Carlué, M.; 
Gomord, V.; Faye, L.; Maftah, A. The presence of Lewis a epitopes in Arabidopsis 
thaliana glycoconjugates depends on an active α4-fucosyltransferase gene. Glycobiology 
2002, 12, 299–306. 
Léonard, R.; Strasser, R.; Altmann, F. Plant glycosidases acting on protein-linked 
oligosaccharides. Phytochemistry 2009, 70, 318–324. 
Leuzinger, K.; Dent, M.; Hurtado, J.; Stahnke, J.; Lai, H.; Zhou, X.; Chen, Q. Efficient 
agroinfiltration of plants for high-level transient expression of recombinant proteins. 
Journal of Visualized Experiments 2013. 
Leymarie, N.; Griffin, P. J.; Jonscher, K.; Kolarich, D.; Orlando, R.; McComb, M.; Zaia, J.; 
Aguilan, J.; Alley, W. R.; Altmann, F. Interlaboratory study on differential analysis of 
protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-
institutional study 2012. Molecular & Cellular Proteomics 2013, 12, 2935–2951. 
Li, F.; Glinskii, O. V.; Glinsky, V. V. Glycobioinformatics: current strategies and tools for 
data mining in MS-based glycoproteomics. Proteomics 2013, 13, 341–354. 
Lige, B.; Ma, S.; van Huystee, R. B. The effects of the site-directed removal of N-
glycosylation from cationic peanut peroxidase on its function. Archives of Biochemistry 
and Biophysics 2001, 386, 17–24. 
Litescu, S. C.; Eremia, S.; Radu, G. L. Biosensors for the determination of phenolic 
metabolites. In Bio-Farms for Nutraceuticals; Giardi, M.T.; Rea, G.; Berra, B., Eds.; 
Springer, 2010; pp. 234–240. 
 133 
 
Livingstone, C. D.; Barton, G. J. Protein sequence alignments: a strategy for the hierarchical 
analysis of residue conservation. Computer applications in the biosciences: CABIOS 
1993, 9, 745–756. 
Nanni, P.; Panse, C.; Gehrig, P.; Mueller, S.; Grossmann, J.; Schlapbach, R. PTM 
MarkerFinder, a software tool to detect and validate spectra from peptides carrying post-
translational modifications. Proteomics 2013, 13, 2251–2255. 
Nielsen, K. L.; Indiani, C.; Henriksen, A.; Feis, A.; Becucci, M.; Gajhede, M.; Smulevich, 
G.; Welinder, K. G. Differential activity and structure of highly similar peroxidases. 
Spectroscopic, crystallographic, and enzymatic analyses of lignifying Arabidopsis 
thaliana peroxidase A2 and horseradish peroxidase A2. Biochemistry 2001, 40, 11013–
11021. 
Olsen, J. V.; Macek, B.; Lange, O.; Makarov, A.; Horning, S.; Mann, M. Higher-energy C-
trap dissociation for peptide modification analysis. Nature Methods 2007, 4, 709–712. 
Ozohanics, O.; Turiák, L.; Puerta, A.; Vékey, K.; Drahos, L. High-performance liquid 
chromatography coupled to mass spectrometry methodology for analyzing site-specific 
N-glycosylation patterns. Journal of Chromatography A 2012, 1259, 200–212. 
Paizs, B.; Suhai, S. Fragmentation pathways of protonated peptides. Mass Spectrometry 
Reviews 2005, 24, 508–548. 
Palm, G. J.; Sharma, A.; Kumari, M.; Panjikar, S.; Albrecht, D.; Jagannadham, M. V.; 
Hinrichs, W. Post‐translational modification and extended glycosylation pattern of a plant 
latex peroxidase of native source characterized by X‐ray crystallography. FEBS Journal 
2014, 281, 4319–4333. 
Petrescu, A.-J. Statistical analysis of the protein environment of N-glycosylation sites: 
implications for occupancy, structure, and folding. Glycobiology 2004, 14, 103–114. 
Rayon, C.; Lerouge, P.; Faye, L. The protein N-glycosylation in plants. Journal of 
Experimental Botany 1998, 49, 1463–1472. 
Regalado, C.; García-Almendárez, B. E.; Duarte-Vázquez, M. A. Biotechnological 
applications of peroxidases. Phytochemistry Reviews 2004, 3, 243–256. 
Resemann, A.; Wunderlich, D.; Rothbauer, U.; Warscheid, B.; Leonhardt, H.; Fuchser, J.; 
Kuhlmann, K.; Suckau, D. Top-down de novo protein sequencing of a 13.6 kDa camelid 
single heavy chain antibody by Matrix-Assisted Laser Desorption Ionization-Time-of-
Flight/Time-of-Flight Mass Spectrometry. Analytical Chemistry 2010, 82, 3283–3292. 
Rodriguez-Lopez, J. N.; Smith, A. T.; Thorneley, R. N. F. Role of arginine 38 in horseradish 
peroxidase: a critical residue for substrate binding and catalysis. Journal of Biological 
Chemistry 1996, 271, 4023–4030. 
 134 
 
Roepstorff, P.; Fohlmann, J. Proposal for a common nomenclature for sequence ions in mass 
spectra of peptides. Biomedical Mass Spectrometry 1984, 11, 601. 
Ruiz-May, E.; Thannhauser, T. W.; Zhang, S.; Rose, J. K. C. Analytical technologies for 
identification and characterization of the plant N-glycoproteome. Frontiers in Plant 
Science 2012, 3. 
Ruiz-May, E.; Kim, S.-J.; Brandizzi, F.; Rose, J. K. C. The secreted plant N-glycoproteome 
and associated secretory pathways. Frontiers in Plant Science 2012, 3. 
Ruiz-May, E.; Hucko, S.; Howe, K. J.; Zhang, S.; Sherwood, R. W.; Thannhauser, T. W.; 
Rose, J. K. A comparative study of lectin affinity based plant N-glycoproteome profiling 
using tomato fruit as a model. Molecular & Cellular Proteomics 2014, 13, 566–579. 
Sakharov, I. Yu. Palm tree peroxidases. Biochemistry Moscow 2004, 69, 823–829. 
Sakharov, I. Yu.; Vesga B, M. K.; Galaev, I. Yu.; Sakharova, I. V.; Pletjushkina, O. Y. 
Peroxidase from leaves of royal palm tree Roystonea regia: purification and some 
properties. Plant Science 2001, 161, 853–860 
Sakharov, I. Yu.; Vorobiev, A. C.; Leon, J. J. C. Synthesis of polyelectrolyte complexes of 
polyaniline and sulfonated polystyrene by palm tree peroxidase. Enzyme and Microbial 
Technology 2003, 33, 661–667. 
Sánchez‐Romero, C.; García‐Gómez, M. L.; Pliego‐Alfaro, F.; Heredia, A. Effect of partial 
deglycosylation on catalytic characteristics and stability of an avocado peroxidase. 
Physiologia Plantarum 1994, 92, 97–101. 
Schuller, D. J.; Ban, N.; van Huystee, R. B.; McPherson, A.; Poulos, T. L. The crystal 
structure of peanut peroxidase. Structure 1996, 4, 311–321. 
Segrest, J. P.; Jackson, R. L.; Andrews, E. P.; Marchesi, V. T. Human erythrocyte membrane 
glycoprotein: a re-evaluation of the molecular weight as determined by SDS 
polyacrylamide gel electrophoresis. Biochemical and Biophysical Research 
Communications 1971, 44, 390–395. 
Segu, Z. M.; Mechref, Y. Characterizing protein glycosylation sites through higher-energy C-
trap dissociation. Rapid Communications in Mass Spectrometry 2010, 24, 1217–1225. 
Shindyalov, I. N.; Bourne, P. E. Protein structure alignment by incremental combinatorial 
extension (CE) of the optimal path. Protein Engineering 1998, 11, 739–747. 
Smulevich, G.; Feis, A.; Howes, B. D. Fifteen years of raman spectroscopy of engineered 
heme containing peroxidases: what have we learned? Accounts of Chemical Research 
2005, 38, 433–440. 
 135 
 
Song, W.; Henquet, M. G. L.; Mentink, R. A.; van Dijk, A. J.; Cordewener, J. H. G.; Bosch, 
D.; America, A. H. P.; van der Krol, A. R. N-Glycoproteomics in plants: perspectives and 
challenges. Journal of Proteomics 2011, 74, 1463–1474. 
Stanley, P.; Schachter, H.; Taniguchi, N. Chapter 8 N-Glycans. In Essentials of 
Glycobiology; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009. 
Strasser, R.; Steinkellner, H.; Boren, M.; Altmann, F.; Mach, L.; Glössl, J.; Mucha, J. 
Molecular cloning of cDNA encoding N-acetylglucosaminyltransferase II from 
Arabidopsis thaliana. Glycoconjugate Journal 1999, 16, 787–791. 
Strasser, R.; Schoberer, J.; Jin, C.; Glössl, J.; Mach, L.; Steinkellner, H. Molecular cloning 
and characterization of Arabidopsis thaliana Golgi α-mannosidase II, a key enzyme in 
the formation of complex N-glycans in plants. The Plant Journal 2006, 45, 789–803. 
Strasser, R.; Bondili, J. S.; Schoberer, J.; Svoboda, B.; Liebminger, E.; Glossl, J.; Altmann, 
F.; Steinkellner, H.; Mach, L. Enzymatic properties and subcellular localization of 
Arabidopsis β-N-acetylhexosaminidases. Plant Physiology 2007, 145, 5–16. 
Strasser, R.; Bondili, J. S.; Vavra, U.; Schoberer, J.; Svoboda, B.; Glossl, J.; Leonard, R.; 
Stadlmann, J.; Altmann, F.; Steinkellner, H.; Mach, L. A unique 1,3-galactosyltransferase 
is indispensable for the biosynthesis of N-glycans containing Lewis a structures in 
Arabidopsis thaliana. The Plant Cell Online 2007, 19, 2278–2292. 
Strasser, R. Biological significance of complex N-glycans in plants and their impact on plant 
physiology. Frontiers in Plant Science 2014, 5. 
Suckau, D.; Resemann, A.; Schuerenberg, M.; Hufnagel, P.; Franzen, J.; Holle, A. A novel 
MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Analytical and Bioanalytical 
Chemistry 2003, 376, 952–965. 
Sultana, N.; Florance, H. V.; Johns, A.; Smirnoff, N. Ascorbate deficiency influences the leaf 
cell wall glycoproteome in Arabidopsis thaliana: ascorbate deficiency and cell wall 
glycoproteome. Plant, Cell & Environment 2015, 38, 375–384. 
Szigeti, K.; Smeller, L.; Osváth, S.; Majer, Z.; Fidy, J. The structure of horseradish 
peroxidase C characterized as a molten globule state after Ca
2+
 depletion. Biochimica et 
Biophysica Acta (BBA) - Proteins and Proteomics 2008, 1784, 1965–1974. 
Szumilo, T.; Kaushal, G. P.; Hori, H.; Elbein, A. D. Purification and properties of a 
glycoprotein processing α-mannosidase from mung bean seedlings. Plant physiology 
1986, 81, 383–389. 
Tabb, D. L.; Fernando, C. G.; Chambers, M. C. MyriMatch: highly accurate tandem mass 
spectral peptide identification by multivariate hypergeometric analysis. :Journal of 
Proteome Research 2007, 6, 654–661. 
 136 
 
Takahama, U. Oxidation of vacuolar and apoplastic phenolic substrates by peroxidase: 
physiological significance of the oxidation reactions. Phytochemistry Reviews 2004, 3, 
207–219. 
Tams, J. W.; Welinder, K. G. Glycosylation and thermodynamic versus kinetic stability of 
horseradish peroxidase. FEBS letters 1998, 421, 234–236. 
Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: molecular 
evolutionary genetics analysis using maximum likelihood, evolutionary distance, and 
maximum parsimony methods. Molecular Biology and Evolution 2011, 28, 2731–2739. 
Tezuka, K.; Hayashi, M.; Ishihara, H.; Akazawa, T.; Takahashi, N. Studies on synthetic 
pathway of xylose-containing N-linked oligosaccharides deduced from substrate 
specificities of the processing enzymes in sycamore cells (Acer pseudoplatanus L.). 
European Journal of Biochemistry 1992, 203, 401–413. 
Veitch, N. C. Aromatic donor molecule binding sites of haem peroxidases. Biochemical 
SocietyTransactions 1995, 23, 232–240. 
Veitch, N. C. Structural determinants of plant peroxidase function. Phytochemistry Reviews 
2004, 3, 3–18. 
von Schaewen, A.; Sturm, A.; O’Neill, J.; Chrispeels, M. J. Isolation of a mutant Arabidopsis 
plant that lacks N-acetyl glucosaminyl transferase I and is unable to synthesize Golgi-
modified complex N-linked glycans. Plant physiology 1993, 102, 1109–1118. 
Watanabe, L.; de Moura, P. R.; Bleicher, L.; Nascimento, A. S.; Zamorano, L. S.; Calvete, J. 
J.; Sanz, L.; Pérez, A.; Bursakov, S.; Roig, M. G. Crystal structure and statistical 
coupling analysis of highly glycosylated peroxidase from royal palm tree (Roystonea 
regia). Journal of Structural Biology 2010, 169, 226–242. 
Waterhouse, A. M.; Procter, J. B.; Martin, D. M. A.; Clamp, M.; Barton, G. J. Jalview 
version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics 
2009, 25, 1189–1191. 
Welinder, K. G.; Justesen, A. F.; Kjaersgård, I. V. H.; Jensen, R. B.; Rasmussen, S. K.; 
Jespersen, H. M.; Duroux, L. Structural diversity and transcription of class III 
peroxidases from Arabidopsis thaliana: 73 peroxidases from Arabidopsis. European 
Journal of Biochemistry 2002, 269, 6063–6081. 
Wilson, I. B.; Zeleny, R.; Kolarich, D.; Staudacher, E.; Stroop, C. J.; Kamerling, J. P.; 
Altmann, F. Analysis of Asn-linked glycans from vegetable foodstuffs: widespread 
occurance of Lewis a, core α1,3-linked fucose and xylose substitutions. Glycobiology 
2001, 11, 261–274. 
 137 
 
Wormald, M. R.; Petrescu, A. J.; Pao, Y.-L.; Glithero, A.; Elliott, T.; Dwek, R. A. 
Conformational studies of oligosaccharides and glycopeptides: complementarity of 
NMR, X-ray crystallography, and molecular modeling. Chemical Reviews 2002, 102, 
371–386. 
Wyss, D. F.; Dayie, K. T.; Wagner, G. The counter receptor binding site of human CD2 
exhibits an extended surface patch with multiple conformations fluctuating with 
millisecond to microsecond motions. Protein Science 1997, 6, 534–542. 
Yang, B. Y.; Gray, J. S.; Montgomery, R. The glycans of horseradish peroxidase. 
Carbohydrate Research 1996, 287, 203–212. 
Zamorano, L. S.; Pina, D. G.; Arellano, J. B.; Bursakov, S. A.; Zhadan, A. P.; Calvete, J. J.; 
Sanz, L.; Nielsen, P. R.; Villar, E.; Gavel, O.; et al. Thermodynamic characterization of 
the palm tree Roystonea Regia peroxidase stability. Biochimie 2008, 90, 1737–1749. 
Zamorano, L. S.; Vilarmau, S. B.; Arellano, J. B.; Zhadan, G. G.; Cuadrado, N. H.; 
Bursakov, S. A.; Roig, M. G.; Shnyrov, V. L. Thermal stability of peroxidase from 
Chamaerops excelsa palm tree at pH 3. International Journal of Biological 
Macromolecules 2009, 44, 326–332. 
Zhang, B.; Chambers, M. C.; Tabb, D. L. Proteomic parsimony through bipartite graph 
analysis improves accuracy and transparency. Journal of Proteome Research 2007, 6, 
3549–3557. 
Zhang, C.; Doherty-Kirby, A.; Huystee, R. van; Lajoie, G. Investigation of cationic peanut 
peroxidase glycans by electrospray ionization mass spectrometry. Phytochemistry 2004, 
65, 1575–1588. 
Zhang, H.; Lu, Y.; Ushio, H.; Shiomi, K. Development of sandwich ELISA for detection and 
quantification of invertebrate major allergen tropomyosin by a monoclonal antibody. 
Food Chemistry 2014, 150, 151–157. 
Zhang, M.; Henquet, M.; Chen, Z.; Zhang, H.; Zhang, Y.; Ren, X.; Van Der Krol, S.; 
Gonneau, M.; Bosch, D.; Gong, Z. LEW3, Encoding a Putative α-1,2-
mannosyltransferase (ALG11) in N-linked glycoprotein, plays vital roles in cell-wall 
biosynthesis and the abiotic stress response in Arabidopsis thaliana: protein N-
glycosylation, plant development and abiotic stress. The Plant Journal 2009, 60, 983–
999. 
Zhang, Y.; Giboulot, A.; Zivy, M.; Valot, B.; Jamet, E.; Albenne, C. Combining various 
strategies to increase the coverage of the plant cell wall glycoproteome. Phytochemistry 
2011, 72, 1109–1123. 
 138 
 
Zhao, H.; Nan, T.; Tan, G.; Gao, W.; Cao, Z.; Sun, S.; Li, Z.; Li, Q. X.; Wang, B. 
Development of two highly sensitive immunoassays for detection of copper ions and a 
suite of relevant immunochemicals. Analytica Chimica Acta 2011, 702, 102–108. 
Zipor, G.; Duarte, P.; Carqueijeiro, I.; Shahar, L.; Ovadia, R.; Teper-Bamnolker, P.; Eshel, 
D.; Levin, Y.; Doron-Faigenboim, A.; Sottomayor, M.; Oren-Shamir, M. In planta 
anthocyanin degradation by a vacuolar class III peroxidase in Brunfelsia calycina 
flowers. New Phytologist 2015, 205, 653–665. 
Zipor, G.; Oren-Shamir, M. Do vacuolar peroxidases act as plant caretakers? Plant Science 
2013, 199, 41–47. 
